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Abstract	  
DNA	  damage	  from	  both	  normal	  metabolic	  activities	  and	  environmental	   factors	  
such	  as	  UV	  and	  radiation	  can	  cause	  as	  many	  as	  1	  million	  individual	  lesions	  to	  the	  
DNA	   per	   cell	   per	   day	   (Lodish	   et	   al	   2004).	   Cells	   respond	   to	   this	   continuous	  
damage	   by	   employing	   many,	   highly	   efficient	   DNA	   repair	   mechanisms	   and	  
undergo	   apoptosis	   when	   normal	   DNA	   repair	   fails.	   Of	   the	  many	   types	   of	   DNA	  
damage	   that	   can	   occur,	   double	   strand	   breaks	   (DSBs)	   are	   the	   most	   toxic	  
(Featherstone	  &	   Jackson	   1999).	   A	   single	   unrepaired	  DSB	   is	   enough	   to	   induce	  
cellular	  apoptosis	  and	  several	  mechanisms	  have	  developed	  to	  repair	  DSBs.	  The	  
recognition,	  signalling	  and	  repair	  of	  DSBs	  involve	  large	  multi-­‐subunit	  complexes	  
that	   bind	   to	   both	   the	   DNA	   and	   modified	   histone	   tails,	   which	   require	  
modification	  of	   the	   chromatin	   in	   order	   to	   access	   their	   bind	   sites	   and	   function	  
effectively	   (Allard et al 2004).	   Consequently	   several	   chromatin-­‐remodelling	  
proteins	  have	  been	  implicated	  in	  DSB	  repair	  (van Attikum et al 2004, Chai et 
al 2005).	  	  
LSH	   (Lymphoid	   specific	  helicase)	   is	   a	  putative	   chromatin-­‐remodelling	  enzyme	  
that	   interacts	   with	   DNA	   methyltransferases	   and	   has	   been	   connected	   to	   DNA	  
methylation	  (Myant	  &	  Stancheva,	  2008).	  Knockouts	  of	  LSH	  or	  its	  homologues	  in	  
A.	   thaliana	   and	  M.	  musculus	   show	  a	   reduction	   in	  DNA	  methylation	   of	   60-­‐70%	  
(Jeddeloh	  et	  al	  1999,	  Dennis	  et	  al	  2001).	  However	  in	  addition	  to	  this	  phenotype,	  
knockout	  A.	  thaliana	  also	  have	  an	  increased	  sensitivity	  to	  DNA	  damage	  (Shaked	  
et	  al	  2006).	  A	  homologue	  of	  LSH	  has	  also	  been	  identified	  in	  S.	  cerevisiae,	  which	  
interacts	  with	  known	  repair	  proteins	  (Collins	  et	  al	  2007)	  and	  may	  be	  involved	  in	  
DSB	  repair.	  	  Although	  the	  majority	  of	  Lsh-­‐/-­‐	  mice	  die	  shortly	  after	  birth,	  40%	  of	  
the	  line	  produced	  by	  Sun	  et	  al	  survive	  and	  show	  unexplained	  premature	  aging	  
(Sun	  et	  al	  2004).	  As	  premature	  aging	   is	  a	  hallmark	  of	   increased	  acquisition	  of	  
DNA	  damage	  there	  is	  the	  possibility	  of	  a	  conserved	  role	  for	  LSH	  in	  mammalian	  
DNA	  damage	  repair.	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Here	   I	   show	   that	  LSH	  depleted	  mammalian	   cells	  have	  an	   increased	   sensitivity	  
specifically	   to	   DSB	   inducing	   agents	   and	   show	   increased	   levels	   of	   apoptosis.	  
Further	  analysis	   shows	   that	   cells	   lacking	  LSH	  repair	  DSBs	  slower,	   indicating	  a	  
novel	  role	  for	  LSH	  in	  mammalian	  repair	  of	  DSB.	  I	  performed	  an	  in	  depth	  analysis	  
of	  the	  DSB	  defects	  in	  LSH	  depleted	  cells	  in	  an	  attempt	  to	  elucidate	  the	  function	  
of	   LSH	   in	   DSB	   repair.	   I	   found	   that	   LSH	   depleted	   cells	   can	   correctly	   recognise	  
DSBs	  but	  recruit	  downstream	  signalling	  and	  repair	  factors,	  such	  as	  γH2AX,	  less	  
efficiently.	  I	  show	  that	  reduced	  recruitment	  of	  downstream	  DSB	  repair	  factors	  is	  
not	  accompanied	  by	  extended	  cell	  cycle	  checkpoint	  signalling.	  This	  suggests	  that	  
LSH	  depleted	   cells	   continue	   through	   the	  mitosis	  with	  unrepaired	  DSBs,	  which	  
most	   likely	   leads	   to	   apoptosis	   and	   the	   increased	   sensitivity	   to	   DSB	   inducing	  
agents.	  These	  experiments	  also	  showed	  that	  recruitment	  of	  DSB	  signalling	  and	  
repair	  factors	  is	  not	  impaired	  equally	  at	  all	  breaks,	  and	  I	  present	  a	  model	  system	  
created	   to	   quantitatively	   compare	   individually	   breaks	   between	   WT	   and	   LSH	  
depleted	   cells	   to	   identify	   DSB	   that	   require	   LSH	   for	   efficient	   repair.	   I	   also	  
preformed	  an	  analysis	  of	  Lsh-­/-­	  MEFs	  containing	  WT	  or	  catalytic	  null	  mutant	  LSH	  
rescue	   constructs	   and	   I	   show	   that	  WT	   but	   not	   catalytic	   null	   LSH	   can	   restore	  
efficient	  DSB	  repair.	  These	  studies	   identify	  a	  novel	  role	   for	  LSH	  in	  mammalian	  








	   8	  
Introduction	  -­	  Chapter	  One	  
1.1	  DNA	  Damage	  Repair	  
1.1.2	  DNA	  damage	  repair	  mechanisms	  
As	  many	  as	  1	  million	  individual	  DNA	  lesions	  can	  occur	  per	  cell	  per	  day	  (Lodish	  
et	   al	   2004).	   These	   arise	   from	   normal	   metabolic	   activities	   and	   environmental	  
factors	  such	  as	  UV	  or	  radiation.	  This	  large	  array	  of	  damaging	  agents	  can	  cause	  a	  
wide	   variety	   of	   DNA	   lesions	   ranging	   from	   mismatches	   caused	   by	   replication	  
errors	   to	  double	  strand	  breaks	   from	  exposure	   to	   ionising	  radiation.	  Cells	  have	  
developed	  many	  different	  repair	  mechanisms	  to	  cope	  with	  these	  different	  types	  
of	   damage.	   These	   mechanisms	   are	   highly	   efficient	   and	   usually	   incorporate	  
backup	   repair	   pathways	   because	   unrepaired	   DNA	   damage	   can	   induce	  
potentially	  harmful	  mutations	  affecting	  transcript	  integrity	  and	  genome	  fidelity.	  
	  
1.1.2.1	  Base	  excision	  repair	  (BER)	  	  
BER	   repairs	   damage	   to	   bases	   resulting	   from	   oxidation,	   deamination,	   the	  
addition	  of	  non-­‐bulky	   side	  groups	  or	   loss	  of	   the	  base	   (Memisoglu	  et	  al	  2000).	  
There	   are	   2	   BER	   pathways	   (Figure	   1.1)	   "short-­‐patch",	   which	   represents	  
approximately	   80-­‐90%	   of	   all	   BER	   and	   "long-­‐patch",	   which	   corrects	   the	  
remaining	   damage	   resistant	   to	   “short-­‐patch”	   repair.	   Both	   are	   initiated	   by	  
cleavage	   of	   the	   N-­‐glycosidic	   bond	   between	   the	   damaged	   base	   and	   the	   sugar	  
phosphate	   backbone.	   In	   humans,	   this	   cleavage	   is	   carried	   out	   by	   one	   of	   eight	  
DNA	  glycosylase,	  each	  specific	  to	  a	  different	  type	  of	  damage	  (Schärer	  &	  Jiricny	  
2001).	  Cleavage	  creates	  an	  abasic	  site	  in	  the	  DNA.	  Subsequent	  processing	  of	  the	  
abasic	   site	   by	   Endonuclease	   1	   (APE1)	   nicks	   the	   DNA	   by	   cleaving	   the	  
phosphodiester	  backbone	   immediately	  5'	  of	   the	   site.	  This	   leaves	  a	  3'	  hydroxyl	  
group	  and	  5'	  abasic	  deoxyribose	  phosphate	  (dRP).	  The	  dRP	  is	  removed	  by	  DNA	  
polymerase	  beta	  (DNA	  Pol	  β).	  DNA	  Pol	  β	  also	  adds	  a	  nucleotide	  to	  the	  3'	  end	  of	  
the	  nick	  (Matsumoto	  &	  Kim	  1995).	  The	  single	  strand	  nick	  in	  the	  DNA	  can	  then	  
be	  repaired	  by	  DNA	  ligase.	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Figure	   1.1:	  A	  model	   of	   BER	   showing	   short	   patch	   (left)	   and	   long	  patch	   (right)	   pathways.	  
“Short-­‐patch”	   refers	   to	   the	   single	   new	   nucleotide	   replacement	   of	   the	   damaged	   base,	  
where	  as	  “long	  patch”	  replaces	  the	  lesion	  with	  between	  2-­‐10	  nucleotides	  (modified	  from	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The	  second	  BER	  pathway	  requires	  many	  of	  the	  same	  factors	  involved	  in	  “short-­‐
patch”	   repair.	   "Long-­‐patch"	   is	   used	   when	   modification	   of	   a	   base	   makes	   the	  
abasic	  site	  resistant	  to	  the	  abasic	   lyase	  activity	  of	  DNA	  Pol	  β	   (Matsumoto	  et	  al	  
1994).	   “Long-­‐patch”	   repair	   results	   in	   the	   replacement	   of	   between	   2-­‐10	  
nucleotides	  by	  PCNA-­‐dependent	  DNA	  polymerase	  activity,	  which	  displaces	   the	  
dRP.	   The	   resulting	   oligonucleotide	   overhang	   is	   excised	   by	   Flap	   endonuclease	  
FEN-­‐1	  prior	  to	  repair	  of	  the	  nick	  by	  a	  DNA	  ligase.	  
	  
1.1.2.2	  Nucleotide	  excision	  repair	  (NER)	  
NER	   repairs	   a	   variety	   of	   DNA	   lesions	   including	   intrastrand	   crosslinks,	  
pyrimidine	  dimers	  caused	  by	  UV	  exposure	  and	  the	  addition	  of	  side	  groups	  too	  
large	   to	   be	   removed	   by	   BER.	   NER	   recognize	   DNA	   damage	   that	   causes	   helical	  
distortion	  of	  the	  DNA	  duplex	  (Hess	  et	  al	  1997).	  NER	  is	  a	  complex	  process	  that	  
requires	   correct	   recognition	  of	   the	  damage	   followed	  by	  unzipping	  of	   the	  DNA	  
double	  helix	   around	   the	   lesion	   (Figure	  1.2).	   The	  damaged	  DNA	   strand	   is	   then	  
incised	  and	  replaced	  by	  gap	  repair	  synthesis	  (Batty	  &	  Wood	  2000).	  Finally	  the	  
ends	   are	   joined	   by	   strand	   ligation.	   More	   than	   30	   proteins	   have	   so	   far	   been	  
identified	  to	  be	  involved	  in	  NER.	  There	  are	  two	  NER	  pathways,	  global	  genomic	  
NER	   (GG-­‐NER)	   and	   transcription	   coupled	   NER	   (TC-­‐NER).	   GG-­‐NER	   repairs	  
damages	   in	   transcriptionally	   silent	   areas	   of	   the	   genome	   where	   as	   TC-­‐NER	  
repairs	   damage	   to	   actively	   transcribed	  DNA.	   Both	   pathways	   rely	   on	   the	   same	  
repair	  mechanism,	  but	  vary	  in	  their	  method	  of	  DNA	  damage	  recognition.	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Figure	  1.2:	  A	  model	  of	  NER	  showing	  the	  steps	  of	  GG	  and	  TC	  DNA	  damage	  recognition	  (1),	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GG-­‐NER	  relies	  on	  the	  XPC-­‐HR23B	  complex	  to	  recognize	  the	  damage	  and	  unwind	  
the	  DNA.	  TC-­‐NER	  does	  not	  require	  XPC,	  but	  is	  thought	  to	  rely	  on	  stalling	  of	  the	  
transcription	  machinery	   at	   sites	   of	  DNA	  damage.	  The	   stalled	  RNA	  polymerase	  
complex	  is	  then	  displaced	  by	  CSA	  and	  CSB	  proteins	  together	  with	  other	  TC-­‐NER	  
specific	  factors.	  The	  following	  repair	  steps	  are	  carried	  out	  the	  same	  in	  GG-­‐	  and	  
TC-­‐NER.	  XPA	  and	  replication	  protein	  A	  (RPA)	  bind	  the	  lesion	  and	  aid	  in	  damage	  
recognition.	  The	  helicases	  XPB	  and	  XPD	  unwind	   the	  DNA	  double	  helix	  around	  
the	  lesion	  allowing	  access	  to	  endonucleases	  XPG	  and	  ERCC1/XPF.	  These	  cleave	  
the	   damaged	   strand	   at	   positions	   3'	   and	   5'	   of	   the	   damage,	   creating	   an	  
oligonucleotide	  approximately	  30	  bases	   in	   length	   that	  contains	   the	   lesion.	  The	  
oligonucleotide	  is	  displaced	  and	  the	  space	  filled	  by	  DNA	  Pol	  δ	  & ε	  with	  the	  aid	  of	  
replication	  accessory	  factors.	  The	  ends	  of	  the	  newly	  synthesized	  DNA	  are	  then	  
joined	  to	  the	  original	  strand	  by	  DNA	  ligase.	  
	  
1.1.2.3	  The	  DNA	  mismatch	  repair	  (MMR)	  
MMR	   is	   essential	   for	   correcting	   replication	   errors	   caused	  by	  DNA	  polymerase	  
during	   replication	   such	   as	   mismatches	   and	   insertion/deletion	   loops	   (IDLs).	  
MMR	   also	   repairs	   mismatches	   generated	   by	   spontaneous	   deamination	   of	  	  	  	  	  	  	  	  	  	  	  
5-­‐methylcytosine	   and	   heteroduplexes	   formed	   by	   recombination.	   Defects	   in	  
MMR	   result	   in	   a	   mutator	   phenotype	   that	   increases	   the	   frequency	   of	  
spontaneous	  mutations	  and	  causes	  microsatellite	   instability	   (Peltomäki	  2001).	  
This	  can	  result	  in	  a	  variety	  of	  sporadic	  tumours.	  MMR	  is	  similar	  to	  “long-­‐patch”	  
BER	  and	  NER,	  which	  also	   rely	  on	  excision	   repair	   to	   correct	  DNA	   lesions.	  First	  
the	  mismatch	  or	  IDL	  is	  recognised,	  then	  a	  section	  of	  DNA	  containing	  the	  lesion	  is	  
excised	  and	   the	  gap	   filled	  by	  DNA	   repair	   synthesis	   followed	  by	   ligation	  of	   the	  
DNA	  nicks	  (Figure	  1.3)	  (Marti	  et	  al	  2002).	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Figure	  1.3:	  A	  model	  of	  mammalian	  MMR,	  showing	  mismatch	  recognition	  by	  MutS	  alpha	  
(MSH6-­‐MSH2)	   and	   strand	   discrimination	   followed	   by	   excision	   of	   the	   mismatched	   base	  
and	  strand	  resynthesis	  (modified	  from	  Martin	  &	  Scharff	  2002).	  
In	   mammals,	   MMR	   is	   initiated	   by	   recognition	   of	   the	   damage	   by	   heterodimer	  
MutS	  alpha	  or	  beta.	  Mismatch	  and	  single-­‐base	  IDL	  recognition	  is	  carried	  out	  by	  
MutS	  alpha,	  where	  as	  MutS	  beta	   recognizes	   larger	   IDLs	   (Genschel	  et	  al	  1998).	  
MutS	  alpha	  or	  beta	  then	  bind	  ATP	  and	  undergo	  a	  conformational	  change.	  They	  
can	  then	  translocate	  along	  DNA	  until	  additional	  MMR	  proteins	  are	  encountered	  
(Gradia	  et	  al	  1999,	  Blackwell	  et	  al	  1998).	  MMR	  proteins	  make	  contact	  with	  the	  
replication	  machinery	  through	  interactions	  with	  the	  replication	  accessory	  factor	  
PCNA	  (Umar	  et	  al	  1996).	  This	  interaction	  allows	  strand	  discrimination	  to	  occur	  
and	  may	  provide	  the	  link	  for	  mismatch	  recognition	  of	  newly	  synthesized	  DNA.	  A	  
nick	  forms	  in	  the	  DNA	  of	  the	  newly	  synthesized	  strand.	  In	  bacteria	  this	  is	  carried	  
out	   by	   endonuclease	   MutH,	   but	   in	   eukaryotes	   its	   unclear	   if	   a	   nick	   is	   already	  
present	  at	  the	  replication	  fork	  or	  produced	  by	  an	  unknown	  homologue	  of	  MutH.	  
Excision	   of	   the	   damage	   is	   carried	   out	   by	   a	   number	   of	   proteins	   including	  
Exonuclease	   I	   (Figure	   1.3).	   The	   resulting	   gap	   is	   filled	   by	   DNA	   Pol	   δ	   &	   ε	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1.1.2.4	  Repair	  of	  DNA	  double-­strand	  breaks	  (DSBs)	  
DSBs	  are	  the	  most	  serious	  form	  of	  DNA	  damage	  because	  they	  pose	  problems	  to	  
replication	   and	   chromosome	   segregation.	   Failure	   to	   repair	   these	   defects	   can	  
lead	  to	  chromosomal	  instability	  and	  loss	  of	  chromosome	  arms,	  which	  can	  result	  
in	  miss	  regulated	  gene	  expression	  and	  carcinogenesis	  (Hoeijmakers	  et	  al	  2001).	  
DSBs	  can	  be	  caused	  by	  a	  variety	  of	  exogenous	  agents	  such	  as	  ionizing	  radiation	  
and	   genotoxic	   chemicals	   as	   well	   as	   from	   endogenous	   sources	   like	   reactive	  
oxygen	  species,	  replication	  across	  single-­‐strand	  DNA	  breaks	  and	  chromosomal	  
stress	  (Featherstone	  &	  Jackson	  1999,	  Kuzminov	  2001).	  DSBs	  differ	   from	  other	  
DNA	   lesions	   as	   they	   affect	   both	   strands	   of	   the	   DNA.	   Therefore	   the	  
complementary	  strand	  is	  unavailable	  as	  a	  template	  for	  DNA	  repair	  synthesis	  as	  
seen	  in	  BER,	  NER,	  and	  MMR.	  
To	   repair	   DSBs	   cells	   have	   developed	   two	   DSB	   repair	   pathways,	   homologous	  
recombination	   (HR)	   and	   non-­‐homologous	   end	   joining	   (NHEJ)	   (Jackson	   et	   al	  
2002).	   HR	   corrects	   DSB	   defects	   in	   an	   error-­‐free	   manner	   by	   using	   the	  
homologous	  chromosome	  as	  a	  template.	  Repair	  by	  HR	  takes	  place	  in	  late	  S/G2	  
phases	  when	  a	  sister	  chromatid	   is	  available	  for	  use	  as	  a	  repair	  template.	  NHEJ	  
takes	   place	   throughout	   the	   cell	   cycle	   and	   does	   not	   require	   a	   homologous	  
template	   for	   repair,	   but	   simply	   connects	   two	   broken	   ends.	   NHEJ	   is	   often	  
referred	   to	   as	   error-­‐prone	   as	   unlike	   HR	   there	   is	   no	   checking	   mechanism	   to	  
ensure	  that	  the	  correct	  DNA	  ends	  have	  been	  connected.	  
The	  decision	  of	  which	  pathway	  to	  use	  for	  DSB	  repair	  is	  influenced	  by	  cell	  cycle	  
stage	  (Takata	  et	  al	  1998).	  Repair	  by	  HR	  requires	  displacement	  of	  the	  Ku70/80	  
heterodimer	  on	  the	  broken	  DNA	  ends	  and	  resection	  of	  the	  broken	  end	  to	  leave	  a	  
3'	  single-­‐stranded	  (ssDNA)	  overhang.	  Resection	  has	  been	  found	  to	  be	  dependent	  
on	  recruitment	  of	  CtIP,	  which	  in	  turn	  has	  been	  shown	  to	  require	  deacetylation	  
by	  Sirtuin	  6	  (SIRT6)	  and	  phosphorylation	  by	  cyclin	  dependent	  kinases	  (Kaidi	  et	  
al	  2010).	  Cyclin	  dependent	  kinases	  and	  SIRT6	  are	  both	  expressed	  in	  a	  cell	  cycle	  
dependent	  manner.	  They	  regulate	  at	  what	  point	  of	   the	  cell	  cycle	  HR	  occurs	  by	  
control	  of	  resection.	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Figure	  1.4:	  Schematic	  representation	  of	  the	  main	  mediator	  complex	  proteins	  involved	  in	  
binding	   the	   broken	   DNA	   end	   to	   facilitate	   repair	   and	   cell	   cycle	   check	   point	   signalling.	  	  
Phosphorylation	  marks	  are	  show	  with	  a	  P	  and	  U’s	  indicate	  polyubiquitination	  of	  histone	  
tails	  by	  Ubc13.	  	  
Initial	   detection	   of	   DSBs	   and	   checkpoint	   signalling	   is	   carried	   out	   in	   a	   similar	  
manner	  in	  both	  HR	  and	  NHEJ	  pathways.	  Initial	  DSB	  detection	  is	  carried	  out	  by	  
the	  MRN	  complex,	  comprised	  of	  MRE11,	  RAD50	  and	  NBS1,	  which	  binds	   to	   the	  
broken	   end	   and	   recruits	   activated	  ATM	  kinase	   (Figure	  1.4).	   	  ATM	   is	   activated	  
through	  auto-­‐phosphorylation	  of	  inactive	  ATM	  dimers	  at	  serine	  residue	  1981	  by	  
trans	   acting	   ATM	   kinase	   domains	   (Bakkenist	   &	   Kastan	   2003),	   although	   how	  
DNA	   damage	   stimulates	   auto-­‐phosphorylation	   of	   inactive	   ATM	   dimers	   is	   not	  
understood.	   Ku70/Ku80	   heterodimers	   also	   bind	   the	   broken	   DNA	   ends	   to	  
protect	   them	   from	   endonuclease	   degradation.	   ATM	   in	   turn	   phosphorylates	  
histone	  variant	  H2AX,	  which	  is	  found	  throughout	  the	  genome	  at	  approximately	  
every	   fifth	   nucleosome.	   Phosphorylated	  H2AX	   (γH2AX)	   is	   recognized	   as	   a	   key	  
marker	   of	   DSB	   repair	   and	   is	   crucial	   for	   mediator	   complex	   assembly	   and	   the	  
recruitment	   of	   many	   downstream	   repair	   factors	   and	   checkpoint	   signalling	  
proteins	  (Figure	  1.4).	  For	  example	  MDC1	  binds	  γH2AX,	  this	  in	  turn	  recruits	  the	  
checkpoint	  signalling	  kinases	  CHK1	  and	  2.	  CHK	  recruitment	  to	  DSBs	  is	  essential	  
for	  their	  activation	  and	  correct	  cell	  cycle	  arrest	  (Lou	  et	  al	  2003,	  Xiao	  et	  al	  2003).	  	  
Following	   initial	  DSB	  recognition	  additional	  protein	  kinases	  are	   recruited	   that	  
facilitate	   the	  DSB	   response,	   such	   as	  DNA-­‐PK	   in	   the	   case	   of	  NHEJ	   and	  ATR	   for	  
repair	   by	   HR	   (Durocher	   2001).	   The	   phosphorylation	   of	   H2AX	   and	   associated	  
protein	  complexes	  can	  spread	  for	  several	  megabases	  on	  either	  side	  of	  the	  break.	  
The	  exact	  reason	  for	  this	  is	  unclear,	  although	  it	  has	  been	  postulated	  that	  γH2AX	  
spreading	  is	  required	  to	  facilitate	  access	  to	  the	  broken	  DNA	  ends	  and	  to	  stabilise	  
the	  repair	  machinery	  (Savic	  et	  al	  2009)	  
RAD50 
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Figure	   1.5:	   An	   overview	   of	   the	  main	   steps	   and	   factor	   required	   for	   DNA	   DSB	   repair	   by	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Repair	  by	  NHEJ	  relies	  on	  the	  Ku70/Ku80	  heterodimer	  bound	  to	  the	  broken	  DNA	  
end	   to	   recruit	  NHEJ	   factors	   such	  as	  DNA-­‐dependent	  protein	  kinase	   (DNA-­‐PK),	  
XRCC4,	  and	  DNA	  Ligase	   IV	  (Jackson	  et	  al	  2009,	  Featherstone	  &	  Jackson	  1999).	  
Upon	   binding	   to	   Ku70/Ku80,	   DNA-­‐PK	   can	   interact	   with	   other	   Ku70/Ku80	  
bound	  DNA-­‐PKs	  to	  bridge	  the	  gap	  between	  broken	  DNA	  ends	  (Figure	  1.5,	  NHEJ	  
2.).	  This	  triggers	  phosphorylation	  of	  DNA-­‐PKs,	  which	  in	  turn	  can	  phosphorylate	  
a	   number	   of	   substrates	   including	   cell	   cycle	   checkpoint	   proteins	   such	   as	   p53.	  
Most	  DSBs	  generated	  by	  genotoxic	  agents	  have	  damaged	  ends	  that	  are	  unable	  to	  
be	   directly	   ligated,	   they	   therefore	   undergo	   processing	   by	   nucleases	   such	   as	  
Artemis	  to	  create	  compatible	  ends	  (Moshous	  et	  al	  2001,	  Petrini	  2000,	  Wu	  et	  al	  
1999).	   To	   complete	   the	   repair,	   DNA	   Ligase	   IV	   is	   recruited	   together	   with	   its	  
cofactor	  XRCC4,	  which	  ligates	  the	  processed	  ends	  and	  repairs	  the	  lesion	  (Figure	  
1.5,	  NHEJ	  4.).	  
In	   contrast	   to	   NHEJ,	   repair	   by	   HR	   requires	   displacement	   of	   the	   Ku70/Ku80	  
heterodimer	  and	  resection	  of	  the	  broken	  DNA	  to	  leave	  a	  3'	  ssDNA	  overhang.	  The	  
3'	  ssDNA	  overhang	  is	  bound	  by	  RAD51	  to	  form	  a	  nucleoprotein	  filament	  (Figure	  
1.5,	  HR	  2.).	  Several	  additional	  proteins	   including	  RPA,	  RAD52	  and	  BRCA1	  &	  2,	  
serve	  as	  accessory	   factors	   in	   filament	  assembly	  and	  aid	   in	  searching	  the	  sister	  
chromatid	   for	   a	   homologous	   repair	   template	   (Jackson	   et	   al	   2009).	   The	  
nucleoprotein	   filament	   invades	   the	   undamaged	  DNA	   duplex	   forming	   a	   D-­‐loop	  
(Figure	   1.5,	   HR	   3.).	   DNA	   polymerase	   is	   then	   able	   to	   extend	   the	   3'	   end	   of	   the	  
damaged	   strand	   using	   the	   complementary	   strand	   on	   the	   homologous	   sister	  
chromatid	  as	  a	  template	  (Figure	  1.5,	  HR	  4.).	  Following	  synthesis	  of	  the	  missing	  
sequence,	  DNA	  Ligase	  I	  closes	  the	  nicks	  the	  DNA,	  resulting	  in	  the	  formation	  of	  a	  
Holliday	   junction.	   Dissolution	   	   	   of	   the	   Holliday	   junction	   can	   be	   achieved	   by	  
topoisomerase	  3	   and	  orthologues	  of	   the	  S.	   cerevisiae	   helicase	   SGS1	   to	  unwind	  
the	  DNA	  and	  cut	  the	  intertwined	  strands.	  Alternatively	  the	  resolvase	  Gen1	  can	  
resolve	   the	   Holliday	   junction	   by	   cleaving	   the	   DNA	   at	   2	   sites,	   resulting	   in	   the	  
formation	   of	   either	   a	   crossover	   or	   non-­‐crossover	   product	   depending	   on	   the	  
orientation	   of	   the	   2	   cleavage	   sites	   (Figure	   1.5,	  HR	  5.).	   Finally	   the	   nicks	   in	   the	  
DNA	  are	  ligated	  to	  complete	  repair	  of	  the	  DSB.	  
	  
	   18	  
1.1.3	  Checkpoint	  signalling	  
If	   DNA	   lesions	   are	   allowed	   to	   persist	   through	  mitosis,	   they	   can	   contribute	   to	  
genome	  instability	  and	  carcinogenesis.	   	  Therefore	  in	  addition	  to	  repair,	  correct	  
checkpoint	   signalling	   is	   also	   important	   in	   the	   DNA	   damage	   response	   (Figure	  
1.6).	  By	  stalling	  the	  cell	  cycle,	  time	  is	  allowed	  for	  the	  repair	  machinery	  to	  correct	  
any	   DNA	   lesions,	   which	   prevents	   DNA	   damage	   from	   becoming	   worse	   by	  
progression	   through	   the	   cell	   cycle.	   For	   example,	   if	   mitosis	   occurs	   while	  
unrepaired	   DSB	   are	   present,	   it	   can	   lead	   to	   loss	   of	   chromosomal	   arms	   or,	   if	  
transcription	   is	   carried	  out	  across	  a	   single	  stranded	  DNA	  nick,	  a	  more	  serious	  
double	   strand	   break	   can	   form.	   Another	   important	   function	   of	   checkpoint	  
signalling	   is	   to	   facilitate	  apoptosis	  when	  DNA	   lesions	  cannot	  be	  repaired,	   thus	  
preventing	  the	  potential	  onset	  of	  carcinogenesis.	  
	  
Figure	  1.6:	  An	  overview	  of	  cell	  cycle	  checkpoints	  leading	  to	  G1,	  S,	  or	  G2	  cell	  cycle	  rest	  in	  
response	  to	  ATM	  /	  ATR	  activation	  (modified	  from	  Khanna	  &	  Tibbetts	  2006).	  
	  
1.1.3.1	  The	  role	  of	  CHK	  1	  and	  2	  in	  checkpoint	  signalling	  
Upon	  induction	  of	  DNA	  damage,	  kinases	  CHK1	  and	  2	  are	  activated	  by	  ATM	  and	  
ATR,	  which	  in	  turn	  phosphorylate	  phosphatase	  Cdc25	  (Peng	  et	  al	  1997,	  Xiao	  et	  
al	   2003).	   	  Activation	  of	  CHK	  kinases	   is	  aided	  by	  sequestering	  CHK	  proteins	   to	  
sites	  of	  DNA	  damage	  such	  as	  transient	  recruitment	  of	  CHK2	  to	  DSB	  by	  the	  DSB	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creates	   a	   binding	   site	   for	   14-­‐3-­‐3	   proteins,	   which	   sequesters	   Cdc25	   in	   the	  
cytoplasm	  leading	  to	   its	  targeted	  degradation	  by	  the	  proteasome.	  The	  result	   is	  
that	  Cdc25	  is	  unable	  to	  dephosphorylate	  cyclin	  dependent	  kinases,	  which	  causes	  
G2/S	   phase	   arrest	   and	   blocks	   entry	   into	   mitosis.	   This	   delay	   gives	   the	   repair	  
machinery	  time	  to	  correct	  the	  DNA	  lesion.	  However	  failure	  to	  repair	  the	  damage	  
results	  in	  persistent	  CHK	  signalling,	  which	  can	  active	  p53	  leading	  to	  apoptosis.	  
	  
1.1.3.2	  The	  role	  of	  p53	  in	  checkpoint	  signalling	  
Transformation	   related	   protein	   53	   (p53)	   is	   a	   tumour	   suppressor	   gene	   that	  
responds	  to	  cellular	  stresses	  to	  regulate	  the	  expression	  of	  genes	  involved	  in	  cell	  
cycle	  arrest,	  apoptosis,	  senescence	  and	  DNA	  repair.	  In	  normal	  dividing	  cells	  p53	  
levels	   are	   kept	   low	  by	  MDM2	   targeted	  degradation,	  which	   exports	   p53	   to	   the	  
cytoplasm	  for	  degradation	  by	   the	  proteasome	  (Alarcon-­‐Vargas	  &	  Ronai	  2002).	  
Upon	  induction	  of	  DNA	  damage,	  kinases	  phosphorylate	  a	  number	  of	  sites	  within	  
p53	  leading	  to	  its	  stabilisation	  and	  activation.	  For	  example,	  phosphorylation	  of	  
residue	  S20	  by	  CHK2	  blocks	  the	  interaction	  between	  p53	  and	  MDM2,	  preventing	  
nuclear	   export	   of	   p53	   and	   subsequent	   degradation	   by	   the	   proteasome,	  
increasing	  p53	   levels	   (Matsuoka	  et	  al	  2000).	  ATM	  also	  phosphorylates	  MDM2,	  
which	  blocks	   its	   ability	   to	   export	  p53	   from	   the	  nucleus	   further	   stabilizing	   the	  
increase	  in	  p53	  levels	  in	  response	  to	  DNA	  damage	  (Cheng	  et	  al	  2011).	  	  
ATM	   and	   ATR	   also	   phosphorylate	   p53	   on	   residue	   S15	   of	   p53,	   allowing	   it	   to	  
function	   as	   a	   transcriptional	   activator	   to	  up-­‐regulate	   a	   variety	   of	   target	   genes	  
involved	   in	   the	  DNA	  damage	   response	  and	  cell	   cycle	  arrest.	  These	   include	   the	  
cyclin-­‐dependent	  kinase	  inhibitor	  p21,	  which	  accumulates	  and	  suppresses	  Cdk2	  
kinase	  activity	   resulting	   in	  G1	  arrest	   (Bartek	  &	  Lukas	  2001).	  Failure	   to	   repair	  
the	  damage	  and	  alleviate	  checkpoint	  signalling	  results	   in	  a	  persistence	  of	  high	  
levels	  of	  active	  p53.	  This	  in	  turn	  leads	  to	  p53	  mediated	  apoptosis.	  Apoptosis	  acts	  
as	  a	  fail-­‐safe	  mechanism	  to	  prevent	  the	  persistence	  of	  DNA	  lesions	  through	  cell	  
division	  leading	  to	  potentially	  harmful	  mutations	  and	  carcinogenesis.	  p53	  is	  the	  
most	   commonly	   mutated	   tumour	   suppressor	   genes	   in	   human	   cancer,	   	   which	  
demonstrates	  the	  importance	  of	  p53	  mediated	  cell	  cycle	  arrest	  and	  apoptosis	  in	  
preventing	  the	  propagation	  of	  potentially	  deleterious	  mutations.	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1.2	  Chromatin	  remodelling	  
DNA	  coiling	  around	  histones	  to	  produce	  a	  compact	  chromatin	  structure	  is	  vital	  
for	   organising	   DNA	   molecules	   to	   fit	   inside	   the	   nucleus.	   However,	   this	   coiled	  
structure	   greatly	   limits	   how	   accessible	   the	  DNA	   is	   to	   protein	   complexes.	   This	  
impacts	  on	  how	  processes	  such	  as	  recombination,	  transcription,	  replication	  and	  
DNA	  repair	  are	  regulated	  to	  allow	  access	  to	  the	  DNA.	  There	  are	  two	  mechanisms	  
for	   relaxing	   the	   chromatin	   to	   overcoming	   the	   barrier	   posed	   by	   a	   compact	  
chromatin	  structure.	  Firstly,	  modification	  of	  histone	  tails	  can	  alter	  the	  charged	  
DNA:histone	   contacts	   or	   secondly	   direct	   manipulation	   of	   DNA:histone	  
interactions	  by	  ATP	  hydrolysis	  driven	  chromatin	  remodelling	  proteins.	  
	  
Figure	  1.7:	  Structure	  of	  the	  histone	  core	  particle.	  Side	  (A.),	  top	  (B.),	  and	  bottom	  (C.)	  views	  
of	   the	   1.9	   Å	   resolution	   crystal	   structure	   of	   the	   nucleosome	   core	   particle	   bound	   to	   147	  
base	  pairs	  of	  DNA	  (Davey	  et	  al	  2002).	  
	  
1.2.1	  Histone	  modifications	  
Post-­‐translational	  modification	   of	   histone	  N-­‐terminal	   tails	   can	   affect	   the	  DNA:	  
histone	  contacts	  resulting	  in	  stronger	  or	  weaker	  interactions.	  This,	  in	  turn	  leads	  
to	  a	  more	  or	   less	  condensed	  chromatin	  structure.	  The	  most	  well	  characterised	  
histone	   N-­‐terminal	   tail	   modifications	   are	   methylation,	   acetylation	   and	  
phosphorylation	   (Kouzarides	   2007),	   although	   several	   other	   types	   of	   post-­‐
translational	  modification	   also	   occur,	   such	   as	   ubiquitination	   and	   sumoylation.	  
Lysine	  acetylation	  has	  an	  especially	  potent	  effect	  as	  it	  neutralises	  a	  basic	  charge,	  
which	   is	   required	   to	   maintain	   the	   structure	   of	   the	   30	   nm	   chromatin	   fibre	  
(Dorigo	  et	  al	  2004,	  Shogren-­‐Kraak	  et	  al	  2006).	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Histone	  modifications	   not	   only	   alter	   chromatin	   compaction	   but	   also	   serve	   as	  
recognition	   sequences	   to	   recruit	   other	   proteins	   to	   sites	   of	   compact	   or	   open	  
chromatin	   (Dillon	   2004,	   Gelato	   &	   Fischle	   2008).	   Specific,	   conserved	   protein	  
motifs	   have	   evolved	   to	   recognise	   and	   bind	   specific	   histone	   modifications.	  
Histone	   acetylation	   serves	   as	   the	   recruitment	   factor	   for	   bromodomain	  
containing	   proteins.	   Likewise	   histone	   methylation	   is	   recognized	   by	  
chromodomains	   and	   phosphorylation	   by	   14-­‐3-­‐3	   proteins	   (Kouzarides	   2007).	  
For	  example,	  HP1	  localises	  to	  heterochromatin	  by	  binding	  di	  and	  tri	  methylated	  
H3K9	  through	  its	  chromodomain	  (Bannister	  et	  al	  2001).	  HP1	  can	  then	  influence	  
chromatin	  structure	  by	  recruiting	  other	  chromatin	  modifying	  enzymes	  such	  as	  
Dnmt1	   &	   3b	   and	   the	   H3K9	   methyltransferase	   Suv39h1,	   which	   aid	  
transcriptional	   silencing	   (Nakayama	   et	   al	   2001).	   This	   example	   demonstrates	  
how	   histone	   modifications	   can	   indirectly	   bring	   about	   changes	   in	   chromatin	  
state	  in	  addition	  to	  altering	  charge	  state	  to	  directly	  effect	  DNA:	  histone	  contacts.	  
	  
1.2.2	  ATP	  dependent	  chromatin	  remodelling	  
ATP	  hydrolysing	  chromatin	  remodelers	  are	  a	  family	  of	  enzymes	  that	  use	  energy	  
from	   ATP	   hydrolysis	   to	   disrupt	   DNA:	   histone	   contacts	   and	   alter	   chromatin	  
structure.	   The	   function	   of	   ATP	   dependent	   chromatin	   remodelling	   enzymes	  
varies	   greatly,	   however	   they	   all	   use	   ATP	   hydrolysis	   to	   alter	   the	  DNA:	   histone	  
contacts	  within	  a	  nucleosome.	  Several	  outcomes	  are	  linked	  with	  ATP-­‐dependent	  
chromatin	   remodelling	   including	   nucleosome	   eviction,	   exchange	   and	   sliding	  
(Dechassa	  et	  al	  2010,	  Mizuguchi	  et	  al	  2004,	  Whitehouse	  et	  al	  1999)	  (Figure	  1.8).	  	  
	  
Figure	   1.8:	   Schematic	   representation	   of	   the	   effects	   of	   nucleosome	   sliding	   (A.),	   eviction	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It	  is	  not	  clear	  if	  these	  represent	  distinct	  reactions	  or	  are	  alternative	  outcomes	  of	  
a	  common	  mechanism	  of	  contact	  disruption.	  Several	  models	  of	  ATP-­‐dependent	  
chromatin	   remodelling	   have	   been	   proposed.	   In	   the	   Bulge	   Diffusion	   model	   a	  
small	  number	  of	  DNA:	  histone	  contacts	  are	  disrupted	  followed	  by	  rebinding	  of	  a	  
more	   distal	   DNA	   sequence.	   A	   loop	   of	   DNA	   forms	   which	   moves	   around	   the	  
nucleosome,	  repositioning	  it	  upon	  the	  DNA	  (Strohner	  et	  al	  2005).	  Alternatively	  
the	  Twist	  Defect	  Diffusion	  model	  suggests	  that	  by	  introducing	  twist	  defects	  into	  
the	  DNA,	   histone	   contacts	   are	   disrupted	   (Havas	   et	   al	   2000).	   The	   twist	  moves	  
along	  the	  DNA	  and	  over	  the	  nucleosome	  disrupting	  contacts	  and	  replacing	  them	  
with	   neighbouring	   ones,	   which	   repositions	   the	   nucleosome.	   Both	   of	   these	  
mechanisms	   rely	   on	   ATP-­‐dependent	   disruption	   of	   DNA:	   histone	   contacts	   by	  
chromatin	   remodelling	  enzymes,	   and	   result	   in	   changes	   in	  DNA	  accessibility.	   It	  
has	   been	   show	   by	   in	   vitro	   nucleosome	   positioning	   assays	   that	   different	  
chromatin	   remodelling	   complexes	   can	   either	   promote	   equal	   spacing	   of	  
nucleosomes	   on	   the	   DNA	   (Langst	   et	   al	   1999)	   or	   randomise	   equally	   spaced	  
nucleosomes	   (Whitehouse	   et	   al	   1999).	   These	   different	   states	   may	   represent	  
different	   roles	   for	   ATP-­‐dependent	   chromatin	   remodelling	   enzymes,	   creating	  
either	  compact	  or	  relaxed	  chromatin.	  
	  
1.2.3	  Classes	  of	  ATP	  hydrolysing	  chromatin	  remodelers	  
ATP	  hydrolysing	  chromatin	  remodelers	  were	  identified	  in	  yeast	  genetic	  screens	  
for	  proteins	  involved	  in	  mating	  type	  switching	  (SWI)	  and	  sucrose	  fermentation	  
(SNF).	   Many	   classes	   of	   ATP	   hydrolysing	   chromatin	   remodelers	   have	  
subsequently	  been	  identified	  that	  share	  a	  core	  SNF2	  domain	  homologous	  to	  the	  
large	  helicase	   super	   family	   (Eisen	  et	   al	   1995,	   Flaus	   et	   al	   2006).	  The	   SWI/SNF	  
subclass	   shares	   seven	   conserved	  helicase	  motifs	   involved	   in	  binding	  DNA	  and	  
ATP	   hydrolysis.	   SWI/SNF	   chromatin	   remodelers	   have	   been	   categorised	   into	  
subfamilies	   depending	   on	   other	   domains	   within	   the	   protein.	   The	   four	   main	  
subfamilies	  are	  the	  SNF2,	  ISWI,	  CHD1	  and	  INO80	  (Figure	  1.9).	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Figure	   1.9:	   SWI/SNF	   subfamilies	   showing	   conserved	  domain	   structures	   that	   help	   define	  
the	  4	  groups;	  SNF2,	  ISWI,	  CHD1	  and	  INO80	  (Hogan	  &	  Varga-­‐Weisz	  2007).	  
SNF2	   proteins	   have	   a	   conserved	   bromodomain	   at	   their	   C-­‐terminus	   and	  
generally	   form	   part	   of	   large	   multi-­‐subunit	   protein	   complexes	   (Narlikar	   et	   al	  
2002).	  In	  vitro	  these	  proteins	  bind	  acetylated	  nucleosomes	  and	  in	  vivo	  promote	  
transcriptional	  activation.	  They	   include	  members	  of	   the	  yeast	  SWI2/SNF2	  and	  
RSC	  (restructure	  of	  chromatin)	  complex,	  which	  include	  RSC	  in	  yeast	  and	  BRG1	  
(Brahma-­‐related	  gene	  1)	  in	  mammals.	  
The	   ISWI	   (imitation	   SWI)	   class	   also	   act	   as	   the	   chromatin	   remodelling	  ATPase	  
component	   in	   a	   number	   of	   different	   complexes	   such	   as	   yeast	   ISW1	   &	   2	   and	  
human	   CHRAC	   (chromatin-­‐accessibility	   complex)	   and	   NoRC	   (nuclear	  
remodelling	   complex).	   They	   contain	   SANT	   domains,	   which	   facilitate	   histone	  
binding	  (Boyer	  et	  al	  2002).	  The	  function	  of	  ISWI	  chromatin	  remodelers	  can	  vary	  
depending	   on	   the	   complex.	   For	   example,	   in	   the	   context	   of	   the	   NoRC	   they	  
promote	   transcriptional	   silencing	   (Santoro	   et	   al	   2002),	   yet	   the	   CHRAC	   forms	  
regularly	   spaced	   nucleosomes	   in	   in	   vitro	   nucleosome	   positioning	   assays,	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The	  CHD1	  class	  contain	  members	  that	  form	  the	  NuRD	  (nucleosome	  remodelling	  
and	   deacetylation)	   complex.	   They	   form	   large	   complexes	   with	   transcriptional	  
repressors	   and	   co-­‐repressors	   like	   histone	   deacetylases	   (HDACs),	   which	  
introduce	   additional	   silencing	   marks	   such	   as	   histone	   tail	   deacetylation	   (Le	  
Guezennec	  et	  al	  2006).	  They	  cause	  transcriptional	  silencing	  in	  vivo	  and	  regularly	  
spaced	  nucleosomal	  arrays	  in	  in	  vitro	  nucleosome	  positioning	  assays	  (Tong	  et	  al	  
1998,	  Zhang	  et	  al	  1998).	  
The	  INO80	  family	  have	  an	  insertion	  between	  their	  ATPase	  domains	  and	  do	  not	  
share	   homology	   to	   other	   SNF2	   family	  members.	   They	   catalyse	   histone	   dimer	  
exchange	  and	  can	  evict	  nucleosomes	  (Mizuguchi	  et	  al	  2004).	  
SWI/SNF	   proteins	   are	   involved	   in	   a	   wide	   range	   of	   processes,	   such	   as	  
transcription,	   replication,	   recombination	   and	   DNA	   repair.	   	   They	   promote	  
alterations	   in	   chromatin	   structure	   to	   either	   relax	   the	   chromatin	   and	   allow	  
proteins	  to	  gain	  access	  to	  the	  DNA	  or	  compact	  the	  chromatin,	  which	  can	  lead	  to	  
transcriptional	  silencing	  (Flaus	  &	  Owen-­‐Huges	  2004).	  
 
1.2.4	   Components	   of	   remodelling	   complexes	   can	   modify	   the	   function	   of	  
ATP	  hydrolysing	  chromatin	  remodeler	  enzymes	  
The	   majority	   of	   SWI/SNF	   chromatin	   remodelers	   display	   remodelling	   activity	  
when	  isolated	  from	  other	  components	  of	  their	  respective	  complexes.	  However,	  
other	  parts	  of	  the	  complex	  can	  play	  critical	  roles	  in	  targeting	  and	  modulating	  the	  
activity	  of	  the	  chromatin-­‐remodelling	  enzyme.	  For	  example,	  the	  ISWI	  containing	  
CHRAC	   complex	   also	   contains	   Acf1	   (ATP-­‐utilizing	   chromatin	   assembly	   and	  
remodelling	   factor)	   (Poot	   et	   al	   2000),	   which	   enhances	   the	   chromatin	  
remodelling	  ability	  of	  ISWI	  and	  alters	  the	  position	  to	  which	  the	  nucleosome	  are	  
moved	   in	   in	  vivo	  nucleosome	  positioning	  assays	   (Langst	  et	  al	  1999,	  Yang	  et	  al	  
2006).	   Other	   components	   may	   aid	   in	   targeting	   of	   the	   chromatin-­‐remodelling	  
enzyme	   through	   recognition	   of	   specific	   histone	   modifications	   or	   sequence	  
specific	  transcription	  factors.	  The	  composition	  of	  protein	  components	  within	  a	  
chromatin-­‐remodelling	  complex	  can	  greatly	  influence	  the	  targeting	  and	  function	  
of	  the	  chromatin-­‐remodelling	  enzyme.	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1.2.5	  Functions	  of	  ATP	  hydrolysing	  chromatin	  remodelers	  
SWI/SNF	   enzymes	   are	   vital	   for	   coordinating	   processes	   such	   as	   transcription,	  
replication,	   recombination	   and	   DNA	   repair.	   They	   ensure	   that	   the	   chromatin	  
either	  remains	  compact	  or	  the	  necessary	  machinery	  can	  gain	  access	  to	  the	  DNA.	  
As	   may	   be	   expected	   for	   such	   a	   fundamental	   process,	   mutations	   in	   SWI/SNF	  
family	  members	   cause	   embryonic	   lethality	   in	  mice	   (Stopka	  &	   Skoultchi	   2003)	  
and	   larval	   lethality	   in	  Drosophila	   (Deuring	  et	  al	  2000).	  Chromatin	  remodelling	  
ATPase	   defects	   have	   also	   been	   linked	   to	   human	   diseases	   such	   as	   Cockayne	  
Syndrome	   B,	   which	   causes	   sensitivity	   to	   UV	   light	   and	   neurodevelopmental	  
defects.	   It	   is	   the	   result	   of	   mutations	   in	   the	   SNF2	   like	   protein	   CSB	   (Cockayne	  
Syndrome	  B	  protein),	  which	  is	  required	  for	  DNA	  excision	  repair	  (Troelstra	  et	  al	  
1992).	   Chromatin	   remodelling	   defects	   have	   also	   been	   implicated	   in	   cancer.	  
Examples	  include	  the	  NuRD	  complex	  component	  and	  tumour	  suppressor	  CHD5	  
and	   the	   SNF2	   chromatin	   remodeler	   BRG1,	   which	   has	   been	   shown	   to	   cause	   a	  
predisposition	  towards	  tumours	  in	  heterozygous	  mice	  (Bultman	  et	  al	  2000)	  and	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1.3	  Chromatin	  remodelling	  in	  the	  DNA	  damage	  response	  
DNA	   repair	   covers	   a	  wide	   variety	   of	   processes	   ranging	   from	   removal	   of	   DNA	  
crosslinks	   to	  mismatch	   repair.	   These	   require	   the	   cellular	   repair	  machinery	   to	  
access	  to	  the	  DNA.	  For	  repair	  of	  DNA	  damage	  within	  euchromatic	  DNA	  this	  may	  
not	  pose	  a	  problem.	  However	  in	  the	  context	  of	  heterochromatin,	  modification	  of	  
chromatin	  structure	   is	   required	   to	  allow	  the	  bulky	  repair	  machinery	   to	  access	  
DNA.	   This	   has	   been	   shown	   in	   DSB	   repair,	   where	   euchromatic	   breaks	   repair	  
faster	   than	   heterochromatic	   breaks,	   which	   require	   additional	   ATP-­‐dependent	  
relaxation	   of	   the	   chromatin	   by	   chromatin	   remodelling	   proteins	   (Table	   1.1)	  
(Kruhlak	  et	  al	  2006,	  Ziv	  et	  al	  2006).	  Histone	  modifications	  also	  occur	  at	  sites	  of	  
DNA	  repair,	  either	  as	  recruitment	   factors	  or	   to	  alter	  DNA:histone	   interactions.	  
Here	   I	   focus	  on	   the	   involvement	  of	  chromatin	  modification	   in	   two	  of	   the	  most	  
well	  characterised	  DNA	  damage	  response	  pathways,	  NER	  and	  DSB	  repair.	  
Family	   Complex	   ATPase	   Species	  
SWI/SNF	   SWI/SNF	   Snf2	   Yeast	  
	   RSC	   Sth1	   Yeast	  
	   BAF	   BRG1,	  BRM	   Mammal	  
	   INO80	   Ino80	   Yeast	  
INO80	   SWR1	   Swr1	   Yeast	  
	   INO80	   INO80	   Mammal	  
	   TRRAP/Tip601	   EP400/p400	   Mammal	  
	   NuRD	   CHD3,	  CHD4	   Mammal	  
CHD	   CHD22	   	   Mammal	  
	   ISWIa	   Isw1	   Yeast	  
ISWI	   ISWIb	   Isw1	   Yeast	  
	   ISW2	   Isw2	   Yeast	  
	   ACF	   SMARCA5/hSNF2H	   Mammal	  
	   CHRAC	   SMARCA5/hSNF2H	   Mammal	  
	   WICH	   SMARCA5/hSNF2H	   Human	  
	   NURF	   SMARCA1/hSNF2L	   Mammal	  
	   Rad16	   	   Yeast	  
Uncategorized	   Rad26	   	   Yeast	  
	   Rad5	   	   Yeast	  
	   Rdh54	   	   Yeast	  
	   CHD1L/ALC1	   	   Mammal	  
	   ERCC6/CSB	   	   Mammal	  
	   HLTF	   	   Mammal	  
	   RAD54L	   	   Mammal	  
	   RAD54B	   	   Mammal	  
	   SHPRH	   	   Mammal	  
	   SMARCAL1	   	   Mammal	  
Table	   1.1:	   Yeast	   and	   mammalian	   ATP-­‐dependent	   chromatin	   remodelling	   proteins	  
implicated	  in	  DNA	  damage	  response	  (Lans	  et	  al	  2012).	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1.3.1	  Chromatin	  remodelling	  in	  nucleotide	  excision	  repair	  
NER	   removes	  DNA	  adducts	   that	   distort	   the	  DNA	  double	  helix,	   including	   those	  
induced	  by	  UV.	  NER	   is	  more	  efficient	  on	  naked	  DNA	   than	   in	   chromatin	  and	   is	  
inhibited	  by	  heterochromatin	  (Gong	  et	  al	  2005,	  Osley	  et	  al	  2007).	  This	  suggests	  
that	   chromatin	   remodelling	   is	   important	   for	   NER	   to	   allow	   repair	   proteins	   to	  
access	   the	   DNA.	   Several	   chromatin-­‐remodelling	   complexes	   have	   been	  
implicated	   in	  NER	  response	   to	  UV	   irradiation	   (Table	  1.1).	  CSB	   is	   an	  SNF2	   like	  
chromatin	   remodelling	   enzyme	   required	   for	   TC-­‐NER,	   which	   can	   remodel	  
chromatin	   in	   vitro	   in	   an	   ATP-­‐dependent	   fashion	   (Selzer	   et	   al	   2002).	   When	  
mutated	  it	   leads	  to	  Cockayne	  Syndrome	  B,	  which	  causes	  sensitivity	  to	  UV	  light	  
and	   neurodevelopmental	   defects.	   Rad16	   is	   another	   SWI/SNF	   chromatin-­‐
remodelling	  enzyme	   that	   is	  also	  a	  NER	   factor	   required	   for	  GG-­‐NER	   in	  yeast.	   It	  
does	  not	  slide	  or	  evict	  nucleosomes,	  but	  alters	  chromatin	  structure	  through	  its	  
DNA	  translocase	  activity	  (Yu	  et	  al	  2004).	  Activation	  of	  NER	  through	  UV	  induced	  
damage	  also	  results	  in	  histone	  modifications.	  For	  example	  acetylation	  of	  histone	  
H3	   by	   the	   histone	   acetyltransferase	   GCN5	   results	   in	   a	   more	   permissive	  
chromatin	   state	   and	   promotes	   chromatin	   remodelling.	   It	   is	   necessary	   for	  
efficient	  repair	  of	  DNA	  damage	  (Yu	  et	  al	  2011).	  
	  
1.3.2.	  Chromatin	  remodelling	  in	  DNA	  double	  strand	  break	  repair	  
DSBs	   present	   a	   major	   challenge	   to	   cells	   as	   they	   can	   lead	   to	   chromosomal	  
instability	  and	  loss	  of	  chromosome	  arms.	  DSBs	  are	  repaired	  by	  HR	  (San	  Filippo	  
et	  al	  2008)	  or	  NHEJ	  (Lieber	  2010),	  which	  begin	  with	  DSB	  detection	  followed	  by	  
processing	   of	   the	   broken	  DNA	   ends.	   This	   is	   associated	  with	   extensive	   histone	  
modifications	  such	  as	  phosphorylation	  and	  ubiquitination	  (Bekker-­‐Jensen	  et	  al	  
2010).	  Histone	  H2AX	   is	  phosphorylated	  by	  kinases	  ATM	  and	  ATR	  and	  recruits	  
mediator	   factors	   like	   MDC1	   and	   53BP1	   required	   for	   cell	   cycle	   checkpoint	  
signalling	   (Jackson	   &	   Bartek	   2009,	   Kinner	   et	   al	   2008).	   Mediator	   factors	   also	  
recruit	   further	   histone	   modifying	   enzymes	   such	   as	   Ubc13,	   which	  
polyubiquitinates	  H2AX	  and	  is	  required	  for	  a	  single	  stranded	  DNA	  overhang	  for	  
repair	   by	  HR	   (Kobayashi	   et	   al	  2008).	   A	   reduction	   in	   either	   histone	  modifying	  
enzyme	  leads	  to	  hypersensitivity	  to	  DNA	  damage.	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Chromatin	  structure	  can	  also	  affect	   the	  efficiency	  of	  DSB	  signalling	  and	  repair.	  
As	   previously	  mentioned	  DSBs	   that	   occur	  within	   heterochromatic	  DNA	   repair	  
slower	   and	   require	   relaxation	   of	   the	   local	   chromatin	   state	   for	   efficient	   DSB	  
signalling	  and	  repair.	  ATM	  dependent	  phosphorylation	  of	  the	  heterochromatin	  
protein	  KAP1	  has	  been	   shown	   to	  promote	  a	  more	  permissive	   chromatin	   state	  
surrounding	   DSBs	   (Goodarzi	   et	   al	   2011).	   Phosphorylated	   KAP1	   promotes	  
disassociation	  of	  heterochromatic	   factors	  such	  as	  HP1	  and	  the	  ATP	  dependent	  
chromatin	   remodelling	   protein	   CHD3,	   which	   normally	   function	   to	   promote	  
chromatin	  compaction	  (Goodarzi	  et	  al	  2008).	  Other	  ATP	  dependent	  chromatin	  
remodelling	  proteins	  are	  actively	  recruited	  to	  DSBs,	  such	  as	  members	  of	  the	  RSC	  
complex	   in	  yeast	  and	  BRG1	  in	  mammals.	  RSC	  cause	  nucleosome	  displacement,	  
which	  increases	  DNA	  accessibility	  at	  the	  site	  of	  damage	  (Kent	  et	  al	  2007).	  BRG1	  
is	  recruited	  to	  DSBs	  in	  a	  γH2AX	  dependent	  manner	  by	  binding	  acetylated	  lysine	  
residues	  of	  histone	  H3	   in	  γH2AX	  containing	  nucleosome	  (Lee	  et	  al	  2010).	  This	  
stimulates	   further	   phosphorylation	   of	   H2AX,	   which	   reinforces	   DSB	   signalling	  
(Park	   et	   al	   2006).	   Mutation	   of	   either	   the	   RSC	   complex	   in	   yeast	   or	   BRG1	   in	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1.4	  Functions	  of	  Lymphoid	  specific	  helicase	  and	  its	  homologs	  
LSH	  (Lymphoid	  specific	  helicase)	  has	  been	  identified	  as	  a	  SWI/SNF	  ATPase	  with	  
SNF2	  and	  helicase	  domains	  homologous	  to	  the	  SNF2	  family	  (Figure	  1.10).	  LSH	  
was	   initially	   characterised	   as	   being	   predominantly	   expressed	   in	   proliferating	  
cells	  such	  as	  lymphoid	  tissue	  (Geiman	  et	  al	  1998)	  and	  was	  shown	  to	  be	  required	  
for	   proliferation	   of	  mature	  T-­‐lymphocytes	   (Geiman	  &	  Muegge	  2000).	   LSH	  has	  
since	   been	   shown	   to	   be	   ubiquitously	   expressed,	   with	   particularly	   high	  
expression	  levels	  recorded	  during	  embryogenesis	  (Geiman	  et	  al	  2001).	  
Figure	  1.10:	  Lsh	  protein	  structure.	  The	  SNF2	  and	  helicase	  domains	  are	  shown	  in	  red	  and	  
yellow	  respectively.	  The	  helicase	  motifs	  are	   in	  green,	   coiled	  coiled	   in	  dark	  blue	  and	   the	  
nuclear	  localisation	  signal	  in	  pink,	  the	  arrow	  shows	  position	  of	  the	  ATP	  binding	  site.	  
LSH	  is	  an	  important	  DNA	  methyltransferase	  (DNMT)	  accessory	  factor,	  required	  
for	   correct	   DNA	   methylation	   (Dennis	   et	   al	   2001).	   However,	   it	   has	   also	   been	  
shown	   to	   be	   required	   for	   other	   process,	   such	   as	   HDAC	   dependent	  
transcriptional	   repression	   and	   meiotic	   recombination	   between	   sister	  
chromosomes	  (Myant	  &	  Stancheva	  2008,	  De	  La	  Fuente	  et	  al	  2006).	  Homologs	  of	  
LSH	  have	  been	   identified	   in	  a	  wide	   range	  of	   species	   such	  Arabidopsis	   thaliana	  
and	   Saccharomyces	   cerevisiae	   (Figure	   1.11).	   Some	   functions	   are	   conserved	  
between	   LSH	   and	   it	   homologues,	   such	   the	   requirement	   of	   the	   A.	   thaliana	  
homolog	  DDM1,	  for	  DNA	  methylation	  in	  plants	  (Jeddeloh	  et	  al	  1999).	  However,	  
an	  additional	  role	   in	   the	  DNA	  damage	  response	  has	  been	  shown	   in	  plants	  and	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Figure	  1.11:	  T-­‐COFFEE	  (Di	  Tommaso	  et	  al	  2011)	  protein	  sequence	  alignments	  of	  LSH	  and	  
its	  homologues	  showing	  amino	  acid	  similarity	  and	  sequence	  conservation.	  
	  
1.4.1	  Functions	  of	  DDM1,	  the	  A.	  thaliana	  homolog	  of	  LSH	  	  
DDM1	  (Decreased	  DNA	  Methylation	  1)	  was	  the	  first	  of	   the	  LSH	  homologues	  to	  
be	   identified	  by	   screening	  A.	   thaliana	  mutants	   for	  defects	   in	  DNA	  methylation	  
(Jeddeloh	   et	   al	   1999,	   Vongs	   et	   al	   1993).	   The	   main	   defect	   observed	   in	   DDM1	  
mutant	  plants	  was	  a	  70%	  reduction	  in	  global	  DNA	  methylation	  levels.	  This	  was	  
associated	  with	  a	  range	  of	  morphological	  defects	  that	  increased	  in	  severity	  with	  
each	  subsequent	  generation,	  due	  to	  the	  activation	  of	  retrotransposons	  through	  
loss	  of	  DNA	  methylation	  (Kakutani	  1997,	  Kakutani	  et	  al	  1995).	  Levels	  of	  DNMTs	  
and	  their	  associated	  activities	  were	  shown	  to	  be	  unaffected	   in	  DDM1	  mutants,	  
suggesting	  that	  DDM1	  directly	  affects	  DNA	  methylation	  (Kakutani	  et	  al	  1995).	  
DDM1	   was	   identified	   as	   a	   member	   of	   the	   SWI/SNF	   family	   of	   ATPases.	  
Biochemical	   studies	   confirmed	   chromatin-­‐remodelling	   activity	   in	   vitro	   by	  
demonstrating	   the	   ability	   of	   DDM1	   to	   reposition	   nucleosomes	   (Brusk	   &	  
Jermanowski	  2003).	  This	  suggested	  a	  mechanism	  that	  could	  account	  for	  the	  link	  
between	  DDM1	  and	  DNA	  methylation,	  where	  by	  DDM1	  is	  able	  to	  regulate	  DNMT	  
activity	  by	  creating	  an	  open	  chromatin	  environment	  that	  would	  allow	  DNMTs	  to	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DDM1	  mutants	  also	  show	  increased	  sensitivity	  to	  DNA	  damage	  when	  exposed	  to	  
ionising	   radiation	   (Shaked	   et	   al	   2006).	   This	   phenotype	   was	   shown	   to	   be	  
independent	   of	   DNA	   methylation,	   as	   it	   was	   not	   reproduced	   in	  met1	   mutants	  
lacking	  maintenance	  DNA	  methyltransferase	  MET1	  and	  DNA	  methylation.	  This	  
sensitivity	   to	   ionising	   radiation	   may	   reflect	   the	   nucleosome	   repositioning	  
activity	   of	   DDM1	   since	   chromatin	   remodelling	   is	   known	   to	   play	   an	   important	  
role	   in	  regulating	  the	  function	  of	  various	  aspects	  of	  the	  DNA	  damage	  response	  
pathway	  (Lans	  et	  al	  2012).	  
	  
1.4.2	  Functions	  of	  IRC5,	  the	  S.	  cerevisiae	  homolog	  of	  LSH	  	  
Little	   is	   known	   about	   irc5	   (Increased	   Recombination	   Centres	   5),	   the	   yeast	  
homologue	   of	   LSH.	   It	   has	   been	   shown	   to	   encode	   a	   putative	   SWI/SNF	   family	  
helicase	   with	   sequence	   similarities	   that	   identify	   IRC5	   as	   a	   LSH	   homologue	  
(Alvaro	  et	  al	  2007,	  Shiraton	  et	  al	  1999).	  It	  has	  also	  been	  shown	  that	  mutation	  of	  
IRC5	   causes	   an	   increase	   in	   the	   number	   of	   spontaneous	   RAD52	   foci	   in	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
S.	   cerevisiae	   (Alvaro	   et	   al	   2007).	   RAD52	   foci	   form	   during	   homologous	  
recombination	   and	   are	   often	   used	   as	   markers	   of	   DNA	   damage	   as	   they	   can	  
indicate	   sites	   of	   double	   strand	   break	   repair.	   An	   increase	   in	   the	   number	   of	  
RAD52	   foci	   in	   IRC5	  mutant	  S.	   cerevisiae	   supports	   the	   hypersensitivity	   to	  DNA	  
damage	  seen	  in	  DDM1	  mutant	  plants	  and	  implicates	  a	  second	  LSH	  homologue	  in	  
DNA	  damage	  response.	  
Genetic	   interaction	   studies	   identified	   enhanced	   growth	   defects	   in	   double	  
mutant	  S.	  cerevisiae	  when	  IRC5	  was	  mutated	  in	  combination	  with	  other	  proteins	  
involved	   in	   the	   DNA	   damage	   response.	   These	   include,	   proteins	   of	   the	   MRX	  
complex	  involved	  in	  DSB	  recognition	  (homologous	  to	  the	  human	  MRN	  complex),	  
RAD	  proteins	   required	   for	  DSB	  HR	  repair	   and	  members	  of	   the	  RSC	  chromatin	  
remodelling	   complex,	   which	   are	   also	   involved	   in	   the	   DNA	   damage	   response	  
(Table	  1.2)	  (Collins	  et	  al	  2007).	  These	  associations	  give	  an	  indication	  that	  IRC5	  
may	  be	  involved	  in	  DNA	  damage	  response.	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Table	   1.2:	   Table	   showing	   selected	   IRC5	   genetic	   interaction	   data	   (Collins	   et	   al	   2007),	  
highlighting	   interactions	  with	   known	   repair	   proteins.	   Red	  are	  DSB	   recognition	  proteins,	  
Blue	  are	  members	  of	   the	  RAD52	  epistasis	  group	   involved	   in	  homologous	  recombination	  
and	  DSB	   repair	   and	  Green	  are	   chromatin	   remodelling	  proteins	  of	   the	  RSC	   complex	  also	  
required	  for	  DSB	  repair.	  	  
	  
1.4.3	  LSH	  is	  required	  for	  DNA	  methylation	  	  
In	  mice,	  LSH	  has	  been	  shown	  to	  be	  essential	  for	  development.	  Mice	  containing	  a	  
deletion	  within	  the	  Lsh	  gene	  where	  a	  part	  of	   the	  helicase	  domain	  and	  the	  ATP	  
binding	   site	   were	   removed	   die	   soon	   after	   birth,	   although	   embryonic	  
development	   appears	   normal	   (Geiman	   et	   al	   2001).	   More	   detailed	   analysis	  
revealed	  widespread	  DNA	  hypomethylation	  throughout	  the	  genome.	  Remaining	  
methylation	  levels	  were	  estimated	  to	  be	  between	  30-­‐40%	  of	  wild	  type	  (Dennis	  
et	  al	  2001).	  A	  second	  study,	  in	  which	  the	  latter	  half	  of	  the	  helicase	  domain	  was	  
deleted	  and	  a	  C-­‐terminal	  truncated	  protein	  produced,	  also	  showed	  that	  genomic	  
DNA	   methylation	   was	   approximately	   30-­‐40%	   of	   wild	   type	   levels	   (Sun	   et	   al	  
2004).	   However,	   in	   this	   study	   40%	   of	   the	   mice	   survived	   and	   displayed	   a	  
phenotype	  of	  reduced	  birth	  weight,	  slow	  growth	  and	  premature	  ageing	  (Sun	  et	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The	   difference	   in	   survival	   between	   the	   complete	   knockout	  mice	   produced	   by	  
Geiman	  et	  al	  and	  the	  mice	  from	  Sun	  et	  al	  expressing	  a	  C-­‐terminal	  truncation	  of	  
LSH	  may	  be	  due	  to	  an	  additional	  role	  for	  LSH	  connected	  to	  its	  C-­‐terminal	  region	  
or	  variation	  in	  the	  genetic	  background	  between	  the	  2	  mice	  strains.	  Since	  similar	  
levels	  of	  loss	  of	  DNA	  methylation	  occur	  in	  both	  mice	  strains,	  the	  survival	  of	  40%	  
of	   the	  Sun	  et	  al	  Lsh-­‐/-­‐	  mice	  suggests	   the	  possibility	  of	  an	  additional	   function	  of	  
LSH.	  The	  premature	  ageing	  displayed	  in	  these	  mice	  also	  hints	  at	  the	  possibility	  
of	  a	  DNA	  repair	  defect	  as	  a	  more	  rapid	  accumulation	  of	  unrepaired	  DNA	  damage	  
may	  lead	  to	  senescence,	  which	  can	  cause	  this	  phenotype	  (Weirich-­‐Schwaiger	  et	  
al	   1994,	   De	   Boer	   et	   al	   2002).	   This	   is	   consistent	   with	   observations	   in	   IRC5	  
mutant	  yeast	  and	  DDM1	  mutant	  plants.	  
These	   two	   studies	   independently	   confirm	   the	   involvement	   of	   LSH	   in	  
establishing	  DNA	  methylation	  within	  the	  embryo.	  The	  mouse	  produced	  by	  Sun	  
et	  al	  also	  shows	  that	  the	  N-­‐terminal	  predicted	  coiled	  coil	  of	  LSH	  cannot	  establish	  
DNA	   methylation	   alone	   and	   that	   the	   SNF2	   domain	   may	   also	   be	   required,	  
suggesting	   that	   LSH	   chromatin	   remodelling	   is	   required	   for	   DNA	  methylation.	  
Experiments	   using	   embryonic	   fibroblast	   cells	   in	   culture	   have	   confirmed	   the	  
findings	   of	   in	   vivo	   studies	   and	   shown	   that	   LSH	   is	   required	   for	   de	   novo	  
methylation	  (Myant	  et	  al	  2011,	  Zhu	  et	  al	  2006).	  	  
It	   was	   shown	   in	   embryonic	   fibroblasts	   that,	   although	   the	   presence	   of	   LSH	   is	  
required	  to	  de	  novo	  methylate	  an	  episomal	  vector,	  it	  is	  not	  required	  to	  maintain	  
existing	   DNA	   methylation,	   suggesting	   that	   LSH	   does	   not	   play	   a	   role	   in	  
methylation	  maintenance	  (Zhu	  et	  al	  2006).	  However,	  observations	  in	  the	  human	  
cell	   line	   TIG-­‐7,	   in	   which	   LSH	   levels	   were	   reduced	   to	   approximately	   20%	   of	  
normal	   levels	   by	   shRNA	   knockdown,	   contradicts	   the	   findings	   from	   mouse	  
embryonic	   fibroblasts	   by	   demonstrating	   that	   LSH	   is	   required	   for	   DNA	  
methylation	   maintenance.	   After	   34	   population	   doublings,	   methylation	   of	  	  	  	  	  	  	  	  	  	  	  	  	  
α-­‐satellite	  DNA	  was	  shown	  to	  be	  gradually	  decreased	  to	  60%	  of	  normal	   levels	  
(Suzuki	   et	   al	   2008),	   suggesting	   that	   in	   somatic	   cells	   LSH	   does	   play	   a	   role	   in	  
maintaining	  DNA	  methylation.	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1.4.4	  LSH	  is	  an	  HDAC	  dependent	  transcriptional	  repressor	  
Study	  of	  DNMT	  1,	  3a	  &	  b	  knockout	  human	  cancer	  cells	  showed	  that	  both	  DNMT1	  
&	  3b	  are	  required	  for	  effective	  LSH	  mediated	  transcription	  silencing	  (Myant	  &	  
Stancheva	   2008).	   LSH	   tethered	   to	   a	   luciferase	   reporter	   by	   a	   GAL4	   binding	  
domain	   was	   insufficient	   to	   repress	   transcription	   in	   either	   DNMT1	   or	   3b	  
knockout	  cells.	  However,	  re-­‐introduction	  of	  DNMTs	  into	  DNMT	  knockout	  cells	  in	  
combination	  with	  LSH-­‐GAL4	  was	  able	  to	  repress	  luciferase	  expression	  (Myant	  &	  
Stancheva	   2008).	   Furthermore,	   a	   truncated	   form	   of	   LSH	   in	   which	   the	   ATP	  
binding	   site	   and	   SNF2	   and	   helicase	   domains	   were	   removed	   was	   also	   able	   to	  
induce	   transcriptional	   repression	  when	   co-­‐transfected	  with	   DNMTs	   (Myant	  &	  
Stancheva	  2008),	  which	  suggests	  that	  the	  ATPase	  activity	  of	  LSH	  is	  not	  required	  
for	  transcriptional	  repression	  in	  this	  system.	  
	  
Figure	  1.12:	  Model	  of	  how	  LSH	  may	  interact	  with	  DNMT3B,	  DNMT1,	  HDAC1,	  and	  HDAC2	  
to	  repress	  transcription	  (Myant	  &	  Stancheva	  2008).	  	  
A	   LSH	   containing	   multisubunit	   complex	   has	   not	   been	   detected,	   however	  	  	  	  	  	  	  	  	  	  	  
co-­‐immunoprecipitation	  experiments	  have	  demonstrated	  interactions	  between	  
LSH	  and	  DNMTs1&3b	  and	  HDACs1&2	  (Myant	  &	  Stancheva	  2008).	  Furthermore	  
DNMT3b	  was	   shown	   to	   be	   required	   for	   interaction	   between	   LSH	   and	  DNMT1	  
and	  DNMTs1&3b	  for	   interactions	  between	  LSH	  and	  HDACs	  1&2.	  This	  suggests	  
an	  order	  of	  binding	  to	  a	  theoretical	  LSH-­‐DNMT-­‐HDAC	  transcriptional	  repression	  
complex	  (Figure	  1.12).	  Interactions	  with	  both	  DNMT1	  &	  3b	  are	  consistent	  with	  













	   35	  
1.4.5	  LSH	  is	  required	  to	  resolve	  synapsed	  chromosomes	  during	  meiosis	  
LSH	   has	   also	   been	   implicated	   in	   correct	   recombination	   occurring	   during	  
meiosis.	  Meiosis	  is	  accompanied	  by	  dynamic	  changes	  in	  global	  DNA	  methylation	  
and	   the	   generation	   of	   double-­‐strand	   DNA	   breaks	   for	   recombination	   between	  
homologous	   paternal	   and	   maternal	   chromosomes	   (Reik	   et	   al	   2001,	  
Mahadevaiah	  et	  al	  2001).	  It	  was	  initially	  thought	  that	  LSH	  might	  have	  a	  function	  
during	  meiosis	  due	   its	  role	   in	   the	  regulation	  of	  DNA	  methylation	  (Dennis	  et	  al	  
2001,	  Muegge	  2005).	  
Prophase	   I	   of	   meiosis	   starts	   during	   foetal	   development	   and	   continues	   until	  
homologous	   chromosomes	   align	   and	  undergo	   recombination	   (Hassold	  &	  Hunt	  
2001).	  Lsh-­‐/-­‐	  mice	  created	  by	  Geiman	  et	  al	  2001	  die	  soon	  after	  birth,	  preventing	  
study	  of	  the	  completion	  of	  meiosis.	  However	  germ	  cells	  were	  seen	  in	  the	  gonads	  
of	  female	  Lsh-­‐/-­‐	  mice	  at	  18	  days	  gestation	  indicating	  that	  LSH	  is	  not	  required	  for	  
primordial	   germ	  cell	   formation.	  When	   these	  were	  cultured	  no	  mature	  oocytes	  
developed,	   suggesting	   that	   LSH	   is	   essential	   for	   post-­‐natal	   oocyte	   growth	   and	  
differentiation	  (De	  La	  Fuente	  et	  al	  2006).	  
Closer	   investigation	  of	  WT	  mouse	  oocytes	   revealed	   that	   LSH	   co-­‐localises	  with	  
condensed	  chromosomes	  during	  the	  pachytene	  stage	  of	  Prophase	  I.	  However	  in	  
Lsh-­‐/-­‐	   oocytes	   asynapsed	   chromosomes	   can	   be	   seen	   in	   the	   pachytene	   stage,	  
accompanied	   with	   persistence	   in	   γH2AX	   staining	   indicating	   unrepaired	   DSBs	  
and	  incomplete	  recombination	  (De	  La	  Fuente	  et	  al	  2006).	  	  This	  shows	  that	  LSH	  
is	  essential	  for	  completion	  of	  recombination	  during	  meiosis,	  possibly	  by	  helping	  
resolve	   synapsed	   chromosomes	  or	   aiding	   in	   repair	   of	  DSBs.	  The	  phenotype	   is	  
consistent	   with	   observations	   in	   A.	   thaliana	   and	   S.	   cerevisiae	   linking	   LSH	  
homologues	  to	  roles	  in	  DNA	  damage	  repair.	  	  This	  raises	  the	  question	  of	  whether	  
mammalian	  LSH	   is	   limited	   to	  aid	   in	   repair	  of	  DSBs	   induced	   for	   recombination	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1.4.6	  LSH	  summary	  
The	  major	  phenotype	  associated	  with	  mutation	  of	  LSH	  or	   its	  plant	  homolog	   is	  
loss	  of	  DNA	  methylation.	  However,	  further	  analysis	  of	  ddm1	  A.	  thaliana	  has	  also	  
implicated	  DDM1	   in	   the	  DNA	  damage	   response	   pathway	   (Shaked	   et	   al	  2006).	  	  	  	  	  	  
S.	  cerevisiae	  deficient	   for	   IRC5	  also	  have	  a	  phenotype	  that	   implicates	  the	  yeast	  
homolog	  of	  LSH	  in	  DNA	  damage	  response	  (Collins	  et	  al	  2007).	  LSH	  has	  not	  been	  
shown	   to	   be	   involved	   in	   the	   mammalian	   DNA	   damage	   response.	   However	  
premature	   aging	   in	   surviving	   Lsh-­‐/-­‐	   mice	   (Sun	   et	   al	   2004)	   and	   chromosomal	  
defects	   in	   Lsh-­/-­	   primordial	   germ	   cells	   (De	   La	   Fuente	   et	   al	   2006),	   suggests	   a	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1.5	  Project	  Aims	  
This	  study	  aims	  to	   investigate	  whether	  LSH	  has	  a	  role	   in	   the	  mammalian	  DNA	  
damage	  response.	  Initial	  investigations	  were	  to	  determine	  if	  LSH	  is	  involved	  in	  
the	  DNA	  damage	  response.	  These	  are	  shown	  in	  chapter	  three,	  where	  the	  effects	  
of	  various	  DNA	  damaging	  agents	  on	  LSH	  deficient	  cells	  demonstrated	  that	  LSH	  is	  
required	   for	   repair	  of	  DSBs.	   	  The	  DSB	  repair	  defects	  of	  LSH	  deficient	   cells	  are	  
characterised	  in	  chapter	  four,	  which	  provide	  a	  more	  detailed	  understanding	  of	  
how	  LSH	  is	   in	   involved	   in	  DSB	  repair.	  We	  show	  correct	  recognition	  of	  DSBs	   in	  
LSH	   deficient	   cells,	   but	  weaker	   phosphorylation	   of	   variant	   histone	  H2AX	   at	   a	  
proportion	  of	  DSBs.	  This	  leads	  to	  impaired	  recruitment	  of	  mediator	  proteins	  to	  
DSBs	   and	   compromised	   cell	   cycle	   arrest.	   In	   chapter	   five	   we	   explored	   the	  
function	  and	  response	  of	  LSH	  to	  the	  induction	  of	  DSB	  repair.	  We	  show	  that	  LSH	  
ATPase	  activity	  is	  vital	  for	  its	  role	  in	  DSB	  repair.	  We	  also	  show	  that	  the	  majority	  
of	  LSH	  is	  normally	  bound	  to	  chromatin	  and	  is	  not	  recruited	  to	  broken	  DNA	  ends.	  	  
Our	  data	  implies	  that	  LSH	  has	  a	  conserved	  function	  in	  DSB	  repair.	  Interestingly	  
LSH	   is	   not	   recruited	   to	   broken	   DNA	   ends	   but	   is	   required	   for	   repair	   at	   a	  
proportion	   of	   DSBs.	   Although	   the	   exact	   role	   of	   LSH	   in	   the	   DSB	   response	   is	  
unclear,	  we	   suggest	   two	   possible	   hypotheses	   to	   explain	   our	   observations	   and	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Materials	  and	  Methods	  -­	  Chapter	  Two	  
2.1	  Materials	  
2.1.1	  Common	  Reagents	  
Phosphate-­buffered	   saline	   (PBS):	   140	  mM	   NaCl,	   3	   mM	   KCl,	   2	   mM	   KH2PO4,	  	  	  	  
10	  mM	  Na2HPO4	  
SDS	  running	  buffer:	  25	  mM	  Tris,	  250	  mM	  Glycine,	  0.1%	  SDS	  
Transfer	   buffer:	   25	   mM	   Tris,	   250	   mM	   Glycine	   (for	   transfers	   using	   PVDF	  
membrane	  this	  was	  supplemented	  with	  20%	  methanol)	  
Tris-­buffered	  saline	  (TBS):	  50	  mM	  Tris-­‐HCl	  pH	  8.0,	  150	  mM	  NaCl	  
Tris-­acetate	  EDTA	  (TAE):	  40	  mM	  Tris,	  20	  mM	  glacial	  acetic	  acid,	  1	  mM	  EDTA	  
and	  adjusted	  to	  pH	  8.0	  
Tris-­EDTA	  (TE):	  10	  mM	  Tris-­‐HCl	  pH	  7.5,	  1	  mM	  EDTA	  pH	  8.0	  
DNA	  isolation	  buffer:	  10	  mM	  Tris	  HCl	  pH8.0,	  10	  mM	  EDTA	  pH	  8.0	  
	  
2.1.2	  Reagents	  for	  manipulation	  of	  proteins	  
NE1:	  20	  mM	  Hepes	  pH	  7.0,	  10	  mM	  KCl,	  1	  mM	  MgCl2,	  0.1%	  (v/v)	  Triton	  X-­‐100,	  
20%	  (v/v)	  glycerol,	  0.5	  mM	  DTT	  and	  complete	  protease	  inhibitors	  (Sigma).	  	  
PonceauS	  staining	  solution:	  1%	  (v/v)	  glacial	  acetic	  acid,	  0.5%	  (w/v)	  PonceauS	  
SDS	   PAGE	   loading	   buffer	   (5×):	   225	  mM	   Tris-­‐HCl	   pH	   6.8,	   50%	   glycerol,	   5%	  
SDS,	  0.05%	  bromophenol	  blue,	  250	  mM	  DTT.	  Stored	  at	  room	  temperature,	  DTT	  
added	  just	  prior	  to	  use.	  
SDS	  PAGE	  separating	  gel:	  7-­‐15%	  (w/v)	  29:1	  acrylamide:bis-­‐acrylamide,	  0.1%	  
(w/v)	  SDS,	  390	  mM	  Tris	  HCl	  pH	  8.8,	  0.08%	  (v/v)	  TEMED,	  0.1%	  (w/v)	  APS.	  	  
SDS	  PAGE	  stacking	  gel:	  5%	  (w/v)	  29:1	  acrylamide:bis-­‐acrylamide,	  0.1%	  (w/v)	  
SDS,	  129	  mM	  Tris	  HCl	  pH	  6.8,	  0.1%	  (v/v)	  TEMED,	  0.1%	  (w/v)	  APS.	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anti-­‐LSH	   Santa	  Cruz,	  	  sc-­‐46665	  
Mouse,	  
monoclonal	   1:1000	   	  
anti-­‐gH2AX	   Millipore,	  	  05-­‐636	  
Mouse,	  
monoclonal	   1:500	   1:8000	  
anti-­‐H2AX	   Active	  Motif,	  39690	  
Rabbit,	  
polyclonal	   1:1000	   	  
anti-­‐H4	   Millipore,	  	  07-­‐108	  
Rabbit,	  






monoclonal	   1:500	   1:1000	  
anti-­‐MRE11	   Calbiochem,	  PC388	  
Rabbit,	  
polyclonal	   1:2000	   	  
anti-­‐CHK2	   Cell	  Signalling,	  	  2662	  
Rabbit,	  











monoclonal	   1:1000	   	  
anti-­‐p53pS15	   Cell	  Signalling,	  	  9284	  
Rabbit,	  
polyclonal	   1:1000	   	  
anit-­‐53BP1	   Cell	  Signalling,	  	  4987	  
Rabbit,	  
polyclonal	   	   1:100	  
anti-­‐MDC1	   Abcam,	  ab11171	   Rabbit,	  polyclonal	   	   1:	  500	  
anti-­‐FLAG	  	   Sigma	  Aldrich,	  F3165	  
Mouse,	  
monoclonal	   	   1:500	  



























Alexa	  Fluor®	   	   1:1000	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2.2	  Tissue	  culture	  
2.2.1	  Cell	  lines	  
Wild	   type	   and	   Lsh-­/-­	   MEFs:	   Mouse	   embryonic	   fibroblasts	   obtained	   from	   the	  
Muegge	   lab	   (Dennis	   et	   al	   2001).	   Grown	   in	   Dulbecco	   modified	   Eagle	   medium	  
(Sigma)	  supplemented	  with	  10%	  (v/v)	  FBS,	  100	  u/mL	  penicillin,	  100	  µg/ml	  of	  a	  
streptomycin	  and	  2	  mM	  L-­‐glutamine	  (Sigma).	  
WT	  and	  mutant	  rescued	  Lsh-­/-­	  MEFs:	  Lsh-­/-­	  MEFs	  (Dennis	  et	  al	  2001)	  that	  have	  
been	   infected	  with	   synthetic	   cDNAs	   (GeneArt)	   of	   3xFLAG	   C-­‐terminally-­‐tagged	  
LSH	   and	  K254Q	  mutant	   LSH	   cloned	   into	   pMSCV-­‐puro	   plasmids	   and	   packaged	  
into	   lentiviral	   particles.	   Infected	   cells	   were	   selected	   with	   2.5	   µg/ml	   of	  
puromycin	   for	   2	  weeks	   and	   stable	   colonies	   derived	   from	   single	   infected	   cells.	  
Grown	   in	   Dulbecco	  modified	   Eagle	  medium	   (Sigma)	   supplemented	  with	   10%	  
(v/v)	   FBS,	   100	   u/mL	   penicillin,	   100	   µg/ml	   of	   a	   streptomycin	   and	   2	   mM	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
L-­‐glutamine	  (Sigma)	  	  
MRC5hT:	  Human,	  primary	  embryonic	  lung	  fibroblasts	  immortalised	  with	  human	  
Telomerase	  by	  retroviral	  infection	  with	  pBabe-­‐hTERT-­‐Neo	  plasmid	  (laboratory	  
stock	   from	   Katrina	   Gordon).	   Grown	   in	   DMEM	  medium	   containing	   10%	   (v/v)	  
FBS,	  supplemented	  with	  100	  u/mL	  penicillin,	  100	  µg/ml	  of	  a	  streptomycin	  and	  
2	  mM	  L-­‐glutamine	  (Sigma).	  
shLSH	  and	  non-­silencing	  MRC5hT:	  LSH	  was	   stably	  knocked	  down	   in	  MRC5hT	  
cells	   by	   introducing	   two	   independent	   pGIPZ-­‐shRNAmir	   plasmids	   V2LHS_	  
155499	   and	   V2LHS_155497	   packaged	   into	   lentiviral	   particles	   (Open	  
Biosystems).	   	  Control	  cells	  were	  infected	  under	  the	  same	  conditions	  with	  non-­‐
silencing	  pGIPZ-­‐shRNAmir	  particles	  RHS4348	  (Open	  Biosystems).	  The	  infected	  
cells	  were	  selected	  with	  2.5	  mg/ml	  of	  puromycin	  for	  7	  days	  and	  LSH	  knockdown	  
assessed	  by	  Western	  blots.	  Grown	  in	  DMEM	  medium	  containing	  10%	  (v/v)	  FBS,	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MRC5hT	   ER-­AsiSI-­HA:	   pBABE	   ER–AsiSI–HA	   plasmid	   (from	   Gaëlle	   Legube)	   was	  
packaged	   into	   lentiviral	   particles	   in	   amphotropic	   Phoenix	   cells	   and	   used	   to	  
infect	   MRC5hT	   cells.	   The	   infected	   cells	   were	   selected	   with	   200	   µg/ml	   of	  
hygromycin	   for	  14	  days	  and	  stable	  colonies	  derived	   from	  single	   infected	  cells.	  
Grown	   in	   DMEM	   medium	   containing	   10%	   (v/v)	   FBS,	   supplemented	   with	  	  	  	  	  	  	  	  	  
100	   u/mL	   penicillin,	   100	   mg/ml	   of	   a	   streptomycin	   and	   2	   mM	   L-­‐glutamine	  
(Sigma).	  
VA13LSH-­GFP:	  Foetal	  human	  diploid	   fibroblast	   cell	   line	  WI-­‐38	   transformed	  with	  
simian	   virus	   40	   and	   stably	   expressing	   LSH-­‐GFP	   (laboratory	   stock).	   Grown	   in	  
DMEM	   medium	   containing	   10%	   (v/v)	   FBS,	   supplemented	   with	   a	   mix	   of	  	  	  	  	  	  	  	  	  	  	  
100	   u/mL	   penicillin,	   100	   μg/ml	   of	   a	   streptomycin	   and	   2	   mM	   L-­‐glutamine	  
(Sigma).	  
	  
2.2.2	  Viability	  screening	  
For	   short-­‐term	   analyses	   of	   cell	   proliferation	   and	   viability,	   human	   fibroblasts	  
were	   plated	   on	   6-­‐well	   plates	   (1x105	   cells/well)	   and	   treated	   with	   a	   range	   of	  
different	  DNA	  damaging	  agents.	  These	  included	  irradiation	  with	  5	  Gy	  of	  ionising	  
radiation	   or	   20	   J/M2	   of	   UV,	   a	   1h	   treatment	   with	   either	   0.02%	   methyl	  
methanesulfonate,	   80mM	   bleomycin	   or	   0.3%	   H2O2	   or	   a	   24	   h	   treatment	   with	  	  	  	  	  	  	  	  	  
2	   mM	   hydroxyurea.	   Cells	   were	   collected	   at	   the	   indicated	   time	   point	   after	  
treatment	   and	   live	   and	   dead	   cells	   distinguished	   by	   staining	  with	   Trypan	  Blue	  
solution.	   Counting	  was	   carried	   out	   in	   triplicate	   using	   a	   Countess	   Cell	   Counter	  
(Invitrogen).	  	  
	  
2.2.3	  Survival	  studies	  
To	   investigate	   cell	   survival	   after	   DNA	   damage,	   wild-­‐type	   and	   LSH-­‐deficient	  
mouse	   or	   human	   fibroblasts	   were	   plated	   on	   10	   cm	   dishes	   in	   triplicate	   at	   a	  
density	  of	  200	  cell/plate	  and	   irradiated	  with	   indicated	  doses	  of	   IR	   in	  a	  Torrex	  	  	  	  
X-­‐ray	  cabinet	  (Faxitron	  Ltd).	  The	  irradiated	  cells	  were	  left	  to	  recover	  and	  form	  
colonies	  for	  10-­‐14	  days,	  stained	  with	  Giemsa	  and	  counted.	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2.2.4	  Laser	  micro-­irradiation	  
VA13	  cells	  expressing	  GFP-­‐tagged	  LSH,	  were	  seeded	  at	  1x105	  over	  cover	  slips	  in	  
a	   35	   mm	   dish.	   Cells	   were	   pre-­‐sensitised	   to	   UV-­‐A	   irradiation	   with	   10	   µM	   of	  	  	  	  	  	  	  	  	  	  
5-­‐bromo-­‐2’-­‐deoxyuridine	   (BrdU,	   Sigma	   Aldrich)	   in	   Dulbecco	   modified	   Eagle	  
medium	   for	  24	  h.	  Laser	  micro-­‐irradiations	  were	  carried	  out	  using	  a	  Lieca	  SP5	  
confocal	  microscope	  (Lieca)	  equipped	  with	  a	  37°C	  heating	  stage	  and	  a	  405	  nm	  
laser	  diode	  (20	  mW)	  focused	  through	  a	  40x	  HCX	  PL	  APO	  CS/1.25	  oil	  objective.	  
Laser	  settings	  (0.40	  mW	  output,	  50	  scans)	  were	  chosen	  to	  generate	  a	  detectable	  
damage	   response	   in	   a	   BrdU	   presensitised,	   dependent	   manner.	   Data	   was	  
analysed	  using	  ImagePro	  9.0	  software	  (Media	  Cybernetics).	  
	  
2.3	  DNA	  manipulation	  and	  analysis	  
2.3.1	  Genomic	  DNA	  extraction	  
Cells	   were	   resuspended	   in	   DNA	   isolation	   buffer,	   and	   treated	  with	   100	  µg/ml	  
RNase	  A	  for	  15	  minutes	  at	  37°C.	  Following	  RNase	  treatment,	  SDS	  and	  Proteinase	  
K	  were	  added	  to	  1%	  (w/v)	  and	  200	  µg/ml	  respectively	  and	  incubated	  overnight	  
at	   65°C.	   Digested	   peptides	   were	   removed	   by	   two	   extractions	   with	  
phenol:chloroform:isoamyl	   alcohol	   and	   a	   single	   extraction	   with	   chloroform.	  
DNA	  was	  precipitated	  by	  addition	  of	  0.7	  volumes	  isopropanol	  and	  centrifuged	  at	  
13000	   rpm	   for	   15	   minutes	   at	   4°C.	   The	   DNA	   was	   washed	   twice	   with	   70%	  
ethanol,	  allowed	  to	  dry	  and	  resuspended	  in	  500	  µl	  of	  TE.	  
	  
2.3.2	  5-­methylcytosine	  ELISA	  assay	  
The	   global	   levels	   of	   5-­‐methyl	   cytosine	   in	   the	   genome	   of	   MRC5hT,	   shLSH	   and	  	  
non-­‐silencing	   control	   cells	  were	   investigated	   by	   ELISA	   assays	   using	   ImprintTM	  
kit	  (Sigma	  Aldrich)	  according	  to	  manufacturer’s	  instructions.	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2.3.3	  Comet	  assays	  
Cells	  were	  plated	  on	  10	  cm	  dishes	  at	  ~60%	  confluency	  and	  cultured	  overnight.	  
Cells	   were	   subjected	   to	   10	   Gy	   of	   ionising	   radiation	   and	   either	   collected	  
immediately	  or	  left	  to	  recover	  for	  8	  hours.	  Cells	  were	  diluted	  to	  6x105	  cells/ml	  
with	   PBS,	   then	   mixed	   1:10	   with	   0.6%	   low	   melting	   point	   agarose.	   55	   µL	   of	  
sample	  were	  pipette	  onto	  glass	  slides	  pre-­‐coated	  with	  1%	  agarose	  and	  left	  to	  set	  
for	  10	  minutes.	  Slides	  were	  placed	  in	  lysis	  buffer	  (2.5	  M	  NaCl,	  10	  mM	  Tris,	  1%	  
Triton-­‐X,	  pH	  10)	  overnight	  at	  4°C.	  Lysis	  buffer	  was	  removed,	  the	  slides	  washed	  
twice	  with	  dH2O	  and	  electrophoresis	  was	   carried	  out	   in	   a	   cold	   alkaline	  buffer	  
(300	  mM	  NaCl,	   1	  mM	  EDTA,	   pH	   13)	   at	   100	   A,	   12	   V	   for	   20	  mins.	   Slides	  were	  
neutralised	  with	  three	  5	  minute	  washes	  with	  cold	  0.4	  M	  Tris,	  pH	  7.5	  followed	  by	  
10	  minutes	  washing	  with	  cold	  dH2O.	  Staining	  was	  carried	  out	  with	  a	  20	  µg/ml	  
propidium	   iodide	   solution	   followed	   by	   two,	   5	   minute	   washes	   in	   cold	   dH2O.	  
Images	   were	   collected	   by	   Olympus	   BX61	   microscope	   equipped	   with	   20X	  
objectives	   and	   AnalySIS	   software	   (Soft	   Imaging	   Systems).	   Comet	   tail	   lengths	  
were	   quantified	   using	   customised	   macro	   in	   ImagePro	   9.0	   software	   (Media	  
Cybernetics).	  
	  
2.4	  Protein	  manipulation	  and	  analysis	  
2.4.1	  Nuclear	  protein	  extraction	  
Nuclei	  were	  prepared	  by	  disrupting	  the	  cells	   in	  hypotonic	  buffer	  (NE1).	  Nuclei	  
were	  released	  by	  10	  plunges	  of	  a	  dounce	  homogeniser.	  Nuclei	  were	  recovered	  
by	   centrifugation	   at	   3000	   rpm	   for	   5	  min	   at	   4°C.	  Nuclei	  were	   re-­‐suspended	   in	  
NE1	  buffer	  supplemented	  with	  25	  U	  of	  Benzonase	  nuclease	  (Merck).	  	  Following	  
1	  hour	   incubation	  on	   ice,	  NaCl	  was	   added	   to	   a	   final	   concentration	  of	  500	  mM	  
and	  incubated	  at	  4°C	  for	  1	  hour.	  After	  centrifugation,	  supernatant	  containing	  the	  
nuclear	   proteins	   was	   collected.	   All	   buffers	   were	   supplemented	   with	  
phosphatase	  (Pierce)	  and	  protease	  inhibitors	  (Sigma	  Aldrich).	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2.4.2	  Chromatin	  retention	  assays	  
Cells	   were	   plated	   on	   20	   cm	   dishes	   at	   ~60%	   confluency,	   subjected	   to	   the	  
indicated	  dose	  of	   IR	  and	  collected	  at	   the	   indicated	  time	  point	  after	   irradiation.	  
Nuclei	   were	   prepared	   by	   disrupting	   the	   cells	   in	   hypotonic	   buffer	   (NE1)	   as	  
previously	  described	  (section	  2.4.1).	  Soluble	  nuclear	  proteins	  and	  those	  loosely	  
associated	   with	   chromatin	   were	   extracted	   using	   NE1	   supplemented	   with	  	  	  	  	  	  	  	  
100	  mM	  NaCl.	  After	  centrifugation,	  pellets	  containing	  chromatin	  bound	  proteins	  
were	   resuspended	   in	   NE1	   buffer	   supplemented	   with	   25	   U	   of	   Benzonase	  
nuclease	  (Merck).	  	  Following	  1	  hour	  incubation	  on	  ice,	  NaCl	  was	  added	  to	  a	  final	  
concentration	  of	  500mM	  and	  incubated	  at	  4°C	  for	  1	  hour.	  After	  centrifugation,	  
supernatant	   containing	   the	   chromatin-­‐associated	   proteins	   was	   collected.	   All	  
buffers	  were	  supplemented	  with	  phosphatase	  (Pierce)	  and	  protease	   inhibitors	  
(Sigma	  Aldrich).	  
	  
2.4.3	  Measuring	  protein	  concentration	  
Protein	   concentration	   was	   measured	   using	   a	   BCA	   Protein	   Assay	   (Pierce	  
Biotechnology).	  Stock	  reagents	  A	  and	  B	  were	  mixed	  together	  at	  a	  50:1	  ratio	  and	  
1	  µL	  protein	  sample	  added	  to	  1	  mL	  of	  the	  mixture.	  The	  reagent	  was	  incubated	  at	  
65°C	  for	  15	  minutes	  after	  which	  absorbance	  at	  562	  nm	  was	  measured.	  Protein	  




70	   µg	   of	   each	   nuclear	   extract	   were	   diluted	   in	   SDS-­‐PAGE	   loading	   buffer	   and	  
heated	   for	   5	   min	   at	   100°C	   to	   denature	   proteins.	   0.75	   mm	   thick	   gels	   were	  
assembled	  in	  a	  Bio-­‐Rad	  Mini-­‐Protean	  3	  apparatus.	  All	  gels	  used	  an	  acrylamide	  to	  
bis-­‐acrylamide	  ratio	  of	  29:1	  with	  0.1%	  SDS.	  The	  acrylamide	  was	  polymerised	  by	  
the	  addition	  of	  ammonium	  persulfate	  and	  TEMED	  as	  a	  catalyst.	  Gels	  consisted	  of	  
a	  stacking	  gel	  buffered	  at	  pH	  6.8	  and	  a	  separating	  gel	  at	  pH	  8.8.	  Gels	  were	  run	  at	  
270V.	  
	   45	  
2.4.5	  Wet	  transfer	  to	  nitrocellulose	  membrane	  
Wet	   transfer	   was	   carried	   out	   on	   a	   Bio-­‐Rad	   Mini	   Trans-­‐Blot	   Electrophoretic	  
Transfer	   Cell	   according	   to	   the	   manufacturer’s	   recommendations.	   A	   layer	   of	  	  	  	  	  
0.3	  mm	  Whatman	  paper	  was	  placed	  on	  the	  SDS-­‐PAGE	  gel	  and	  soaked	  in	  transfer	  
buffer.	  A	  Trans-­‐Blot	   transfer	  membrane	  (BioRad)	  was	  pre-­‐wetted	   in	  dH20	  and	  
placed	   on	   top	   of	   the	   gel.	   For	   the	   transfer	   of	   histones,	   Immuno-­‐Blot	   PVDF	  
Membrane	  (BioRad)	  membrane	  pre-­‐wetted	  in	  methanol	  was	  used.	  An	  additional	  
layer	  of	  0.3	  mm	  Whatman	  paper	  pre-­‐soaked	  in	  transfer	  buffer	  was	  placed	  on	  top	  
on	   the	  gel.	  The	   construct	  was	  assembled	   into	   the	  gel	  holder	   cassette	  between	  
two	   fibre	  pads	  also	  pre-­‐soaked	   in	   transfer	  buffer.	  The	  assembled	  cassette	  was	  
inserted	  into	  the	  electrode	  module	  and	  transferred	  with	  270	  V	  for	  1	  hour.	  After	  
transfer	   the	   gel	   sandwich	  was	   disassembled	   and	   the	  membrane	   stained	  with	  
PonceauS	  stain	  to	  ensure	  efficient	  transfer.	  
	  
2.4.6	  Western	  Blots	  
Membranes	  were	  blocked	  in	  TBS	  supplemented	  with	  2%	  milk	  and	  0.1%	  Tween,	  
for	  1	  hour.	  Fresh	  blocking	  solution	  containing	  a	  1:1000	  dilution	  of	  the	  primary	  
antibody	   was	   applied	   and	   incubated	   overnight	   at	   4°C.	   Unbound	   primary	  
antibody	  was	  removed	  by	  three	  consecutive	  15	  minute	  washes	  with	  PBS	  /	  0.1%	  
Tween.	  Membranes	  were	  blocked	  again,	   for	  1	  hour	   at	   room	   temperature.	  The	  
secondary	   antibody	   was	   applied	   at	   a	   dilution	   of	   1:2000	   in	   fresh	   blocking	  
solution	   for	   3	   hours	   at	   room	   temperature.	   Unbound	   secondary	   antibody	  was	  
removed	   by	   three	   consecutive	   15	   minute	   washes	   with	   PBS	   /	   0.1%	   Tween.	  
Membranes	   were	   imaged	   on	   an	   Odyssey	   Imager	   (LiCOR	   Biosciences)	   and	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2.4.7	  Immunofluorescence	  
Cells	  were	  seeded	  over	  cover	  slips	  in	  a	  35	  mm	  dish	  and	  cultured	  overnight.	  Cells	  
were	  fixed	  either	  with	  4%	  paraformaldehyde	  for	  5	  minutes	  or	  with	  cold	  100%	  
methanol	   for	   1	  minute.	   After	   fixation	   cell	   and	   cover	   slips	  were	  washed	   twice	  
with	  PBS	  and	  before	  incubating	  in	  PBS	  with	  0.1%	  Triton	  (Sigma)	  at	  37°C	  for	  15	  
minutes	   to	   permeablise	   the	   cell	  membranes.	   Fixed	   cells	   were	   blocked	   in	   PBS	  
with	   4%	   (w/v)	   immunofluorescence	   grade	   BSA	   (Fisher	   Scientific)	   for	   1	   hour.	  
Fresh	  blocking	  solution	  containing	  a	  dilution	  of	  primary	  antibody	  was	  applied	  
for	  1	  hour	  at	  room	  temperature.	  Fixed	  cells	  were	  washed	  three	  times	  in	  PBS	  for	  
10	   minutes	   before	   blocked	   again	   for	   30	   minutes	   at	   room	   temperature.	   The	  
secondary	   antibody	   was	   applied	   at	   a	   dilution	   of	   1:1000	   in	   fresh	   blocking	  
solution	  for	  1	  hour	  at	  room	  temperature.	  Fixed	  cells	  were	  washed	  three	  times	  in	  
PBS	   for	   10	   minutes	   and	   counterstained	   with	   DAP.	   Fixed,	   stained	   cells	   were	  
washed	   in	   PBS	   before	  mounting	   in	   Vectashield	   (Vector	   Laboratories).	   Images	  
were	   collected	   by	   Olympus	   BX61	   microscope	   equipped	   with	   20x	   and	   40x	  
PlanApo	  objectives	  (Olympus),	  ColorViewII	  camera	  and	  AnalySIS	  software	  (Soft	  
Imaging	  Systems).	  Where	  indicated,	  fluorescent	  images	  were	  quantified	  using	  a	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Results	  -­	  Chapter	  Three	  	  
3.0	  Identification	  of	  a	  sensitised	  DNA	  damage	  phenotype	  in	  LSH	  
depleted	  mammalian	  cells	  
	  
3.1	  Introduction	  
Initial	   identification	   and	   characterisation	   of	   the	   LSH	   homolog,	   DDM1	   in	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
A.	   thaliana	   showed	   a	   loss	   in	   DNA	   methylation	   by	   up	   to	   70%	   to	   be	   a	   major	  
phenotype	  associated	  with	  deletion	  of	  this	  protein	  (Shaked	  et	  al	  2006).	  	  Further	  
studies	   of	   the	   homologous	   mammalian	   protein,	   LSH,	   have	   also	   shown	   a	  
conserved	  role	   in	  DNA	  methylation	   in	  mammals	   (Geiman	  et	  al	  2001,	  Sun	  et	  al	  
2004).	  However	   the	   initial	   characterisation	  of	  DDM1	  also	   indicated	   that	  ddm1	  	  
A.	   thaliana	  have	  an	   increased	  sensitivity	   to	   the	  DNA	  damaging	  agents,	  UV	  and	  
gamma	   irradiation,	   which	   was	   found	   to	   be	   independent	   of	   the	   loss	   of	   DNA	  
methylation	  (Shaked	  et	  al	  2006).	  This	  increased	  sensitivity	  to	  DNA	  damage	  has	  
not	  been	  further	  characterised	  since	  it’s	  preliminary	  description.	  	  
Conservation	   of	   the	   LSH	  homolog,	   IRC5	   in	  S.	   cerevisiae,	   despite	   a	   lack	   of	  DNA	  
methylation	   in	   this	   species	   indicated	   an	   additional	   function	  of	   IRC5.	   Synthetic	  
growth	  defects	  of	  IRC5	  double	  mutants	  highlighted	  interactions	  with	  members	  
of	  the	  homologous	  recombination	  pathway	  (Collins	  et	  al	  2007),	  which	  suggested	  
a	  role	  for	  IRC5	  in	  the	  DNA	  damage	  response.	  The	  premature	  ageing	  phenotype	  
of	   surviving	   Lsh-­/-­	   mice	   produced	   by	   Sun	   et	   al	   2004	   and	   meiotic	   defects	   in	  
oocytes	  derived	  from	  Lsh-­/-­	  embryos	  (De	  La	  Fuente	  et	  al	  2006)	  could	  both	  be	  the	  
result	  of	  defects	  in	  DNA	  repair.	  Defects	  caused	  by	  the	  mutation	  of	  LSH	  homologs	  
in	   	   	   	   	  A.	   thaliana	   and	  S.	   cerevisiae,	   coupled	  with	  observations	   from	  Lsh-­/-­	  mice,	  
suggested	   that	   in	   addition	   to	   a	   role	   in	   DNA	   methylation,	   LSH	   may	   have	   a	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3.2	   LSH	   KD	   MRC5hT	   cells	   show	   a	   higher	   degree	   of	   cell	   death	   following	  
treatment	   with	   DSB	   inducing	   agents	   but	   not	   with	   other	   forms	   of	   DNA	  
damaging	  agents	  	  
To	  test	  whether	  LSH	  has	  a	  conserved	  function	  in	  the	  mammalian	  DNA	  damage	  
response,	  we	  wished	   to	   perform	  a	   screen	   of	   various	  DNA	  damaging	   agents	   in	  
order	   to	   determine	   if	   LSH	   depleted	   cells	   have	   enhanced	   sensitivity.	   LSH	   was	  
depleted	  by	  shRNA	  knockdown	  in	  human	  lung	  fibroblast	  (Figure	  3.1),	  which	  had	  
been	   previously	   immortalised	   by	   the	   introduction	   of	   human	   telomerase	  
(MRC5hT)	   (produced	   by	   Kat	   Gordon,	   unpublished).	   These	   provided	   a	   suitable	  
comparison	   for	   screening	   as	   both	   shLSH	   and	   non-­‐silencing	   controls	   were	  
derived	   from	   the	   same	   genetic	   background	   and	   following	   knockdown	   of	   LSH,	  
MRC5hT	  cells	  had	  similar	  global	  levels	  of	  DNA	  methylation	  (Burrage	  et	  al	  2012).	  
Figure	   3.1:	   Nuclear	   extracts	   examined	   by	   Western	   blotting	   using	   an	   anti-­‐LSH	   primary	  
antibody	   to	   examine	   shLSH	   knockdown	   efficiency	   in	   MRC5hT	   cells.	   An	   anti-­‐HDAC1	  
antibody	  was	  as	  a	  loading	  control.	  The	  graph	  shows	  LSH	  expression	  relative	  to	  HDAC1	  as	  a	  
percentage	  of	  WT	  LSH	  expression	  (Quantified	  using	  Odyssey	  V3.0).	  
Sensitivity	   to	  DNA	  damaging	   agents	  was	  determined	  by	   counting	   cell	   viability	  
48	   hours	   and	   96	   hours	   after	   treatment.	   Viability	   was	   established	   by	   staining	  
cells	  with	  a	  negatively	  charged	  chromopore,	  Trypan	  Blue,	  which	  can	  only	  enter	  
a	  cell	  if	  the	  membrane	  is	  damaged.	  Viable	  cells	  exclude	  Trypan	  Blue	  and	  appear	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• UV	   was	   used	   to	   create	   pyrimidine	   dimers,	   which	   are	   repaired	   by	   the	  
nucleotide	   excision	   repair	   pathway.	   This	   was	   of	   particular	   interest	   since	  
ddm1	  A.	  thaliana	  have	  an	  increased	  sensitivity	  to	  UV.	  	  	  
• MMS	   treatment	   was	   used	   to	   induce	   mainly	   double	   strand	   breaks	   (DSBs),	  
although	   MMS	   is	   known	   to	   methylate	   DNA	   at	   N7-­‐deoxyguanine	   and	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
N3-­‐deoxyadenine.	  Its	  mechanism	  of	  DSB	  formation	  is	  still	  unclear.	  	  	  
• H2O2	   and	   ionising	   radiation	  where	  used	   to	   induce	  oxidative	  damage,	  which	  
creates	  double	  and	  single	  strand	  breaks.	  
• Hydroxyurea	  was	  used	  to	  deplete	  the	  nucleotide	  pool	  and	  induce	  replication	  
fork	   collapse,	   generating	   both	   double	   and	   single	   strand	   breaks	   although	  
through	  a	  different	  mechanism	  to	  H2O2	  and	  ionising	  radiation.	  
• Bleomycin	  is	  an	  intercalating	  agent	  with	  several	  actions,	  able	  to	  create	  both	  
single	  and	  double	  strand	  breaks.	  However	  treatment	  is	  used	  to	  induce	  mainly	  
single	  strand	  breaks	  (SSBs)	  at	  a	  ratio	  approximately	  7	  fold	  higher	  than	  DSB	  
induction	  (Stubbe	  et	  al	  2008).	  
The	  results	  of	  the	  viability	  study	  showed	  that	  20	  J/m2	  UV	  reduced	  the	  viability	  
of	   both	   shLSH	   and	  non-­‐silencing	   control	  MRC5hT	   cells	   by	   approximately	   40%,	  	  
96	  h	  post	  treatment	  (Figure	  3.2).	  Interestingly	  shLSH	  MRC5hT	  cells	  do	  not	  have	  
an	   increased	   sensitivity	   to	   UV	   unlike	   ddm1	   A.	   thaliana.	   96	   h	   after	   H2O2	   or	  
ionising	  radiation	  treatment,	  shLSH	  MRC5hT	  had	  reduced	  viability	  compared	  to	  
non-­‐silencing	  control	  cells.	  0.03%	  H2O2	  only	  caused	  reduced	  viability	   in	  shLSH	  
MRC5hT	   cells,	   but	   a	   5	   Gy	   dose	   of	   ionising	   radiation	   was	   more	   damaging	   and	  
reduced	  the	  viability	  of	  non-­‐silencing	  and	  shLSH	  MRC5hT	  cells	  by	  29%	  and	  48%	  
respectively	  (Figure	  3.2).	   	  This	   indicated	  that	  LSH	  depleted	  cells	  are	  sensitised	  
to	   oxidative	   damage,	   consistent	   with	   findings	   from	   γ-­‐irradiation	   of	   ddm1	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Figure	  3.2:	  	  Graphs	  comparing	  viability	  of	  untreated	  and	  treated	  shLSH	  and	  non-­‐silencing	  
control	  MRC5hT	  cells	  as	  determined	  by	  Trypan	  Blue	  staining,	  48	  h	  and	  96	  h	  after	  treatment	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2	  mM	  Hydroxyurea	   treatment	  also	  caused	  a	  decrease	   in	   the	  viability	  of	  shLSH	  
MRC5hT	   over	   non-­‐silencing	   controls	   (Figure	   3.2).	   Hydroxyurea	   induces	   a	  
mixture	  of	  single	  and	  double	  strand	  break.	  However	  MMS	  treatment	  exclusively	  
causes	  DSBs,	  and	  showed	  reduced	  viability	  of	  shLSH	  MRC5hT	  cells	  compared	  to	  
non-­‐silencing	  controls	  96	  h	  after	  treatment.	  Bleomycin	  treatment	  only	  caused	  a	  
modest	   decrease	   in	   viability	   and	   did	   not	   have	   a	   sensitising	   effect	   on	   shLSH	  
MRC5hT	  cells.	  
These	   preliminary	   viability	   screening	   data	   suggest	   that	   mammalian	   cells	  
depleted	   of	   LSH	   are	   sensitive	   to	   DSB	   inducing	   agents,	   consistent	   with	   a	  
conserved	  function	  of	  LSH	  in	  DNA	  repair.	  	  However	  the	  function	  of	  LSH	  has	  not	  
been	   completely	   conserved,	   as	  depletion	  of	  LSH	  does	  not	   sensitise	   cells	   to	  UV	  
unlike	  DDM1	  knockout	  in	  A.	  thaliana.	  
	  
3.3	  LSH	  KD	  MRC5hT	  and	  Lsh-­/-­	  MEFs	  are	  sensitised	  to	  ionising	  radiation	  
To	   further	   investigate	   the	   function	   of	   LSH	   in	   the	   DNA	   damage	   response	   we	  
performed	   survival	   studies	   on	   both	   shLSH	   MRC5hT	   and	   Lsh-­/-­	   MEFs.	   These	  
studies	  involved	  seeding	  cells	  at	  a	  low,	  single	  cell	  density	  just	  prior	  to	  treatment.	  
Each	  colony	  represents	  a	  single	  cell	  that	  survived.	  Examining	  the	  MEFs	  provided	  
the	   opportunity	   to	   study	   the	   function	   of	   LSH	   in	   a	   mammalian	   DNA	   damage	  
response	  other	  than	  H.	  sapiens.	  Survival	  studies	  were	  carried	  out	  using	  ionising	  
radiation,	  as	   this	  produced	  the	  most	  significant	  difference	   in	  viability	  between	  
non-­‐silencing	  and	  shLSH	  MRC5hT	  cells.	  The	  effects	  of	  x-­‐rays	  also	  closely	  mirror	  
those	   of	   gamma	   irradiation,	   to	   which	   ddm1	   A.	   thaliana	   have	   an	   increased	  
sensitivity.	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Figure	  3.3:	  Giemsa	  stained	  plates	  and	  colony	  counts	  of	  WT	  and	  Lsh-­‐/-­‐	  MEFs	  and	  shLSH	  and	  
non-­‐silencing	   control	  MRC5hT	   cells	   plated	   at	   100	   cells	   per	   dish	   and	   irradiated	   with	   the	  
indicated	  dose	  of	  ionising	  radiation.	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The	   results	   show	   that	   the	   survival	   of	   shLSH	   MRC5hT	   cells	   following	   ionising	  
radiation	   treatment	   was	   decreased	   compared	   to	   the	   non-­‐silencing	   controls	  
(Figure	  3.3).	  This	  agrees	  with	  the	  reduced	  viability	  of	  shLSH	  MRC5hT	  cells,	  96	  h	  
after	  a	  5	  Gy	  dose	  of	  ionising	  radiation.	  Lsh-­/-­	  MEFs	  also	  show	  decreased	  survival	  
following	   ionising	   radiation	   treatment	   compared	   WT	   cells	   from	   a	   matched	  
littermate	   (Figure	  3.3).	  However	   the	  MEFs	  have	  a	  much	  greater	   tolerance	  and	  
can	  withstand	  higher	  doses	  of	   ionising	   radiation	   than	  MRC5hT	   cells.	   	  Although	  
these	   data	   show	   that	   LSH	   deficient	   cells	   have	   a	   reduced	   tolerance	   to	   DSB	  
inducing	  agents	  leading	  to	  decreased	  survival,	   it	   is	  unclear	  whether	  this	  is	  due	  
to	   a	   failure	   to	   repair	   breaks	   or	   the	   result	   of	   a	   larger	   number	   of	   breaks	   being	  
induced	  in	  LSH	  depleted	  cells.	  	  
	  
3.4	  Lsh-­/-­	  MEFs	  repair	  DSBs	  less	  efficiently	  
The	  increased	  sensitivity	  of	  LSH	  deficient	  cells	  to	  DSB	  inducing	  agents	  could	  be	  
due	   to	   defects	   in	   DSB	   repair	   or	   from	   an	   increase	   in	   the	   number	   of	   breaks	  
induced	  in	  LSH	  deficient	  cells.	  To	  further	  investigate	  why	  LSH	  deficient	  cells	  are	  
more	   sensitive	   to	   ionizing	   radiation	   a	   neutral	   comet	   assay	  was	   performed	   to	  
establish	   if	   the	   same	   number	   of	   DSBs	   were	   induced	   in	   Lsh-­/-­	   and	   WT	   MEFs	  
Following	  10	  Gy	  ionizing	  radiation,	  cells	  were	  immobilised	  in	  agarose	  on	  a	  glass	  
slide	   and	   lysed	   in	   situ.	   Electrophoresis	   was	   carried	   out	   in	   a	   neutral	   buffer	  
followed	   by	   propidium	   iodide	   staining.	   The	   greater	   the	   number	   of	   DSBs	  
induced,	  the	  more	  fragmented	  the	  DNA,	  leading	  to	  a	  proportional	  increase	  in	  the	  
distance	   the	   DNA	   travels	   away	   from	   the	   nucleus.	   A	   measure	   of	   this	   distance	  
away	  from	  the	  nucleus	  or	  ‘tail’	  gives	  a	  relative	  indication	  of	  the	  number	  of	  DSBs	  
induced.	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Figure	   3.4:	   Representative	   images	   of	   comet	   assays	   performed	   on	  WT	   and	   Lsh-­‐/-­‐	   MEFs.	  
Graphs	  show	  average	  tail	  lengths	  of	  n=35	  cells	  measured	  from	  the	  centre	  of	  the	  nucleus	  
and	  percentage	  of	  damage	  repaired	  by	  plotting	  tail	   length	  at	  8	  h	  as	  a	  proportion	  of	   tail	  
length	  after	  irradiation	  minus	  NoIR	  background	  tail	  length.	  
Prior	  to	  treatment	  both	  WT	  and	  Lsh-­/-­	  MEFs	  had	  little	  or	  no	  tail,	  indicating	  intact,	  
unbroken	  DNA	  (Figure	  3.4).	  However	  immediately	  after	  a	  10	  Gy	  dose	  of	  ionising	  
radiation	  both	  WT	  and	  Lsh-­/-­	  MEFs	  had	  longer	  tails	  as	  a	  result	  of	  DSBs	  induced	  
by	   the	   ionising	   radiation	   treatment.	  There	  was	  no	  significant	  difference	   in	   the	  
tail	   length	  between	  WT	  and	  Lsh-­/-­	  MEFs	   (Figure	  3.4),	  which	   indicates	   that	   the	  
same	  number	  of	  DSBs	  have	  been	  generated	  in	  both	  cell	  lines.	  From	  this	  we	  can	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In	  addition	  to	  examining	  the	  tail	  length	  immediately	  post	  treatment	  we	  also	  left	  
cells	  to	  recover	  for	  8	  h	  before	  carrying	  out	  comet	  assays.	  Since	  a	  10	  Gy	  dose	  of	  
ionising	   radiation	   induced	   the	   same	   number	   of	   DSBs	   in	   both	   WT	   and	   Lsh-­/-­	  
MEFs,	   the	   tail	   length	   8	   h	   post	   treatment	   gives	   an	   indication	   of	   the	   relative	  
efficiency	   of	  DSB	   repair.	   	   In	   this	   case	  WT	  MEFs	   had	   significantly	   shorter	   tails	  
than	  Lsh-­/-­	  MEFs	  (Figure	  3.4),	  suggesting	  that	  lack	  of	  LSH	  results	  in	  less	  efficient	  
repair	   of	  DSBs.	  When	   the	   tail	   length	   at	   8	   h	   is	   plotted	   as	   a	   function	   of	   the	   tail	  
length	  immediately	  post	  treatment,	  it	  appears	  that	  Lsh-­/-­	  MEFs	  repair	  DSBs	  with	  
half	  the	  efficiency	  of	  WT	  MEFs.	  
	  
3.5	  Summary	  
Depletion	  of	  LSH	  in	  mammalian	  cells	  increases	  their	  sensitivity	  to	  DSB	  inducing	  
agents	  (Figures	  3.2).	  These	  cells	  repair	  DSBs	  less	  efficiently	  (Figure	  3.4),	  leading	  
to	   a	   decrease	   in	   viability	   post	   treatment	   and	   reduced	   survival	   compared	   to	  
control	  cells	  (Figure	  3.3).	  These	  data	  confirm	  a	  conserved	  requirement	  for	  LSH	  
in	   mammalian	   DNA	   repair,	   specifically	   in	   the	   repair	   of	   DSBs.	   However	   its	  
homologous	   protein	   in	   A.	   thaliana,	   DDM1,	   is	   also	   required	   for	   repair	   of	   UV	  
induced	  pyrimidine	  dimers,	  a	  function	  which	  does	  not	  appear	  to	  be	  conserved	  in	  
mammalian	   cells.	   Although	   these	   data	   show	   that	   LSH	   is	   required	   for	   efficient	  
DSB	  repair	  they	  do	  not	  give	  any	  indication	  of	  how	  LSH	  functions	  to	  aid	  in	  repair.	  
To	   further	   characterise	  why	  LSH	   is	   required	   for	  DSB	   repair	  we	   compared	   the	  
DSB	   repair	   response	   of	  WT	   and	   LSH	   deficient	   cells	   in	   greater	   detail.	  We	   also	  
examined	  the	  other	  effects	  of	  LSH	  depletion	  for	  any	  indirect	  causes	  of	  the	  DSB	  
repair	   phenotype,	   such	   as	   the	   loss	   of	   DNA	   methylation	   or	   changes	   in	   the	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Although	  we	  had	  identified	  a	  DSB	  repair	  phenotype	  in	  LSH	  deficient	  cells,	  it	  was	  
unclear	   how	   LSH	   functions	   to	   aid	   DSB	   repair.	   Repair	   of	   DSBs	   is	   a	   complex	  
process	   involving	  several	  stages	  and	  many	   interacting	  proteins.	  The	  cells	  have	  
to	   first	   correctly	  detect	   the	  presence	  of	  DSBs	  and	   signal	   checkpoints	   to	   arrest	  
the	  cell	  cycle	  while	  the	  breaks	  are	  repaired.	  Mediator	  proteins	  bind	  at	  the	  break	  
to	  aid	   in	  the	  recruitment	  of	  repair	  proteins,	  which	  prepare	  the	  broken	  end	  for	  
repair	  by	  either	  HR	  or	  NHEJ	  and	  maintain	   signalling	   to	   cell	   cycle	   checkpoints.	  
Finally	  the	  break	  has	  to	  be	  repaired	  and	  native	  epigenetic	  marks	  and	  chromatin	  
state	   restored.	  By	   identifying	  which	  parts	   of	   the	  DSB	   response	   are	   affected	   in	  
LSH	  depleted	  cells	  we	  hoped	  to	  be	  able	  to	  hypothesise	  how	  LSH	  may	  be	  involved	  
in	  repair.	  
We	  also	  needed	   to	   consider	  other	   indirect	  ways	   in	  which	  LSH	  may	  affect	  DSB	  
repair.	   LSH	   deficient	   cells	   are	   known	   to	   lose	   a	   large	   proportion	   of	   their	   DNA	  
methylation.	  This	   could	   effect	   chromatin	   compaction	   and	   alter	  how	  efficiently	  
the	  repair	  machinery	  can	  assemble	  at	  broken	  DNA	  ends.	  Alternative,	  LSH	  may	  
affect	   the	   distribution	   of	   variant	   histone	   H2AX,	   which	   is	   normally	   found	   at	  
approximately	   every	   fifth	   nucleosome	   and	   required	   as	   a	   major	   recruitment	  
factor	   for	   DSB	   repair	   and	   signalling	   proteins.	   LSH	   is	   also	   a	   HDAC	   dependent	  
transcriptional	   repressor	   and	   LSH	   deficient	   cells	   may	   have	   changes	   in	  
expression	   of	   DSB	   repair	   proteins,	   which	   could	   be	   causing	   the	   DSB	   repair	  
phenotype	  in	  LSH	  deficient	  cells.	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4.2	   Lsh-­/-­	   MEFs	   have	   no	   significant	   changes	   in	   expression	   of	   known	  DSB	  
response	  proteins	  
Firstly,	  we	  examined	  if	  the	  increased	  sensitivity	  to	  DSB	  causing	  agents	  could	  be	  
caused	   by	   changes	   in	   expression	   of	   known	   components	   of	   the	   DSB	   response.	  	  
Previous	  work	  carried	  out	   in	   the	   lab	  used	  expression	  arrays	   to	  compare	  Lsh-­/-­	  
MEFs	  with	  WT	  MEFS	   from	  matched	   littermates	   (Myant	  et	  al	   2011).	   From	   this	  
expression	  data	  known	  components	  of	  the	  DSB	  repair	  pathway	  were	  extracted	  
and	   found	   to	   not	   have	   any	   changes	   in	   expression	   greater	   than	   a	   1.5	   fold	  
difference	  between	  WT	  and	  Lsh-­/-­	  MEFs	  (Table	  4.1).	  This	  suggested	  that	  the	  DSB	  
phenotype	  of	  Lsh-­/-­	  MEFs	  was	  not	   the	  result	  of	   changes	   in	  expression	  of	  know	  







H2AX	   15270	   H2A	  histone	  family,	  member	  X	   0.9	  
Mre11	   17535	   Meiotic	  recombination	  11	   0.7	  
Rad50	   19360	   RAD50	  homolog	  (S.	  cerevisiae)	   0.9	  
Nbs	   27354	   Nibrin,	  Cell	  cycle	  regulatory	  protein	  p95	   0.9	  
Ku70	   14375	   X-­‐ray	  repair	  complementing	  defective	  repair	   0.6	  
Ku80	   22596	   X-­‐ray	  repair	  complementing	  defective	  repair	   0.9	  
Atm	   11920	   Ataxia	  telangiectasia	  mutated	  homolog	  (H.	  sapien)	   0.8	  
DNA-­‐PK	   19090	   Protein	  kinase,	  DNA	  activated,	  catalytic	  polypeptide	   1.5	  
CtIP	   225182	   Retinoblastoma	  binding	  protein	  8	   0.7	  
Xrcc2,	  Rad51	   57434	   X-­‐ray	  repair	  complementing	  defective	  repair	   0.5	  
Rad51l3	   19364	   RAD51-­‐like	  3	  (S.	  cerevisiae)	   0.9	  
Rad51c	   114714	   Rad51	  homolog	  c	  (S.	  cerevisiae)	   0.8	  
Rad51l1	   19363	   RAD51-­‐like	  1	  (S.	  cerevisiae)	   0.9	  
Rad51l3	   19364	   RAD51-­‐like	  3	  (S.	  cerevisiae)	   0.9	  
Rpa1	   68275	   Replication	  protein	  A1	   0.7	  
Rad52	   19365	   RAD52	  homolog	  (S.	  cerevisiae)	   0.8	  
Rad54l2	   81000	   Rad54	  like	  2	  (S.	  cerevisiae)	   1.3	  
Rad54l	   19366	   RAD54	  like	  (S.	  cerevisiae)	   0.6	  
Mdc1	   240087	   Mediator	  of	  DNA	  damage	  checkpoint	  1	   0.6	  
p53BP1	   19367	   RAD9	  homolog	  (S.	  pombe)	   0.7	  
Dclre1c	   227525	   DNA	  cross-­‐link	  repair	  1C,	  PSO2	  homolog	  (S.	  cerevisiae)	   1	  
Xrcc4	  (lig3)	   108138	   X-­‐ray	  repair	  complementing	  defective	  repair	   1	  
Xrcc1	  (lig3)	   22594	   X-­‐ray	  repair	  complementing	  defective	  repair	   0.7	  
Xrcc3	  	   74335	   X-­‐ray	  repair	  complementing	  defective	  repair	   1.3	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Rad1	   19355	   RAD1	  homolog	  (S.	  pombe)	   1	  
Rad21	   19357	   RAD21	  homolog	  (S.	  pombe)	   1	  
Rad17	   19356	   RAD17	  homolog	  (S.	  pombe)	   0.9	  
Rad23a	   19358	   RAD23a	  homolog	  (S.	  cerevisiae)	   1.5	  
Rad18	   58186	   RAD18	  homolog	  (S.	  cerevisiae)	   0.6	  
Rad9b	   231724	   RAD9	  homolog	  B	  (S.	  cerevisiae)	   1.5	  
Rad23b	   19359	   RAD23b	  homolog	  (S.	  cerevisiae)	   0.8	  
Rad52	   19365	   RAD52	  homolog	  (S.	  cerevisiae)	   0.8	  
Brca1	   12189	   Breast	  cancer	  1	   0.9	  
Brca2	   12190	   Breast	  cancer	  2	   0.8	  
Chk1	   12649	   Checkpoint	  kinase	  1	  homolog	  (S.	  pombe)	   0.9	  
Chk2	  	   50883	   Checkpoint	  kinase	  2	  homolog	  (S.	  pombe)	   0.6	  
p53	   22059	   Transformation	  related	  protein	  53	   1.5	  
Tip60	   81601	   HIV-­‐1	  tat	  interactive	  protein,	  homolog	  (H.	  sapien)	   1	  
Htatip2	   53415	   HIV-­‐1	  tat	  interactive	  protein	  2,	  homolog	  (H.	  sapien)	   1.4	  
Ddb1	   13194	   Damage	  specific	  DNA	  binding	  protein	  1	   0.9	  
Ddb2	   107986	   Damage	  specific	  DNA	  binding	  protein	  2	   1.4	  
Cul4a	   99375	   Cullin	  4A	   0.7	  
Cul4b	   72584	   Cullin	  4B	   0.8	  
Rnf8	   58230	   Ring	  finger	  protein	  8	   0.6	  
Rnf168	   70238	   Ring	  finger	  protein	  168	   1	  
Smarcal1	   54380	   Swi/SNF	  related,	  actin	  dependent	  chromatin	  regulator	   1.4	  
Ino80	   68142	   INO80	  complex	  homolog	  1	  (S.	  cerevisiae)	   1	  
Smarca3	   20585	   SWI/SNF	  related,	  actin	  dependent	  chromatin	  regulator	   0.4	  
Smarca3	   20585	   SWI/SNF	  related,	  actin	  dependent	  chromatin	  regulator	   0.5	  
Chd1l	   68058	   Chromodomain	  helicase	  DNA	  binding	  protein	  1-­‐like	   0.3	  
Smarcad1	   13990	   SWI/SNF	  related,	  actin-­‐dependent	  chromatin	  regulator	   0.7	  
Snf2h	   93762	   SWI/SNF	  related,	  actin	  dependent	  chromatin	  regulator	   0.7	  
Brg1	   20586	   SWI/SNF	  related,	  actin	  dependent	  chromatin	  regulator	   0.9	  
Brm	   67155	   SWI/SNF	  related,	  actin	  dependent	  chromatin	  regulator	   1	  
Snf2L	   93761	   SWI/SNF	  related,	  actin	  dependent	  chromatin	  regulator	   0.2	  
Chd4	   107932	   Chromodomain	  helicase	  DNA	  binding	  protein	  4	   1.1	  
Ppp1ca	   19045	   Protein	  phosphatase	  1,	  catalytic	  subunit,	  alpha	  isoform	   0.8	  
Ppp2ca	   19052	   Protein	  phosphatase	  2,	  catalytic	  subunit,	  alpha	  isoform	   1	  
Ppp4c	   56420	   Protein	  phosphatase	  4,	  catalytic	  subunit	   1.1	  
Ppp6c	   67857	   Protein	  phosphatase	  6,	  catalytic	  subunit	   1.4	  
Ppm1d	  (Wip1)	   53892	   Protein	  phosphatase	  1D	  magnesium-­‐dependent	   1	  
	  
Table	  4.1:	  Selective	  expression	  array	  data,	  highlighting	  genes	  encoding	  proteins	  that	  have	  
been	   shown	   to	   be	   involved	   the	   DSB	   response.	   The	   data	   shows	   the	   fold	   change	   in	  
expression	  between	  Lsh-­‐/-­‐	  and	  WT	  MEFs.	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4.3	  Lsh-­/-­	  MEF	  correctly	  recognise	  broken	  DNA	  ends	  
To	  explore	  the	  DSB	  repair	  pathway	  in	  greater	  detail	  we	  began	  by	  examining	  if	  
Lsh-­/-­	   MEFs	   could	   correctly	   recognise	   the	   breaks	   induced	   following	   treatment	  
with	  10	  Gy	  of	  ionising	  radiation.	  Initial	  recognition	  is	  carried	  out	  by	  the	  proteins	  
of	   the	  MRN	  complex,	  which	  bind	  to	  the	  broken	  DNA	  ends.	   In	   the	  nucleoplasm,	  
inactive	  dimers	  of	  ATM	  kinase	  are	  signalled	  by	  an,	  as	  yet	  unknown,	  mechanism	  
and	   auto-­‐phosphorylates	   serine	   residue	   1981	   to	   form	   ATM	   monomers	  
(Bakkenist	   &	   Kastan	   2003).	   	   These	   are	   recruited	   to	   the	  MRN	   complex	   at	   the	  
broken	   end	   and	   help	   to	   establish	   the	   mediator	   complex	   through	  
phosphorylation	   of	   a	   range	   of	   key	   recruitment	   proteins	   such	   as	   the	   variant	  
histone	  H2AX.	  
We	  examined	  the	  localisation	  of	  the	  MRN	  complex	  following	  ionising	  radiation	  
treatment	  to	  determine	  if	  DSB	  are	  correctly	  recognised	  in	  the	  Lsh-­/-­	  MEFs.	  Initial	  
investigations	  were	  made	   using	   immunofluorescence	   imaging	   to	   visualise	   the	  
localisation	   of	   RAD50,	   NBS1	   or	   MRE11	   following	   a	   10	   Gy	   dose	   of	   ionising	  
radiation.	  Unfortunately,	  antibodies	  against	  all	  3	  members	  of	  the	  MRN	  complex	  
proved	   unsuitable	   for	   immunofluorescence	   in	   our	   hands.	   We	   therefore	  
performed	   chromatin	   retention	   studies	   of	   MRE11	   which	   utilised	   a	   low	   salt	  
nuclear	  extraction	  followed	  by	  Benzonase	  endonuclease	  treatment	  and	  high	  salt	  
extraction	   of	   the	   remaining	   proteins	   to	   examine	   the	   strength	   of	   protein	   /	  
chromatin	   interaction	  pre	   and	  post	   ionising	   radiation	   treatment.	   Free	   nuclear	  
proteins	  and	  those	  with	  weak	  chromatin	  interaction	  will	  be	  extracted	  under	  low	  
salt	   conditions,	   proteins	   more	   tightly	   associated	   with	   chromatin	   will	   be	  
extracted	   following	   Benzonase	   treatment	   and	   high	   salt	   conditions.	   MRE11	   is	  
expected	   to	   be	   more	   tightly	   associated	   with	   chromatin	   following	   ionising	  
radiation	  treatment,	  as	  it	  binds	  to	  the	  broken	  DNA	  ends.	  Since	  the	  same	  number	  
of	  DSB	  are	  induced	  in	  WT	  and	  Lsh-­/-­	  MEFs,	  correct	  recognition	  of	  the	  broken	  end	  
by	   the	  MRN	   complex	   should	   result	   in	   similar	   chromatin	   association	   following	  
treatment.	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Figure	  4.1:	  Chromatin	  retention	  assay	  followed	  by	  Western	  blot	  analysis	  of	  WT	  and	  Lsh-­‐/-­‐	  
MEFs	   using	   anti-­‐MRE11	   and	   antI-­‐H2AX	   primary	   antibodies	   to	   highlight	   soluble	   and	  
chromatin	   bound	   fractions	   before	   and	   4	   h	   post	   treatment	   with	   10	   Gy	   of	   ionising	  
radiation.	  Quantification	  of	  MRE11	   is	  plotted	  as	  a	  percentage	  of	   soluble	  and	  chromatin	  
bound	  signals	  combined,	  (Quantified	  using	  Odyssey	  V3.0).	  
Western	   Blot	   analysis	   shows	   that	   approximately	   70%	   of	   MRE11	   can	   be	  
extracted	  under	  soluble	  extraction	  conditions,	   in	  both	  WT	  and	  Lsh-­/-­	  untreated	  
MEFs	   (Figure	   4.1).	   This	   shifts	   to	   approximately	   60%	   of	   MRE11	   becoming	  
chromatin-­‐bound	   following	   ionising	   radiation	   treatment	   (Figure	   4.1).	   This	  
demonstrates	   that	  MRE11	  binds	  DNA	  more	   tightly	   in	  response	   to	   induction	  of	  
DSBs.	   The	   results	   also	   show	  no	   difference	   in	   the	   amount	   of	  MRE11	   bound	   to	  
chromatin	   in	  WT	  and	  Lsh-­/-­	  MEFs	  post	   treatment,	   suggesting	   loss	   of	   LSH	  does	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Figure	   4.2:	   Nuclear	   extracts	   examined	   by	   Western	   blotting	   using	   an	   anti-­‐ATMpS1981	  
primary	  antibody	  to	  examine	  phosphorylated	  ATM	  levels	  in	  WT	  and	  Lsh-­‐/-­‐	  MEFs	  at	  a	  range	  
of	   time	  points	   following	   10	  Gy	  of	   ionising	   radiation.	  An	   anti-­‐DNMT1	  antibody	  was	   also	  
used	  to	  show	  the	  level	  of	  DNMT1	  to	  act	  as	  a	  loading	  control.	  
We	   further	   investigated	   DSB	   recognition	   by	   comparing	   the	   levels	   of	  
phosphorylated	  ATM	  in	  the	  nucleus	  of	  WT	  and	  Lsh-­/-­	  MEFs.	  	  This	  was	  carried	  out	  
by	  Western	  Blot	   analysis	   of	   nuclear	   extracts	   from	  Lsh-­/-­	   and	  WT	  MEFs	   over	   a	  
range	  of	  time	  points	  post	  ionising	  radiation	  treatment.	  The	  results	  show	  similar	  
kinetics	  and	  levels	  of	  phosphorylated	  ATM	  at	  serine	  residue	  1981	  in	  both	  Lsh-­/-­	  
and	  WT	  MEFs	  (Figure	  4.2).	  Although	  this	  shows	  that	  activation	  of	  ATM	  functions	  
correctly	   in	  Lsh-­/-­	  MEFs,	   it	  does	  not	   indicate	   that	  DSB	  are	  recognised	  correctly	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Figure	   4.3:	   (A.)	   Representative	   immunofluorescence	   images	   showing	   localisation	   of	  
phosphorylated	  ATM	   in	  WT	  and	  Lsh-­‐/-­‐	  MEFs	   at	   the	   indicated	   time	  points	   after	   10	  Gy	  of	  
ionising	   radiation.	   (B.)	   The	   graph	   shows	   the	   number	   of	   IRIF	   per	   cell,	   n=35	   cells.	   Lines	  
indicate	  the	  mean	  and	  SEM.	  
To	   examine	   phosphorylated	   ATM	   recruitment	   in	   addition	   to	   activation,	  
immunofluorescence	  imaging	  was	  performed	  on	  Lsh-­/-­	  and	  WT	  MEFs	  at	  various	  
time	   points	   after	   ionising	   radiation	   treatment.	   Ionising	   radiation	   induced	   foci	  
(IRIF)	   can	   clearly	  be	   seen	   following	   treatment,	   consistent	  with	   recruitment	  of	  
phosphorylated	  ATM	  to	  the	  broken	  DNA	  ends	  (Figure	  4.3).	  When	  the	  number	  of	  
IRIF	  per	  cell	  were	  counted	  and	  plotted	  as	  column	  scatter	  plots	  the	  data	  indicates	  
that	   the	   foci	   of	   phosphorylated	   ATM	   significantly	   increase	   following	   ionising	  
radiation	  treatment,	  peaking	  at	  1	  h	  and	  falling	   in	  number	  again	  by	  4	  h	  (Figure	  
4.3).	  Theses	  plots	  are	  consistent	  with	  the	  induction	  of	  total	  phosphorylated	  ATM	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Furthermore	  there	  was	  no	  significant	  difference	  between	  the	  number	  of	  IRIF	  in	  
Lsh-­/-­	   and	  WT	  MEFs	   at	   0.25h	   or	   1	   h,	   suggesting	   that	   phosphorylated	   ATM	   is	  
correctly	   recruited	   to	   DSBs.	   However,	   4	   h	   after	   treatment	   fewer	   IRIF	   were	  
observed	   in	   Lsh-­/-­	   cells	   compared	   to	   WT	   (Figure	   4.3).	   As	   well	   its	   initial	  
recruitment	  to	  the	  broken	  DNA	  end	  via	  the	  MRN	  complex,	  phosphorylated	  ATM	  
can	  also	  aid	  in	  mediator	  complex	  formation	  later	  in	  repair	  (Riches	  et	  al	  2008).	  It	  
is	  unlikely	  that	  4	  h	  post	  ionising	  radiation	  treatment	  the	  reduced	  number	  of	  IRIF	  
in	   Lsh-­/-­	   cells	   represents	   a	   defect	   in	   DSB	   recognition,	   especially	   since	   no	  
difference	  can	  be	  observed	  at	  the	  earlier	  time	  points	  0.25	  h	  or	  1	  h.	  Therefore	  we	  
hypothesised	  that	   the	   inefficient	  recruitment	  of	  ATM	  phosphorylated	  at	  serine	  
1981	  to	  IRIF	  4	  h	  post	  treatment	  could	  be	  result	  of	  defects	  in	  mediator	  complex	  
assembly.	  
	  
4.4	  H2AX	  is	  phosphorylated	  less	  efficiently	  in	  LSH	  depleted	  cells	  
We	   have	   shown	   that	   the	   increased	   sensitivity	   of	   LSH	   depleted	   cells	   to	   DSB	  
inducing	   agents	   is	   the	   result	   of	   a	   deficiency	   in	   repair,	   but	   not	   because	   of	  
inefficient	  DSB	  detection.	  However,	  a	  reduction	  in	  the	  number	  phosphorylated	  
ATM	  IRIF	  after	  initial	  break	  recognition,	  without	  an	  accompanying	  decrease	  in	  
phosphorylated	  ATM	  levels,	  has	  led	  us	  to	  hypothesise	  that	  the	  inefficient	  repair	  
of	   DSBs	   in	   LSH	   depleted	   cells	  may	   be	   caused	   by	   defects	   in	  mediator	   complex	  
assembly	  /	  recruitment.	  
The	   fist	   step	   in	   mediator	   complex	   assembly	   is	   phosphorylation	   of	   H2AX	   by	  
phosphorylated	   ATM.	   Phosphorylated	   H2AX	   (γH2AX)	   acts	   as	   the	   initial	  
recruitment	   factor	   which	   either	   directly	   or	   indirectly	   recruits	   the	   remaining	  
components	  of	   the	  mediator	  complex	  such	  as	  MDC1	  and	  53BP1.	  These	  help	  to	  
bringing	  about	  other	  histone	  modifications,	  recruit	  repair	  proteins	  and	  maintain	  
cell	  cycle	  checkpoint	  signalling	  (Fernandez-­‐Capetillo	  et	  al	  2004).	  γH2AX	  foci	  are	  
widely	  regarded	  as	  one	  of	  the	  major	  diagnostic	  markers	  of	  DSBs.	  We	  therefore	  
wished	  to	  examine	  whether	  H2AX	   is	  efficiently	  phosphorylated	   in	  Lsh-­/-­	  MEFs.	  
Initially	  γH2AX	   immunofluorescence	   imaging	  was	  performed	  on	  WT	  and	  Lsh-­/-­	  
MEFs	  at	  a	  range	  of	  time	  points	  following	  10	  Gy	  of	  ionising	  radiation.	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Figure	  4.4:	  Representative	   immunofluorescence	   images	  showing	  γH2AX	   in	  WT	  and	  Lsh-­‐/-­‐	  
MEFs	  at	  the	  indicated	  time	  points	  after	  10	  Gy	  of	  ionising	  radiation.	  The	  graph	  shows	  total	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It	  was	  not	  possible	  to	  count	  the	  γH2AX	  IRIF	  following	  a	  10	  Gy	  dose	  of	  ionising	  
radiation	   due	   to	   the	   high	   number	   of	   IRIF	   making	   individual	   foci	  
undistinguishable.	   However,	   since	   the	   antibody	   used	   is	   specific	   for	  
phosphorylated	   H2AX,	   the	   total	   fluoresce	   per	   cell	   was	   taken	   as	   a	  measure	   of	  
H2AX	  phosphorylation.	   In	  WT	  MEFs	   a	   clear	   increase	   in	   γH2AX	   could	  be	   seen,	  
peaking	  at	  1	  h,	  which	  fell	  back	  to	  approximately	  basal	  levels	  after	  12	  h	  (Figure	  
4.4).	  Lsh-­/-­	  MEFs	  displayed	  similar	  kinetics,	  with	  the	  peak	  signal	  occurring	  after	  
1h.	  However	  the	  levels	  of	  H2AX	  phosphorylation	  in	  Lsh-­/-­	  MEFs	  never	  achieved	  
those	  reached	  in	  the	  WT	  cells.	  The	  quantification	  of	  total	  fluorescence	  indicated	  
a	  decrease	  in	  H2AX	  phosphorylation	  at	  1h	  by	  approximately	  a	  third	  (Figure	  4.4).	  
The	   observed	   reduction	   in	  H2AX	   phosphorylation	   in	   the	  Lsh-­/-­	  MEFs	   could	   be	  
the	   result	  of	   a	   reduction	   in	   the	  amount	  of	  H2AX	  phosphorylation	  at	  DSBs,	   the	  
failure	  to	  phosphorylated	  H2AX	  at	  a	  proportion	  of	  breaks	  or	  mis-­‐localisation	  of	  
H2AX	   throughout	   the	   chromatin.	   It	   is	   also	   possible	   that	   the	   reduced	   H2AX	  
phosphorylation	   in	   LSH	   deficient	   cells	   is	   due	   to	   the	   70%	   decrease	   in	   DNA	  
methylation	  in	  Lsh-­/-­	  MEFs.	  
	  
4.4.1	  H2AX	  is	  phosphorylated	  at	  fewer	  broken	  DNA	  ends	  in	  Lsh-­/-­	  MEFs	  	  
To	  test	  whether	  the	  reduction	  in	  H2AX	  phosphorylation	  was	  caused	  by	  a	  failure	  
to	  phosphorylated	  H2AX	  at	  a	  proportion	  of	  breaks,	  we	  counted	  the	  number	  of	  
IRIF	   per	   cell.	   A	   failure	   to	   phosphorylate	   H2AX	   at	   a	   proportion	   of	   breaks	  was	  
expected	   to	   result	   in	   fewer	   IRIF.	   Since	   a	   10	   Gy	   dose	   of	   ionising	   radiation	  
resulted	   in	   too	  many	   IRIF	   to	   count,	   DSBs	  were	   induced	   using	   a	   5	   Gy	   dose	   of	  
ionising	  radiation	  and	  the	  number	  of	   IRIF	  per	  cell	  plotted	  as	  a	  column	  scatted	  
plot.	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Figure	  4.5:	  Representative	  immunofluorescence	  images	  showing	  localisation	  of	  γH2AX	  in	  
WT	  and	  Lsh-­‐/-­‐	  MEFs	  at	  the	  indicated	  time	  points	  after	  5	  Gy	  of	  ionising	  radiation.	  The	  graph	  
shows	  the	  number	  of	  IRIF	  per	  cell,	  n=35	  cells.	  Lines	  indicate	  the	  mean	  and	  SEM.	  
The	  results	  showed	  significantly	  fewer	  γH2AX	  IRIF	  in	  Lsh-­/-­	  MEF	  both	  1h	  and	  4h	  
post	   ionising	   radiation	   treatment	   (Figure	  4.5).	   Since	  DSB	  are	  detected	   equally	  
well	   in	   both	  WT	   and	   Lsh-­/-­	   MEF,	   as	   shown	   by	   no	   significant	   difference	   in	   the	  
number	   of	   phosphorylated	   ATM	   IRIF	   1	   h	   post	   treatment	   (Figure	   4.3),	   the	  
significant	  difference	  in	  γH2AX	  IRIF	  suggests	  that	  a	  proportion	  of	  DSB	  in	  Lsh-­/-­	  
MEFs	  do	  not	  have	  phosphorylated	  H2AX.	  
No IR 5 Gy + 1 h 5 Gy + 4 h 
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The	  amount	  of	  H2AX	  and	  its	  association	  with	  the	  chromatin	  remains	  unchanged	  
between	   WT	   and	   Lsh-­/-­	   MEFs,	   as	   shown	   by	   the	   chromatin	   retention	   assays	  
(Figure	  4.1).	  Although	  we	  were	  are	  unable	  to	  conclude	  that	  the	  reduced	  number	  
of	   γH2AX	   IRIF	   is	   not	   a	   result	   of	   mis-­‐localisation	   of	   H2AX	   containing	  
nucleosomes,	   we	   have	   shown	   that	   it	   is	   not	   as	   a	   result	   of	   a	   reduction	   in	   the	  
amount	   of	   total	   H2AX	   contained	  within	   the	   chromatin.	   Another	   hypothesis	   of	  
why	  Lsh-­/-­	  MEFs	  have	   reduced	  γH2AX	   IRIF	   could	  be	   linked	   to	   the	   loss	  of	  DNA	  
methylation	   detected	   in	   Lsh-­/-­	   cells.	   We	   hypothesised	   that	   substantial	   loss	   of	  
DNA	   methylation	   might	   affect	   chromatin	   compaction	   and	   may	   result	   in	   mis-­‐
localisation	  of	  H2AX	  containing	  nucleosomes,	  which	  could	  cause	  the	  described	  
reduction	  in	  H2AX	  phosphorylation.	  
	  
4.4.2	  Loss	  of	  DNA	  methylation	  does	  not	  affect	  H2AX	  phosphorylation	  
To	  control	  for	  the	  effects	  of	  DNA	  methylation	  loss	  on	  H2AX	  phosphorylation	  we	  
examined	  γH2AX	  levels	  following	  ionising	  radiation	  treatment	  in	  Dnmt1-­/-­	  MEFs.	  
Dnmt1-­/-­	   MEFs	   lack	   the	   maintenance	   DNA	   methyltransferase	   DNMT1	   and	  
reportedly	   lose	   90%	   of	   their	   DNA	   methylation	   (Jackson-­‐Grusby	   et	   al	   2001).	  
Since	   this	   degree	   of	  methylation	   loss	   triggers	   activation	   of	   the	   p53	   apoptotic	  
pathway,	  Dnmt1-­/-­	  cells	  are	  by	  necessity	  also	  p53-­/-­.	  We	  therefore	  also	  examined	  
p53-­/-­	  MEFs	   as	   a	   control.	   γH2AX	   levels	  were	   investigated	   by	  Western	  Blots	   of	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Figure	  4.6:	  Nuclear	  extracts	  examined	  by	  Western	  blotting	  using	  an	  anti-­‐γH2AX	  primary	  
antibody	  to	  examine	  γH2AX	  levels	  in	  WT,	  Lsh-­‐/-­‐,	  p53-­‐/-­‐	  and	  DNMT1,	  p53-­‐/-­‐	  MEFs	  at	  a	  range	  
time	  points	   following	  10	  Gy	  of	   ionising	   radiation.	  An	  anti-­‐H4	  antibody	  was	  also	  used	   to	  
show	  the	  level	  of	  H4	  to	  act	  as	  a	  loading	  control.	  
These	   experiments	   showed	   that	   the	  Lsh-­/-­	  MEFs	   clearly	   display	   a	   reduction	   in	  
γH2AX	  when	   compared	   to	  WT	  MEFs	   (Figure	   4.6),	   as	   previously	   described	   by	  
immunofluorescence	   imaging.	   However,	   we	   detected	   no	   difference	   in	   γH2AX	  
when	  we	  compared	  the	  WT,	  p53-­/-­	  and	  Dnmt1-­/-­,	  p53-­/-­	  MEFs.	  This	  suggests	  that	  
the	  reduction	  in	  H2AX	  phosphorylation	  seen	  in	  the	  Lsh-­/-­	  MEFs	  (Figure	  4.4,	  4.5	  
and	  4.6)	  is	  independent	  of	  the	  loss	  of	  DNA	  methylation.	  Interestingly,	  this	  is	  in	  
agreement	  with	  data	  from	  ddm1	  A.	  thaliana,	  where	  the	  increased	  sensitivity	  of	  
ddm1	  plants	  to	  γ-­‐radiation	  was	  independent	  of	  the	  loss	  of	  DNA	  methylation.	  
We	   further	   investigated	   whether	   reduction	   in	   H2AX	   phosphorylation	   can	   be	  
observed	  by	  Western	  blot	   in	   LSH	  knockdown	  MRC5hT	   cells	   to	   ensure	   that	   the	  
phenomenon	   was	   not	   an	   artefact	   of	   Lsh-­/-­	   MEFs.	   We	   again	   saw	   a	   substantial	  
reduction	   in	   γH2AX	   in	   the	   knockdown	   cells	   when	   compared	   to	   the	   control	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Figure	  4.7:	  Nuclear	  extracts	  examined	  by	  Western	  blotting	  using	  an	  anti-­‐γH2AX	  primary	  
antibody	   to	  examine	  γH2AX	   levels	   in	   shLSH	  and	  non-­‐silencing	   control	  MRC5hT	   cells	   at	   a	  
range	   time	   points	   following	   10	   Gy	   of	   ionising	   radiation.	   An	   anti-­‐H4	   antibody	   was	   also	  
used	   to	   show	   the	   level	   of	   H4	   to	   act	   as	   a	   loading	   control,	   (Quantified	   by	   Odyssey	   V3.0	  
using	  Integrated	  Intensity	  values).	  
These	  results	  indicate	  that	  the	  initial	  establishment	  of	  the	  mediator	  complex	  is	  
impaired	   in	   LSH	  depleted	   cells	   at,	   at	   least	   a	   proportion,	   of	  DSBs.	   This	   is	  most	  
likely	  the	  contributing	  factor	  to	  the	  increased	  sensitivity	  of	  LSH	  depleted	  cells	  to	  
DSB	   inducing	   agents.	   Although	   our	   data	   shows	   that	   the	   reduced	  
phosphorylation	   of	   H2AX	   in	   response	   to	   DNA	   damage	   in	   Lsh-­/-­	   MEFs	   is	   not	   a	  
result	   of	   reduced	   H2AX	   incorporation	   into	   the	   chromatin,	   we	   cannot	   yet	  
determine	  the	  mechanistic	  defect	  by	  which	  lack	  of	  LSH	  causes	  fewer	  IRIF	  in	  the	  
Lsh-­/-­	   MEFs.	   	   Although	   the	   likely	   contributing	   factor,	   it	   is	   also	   unclear	   how	  
reduced	   H2AX	   phosphorylation	   results	   in	   decreased	   viability	   and	   increased	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4.5	   The	   formation	   of	   DSB	   repair	  mediator	   complex	   is	   impaired	   in	   Lsh-­/-­	  
MEFs	  
To	   further	   investigate	   the	   impact	   of	   reduced	   H2AX	   phosphorylation	   on	  
downstream	  mediator	   complex	   assembly	   in	   the	  Lsh-­/-­	  MEFs,	  we	   examined	   the	  
recruitment	  of	  downstream	  mediator	  complex	  components	  MDC1	  and	  53BP1	  to	  
IRIF	  by	  immunofluorescence	  imaging.	  MDC1	  was	  chosen	  as	  it	  binds	  directly	  to	  
γH2AX	  and	  is	  responsible	  for	  the	  recruitment	  of	  checkpoint	  kinase	  CHK2,	  which	  
is	   important	   for	   cell	   cycle	   arrest.	   We	   also	   examined	   53BP1	   as	   it	   is	   recruited	  
further	  downstream	   in	  mediator	   complex	  assembly	  and	   relies	  on	  both	  γH2AX	  
(Ward	  et	  al	  2003)	  and	  MDC1	  (Eliezer	  et	  al	  2008)	   for	  recruitment	  to	  breaks	  as	  
well	   as	   additional	  histone	  modifications	   such	  as	  H4K20	  methylation	   (Pei	  et	  al	  
2011),	  which	  are	  established	  indirectly	  as	  a	  result	  of	  H2AX	  phosphorylation.	  
53BP1	   recruitment	   to	   IRIF	   in	   WT	   and	   Lsh-­/-­	   MEFs	   was	   examined	   by	  
immunofluorescence	   imaging.	   53BP1	   is	   located	   throughout	   the	   nucleoplasm	  
and	  appears	  as	  diffuse	  nuclear	  staining	   in	  un-­‐irradiated	  cells.	  Upon	  irradiation	  
53BP1	   is	   recruited	   to	   DSBs	   as	   a	   downstream	   component	   of	   the	   mediator	  
complex,	   relying	   on	   γH2AX	   dependent	   recruitment	   of	   ubiquitinases	   and	  
methylases	   to	   alter	   local	   histone	   modifications	   for	   efficient	   53BP1	   binding,	  
which	   can	   be	   seen	   as	   IRIF.	   The	   immunofluorescence	   imaging	   revealed	   cells	  
could	   be	   classified	   into	   two	   groups,	   those	   with	   IRIF	   and	   cells	   that	   displayed	  
diffuse	  nuclear	  staining	  (Figure	  4.8).	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Figure	  4.8:	  Representative	  immunofluorescence	  images	  showing	  53BP1	  localisation	  in	  WT	  
and	  Lsh-­‐/-­‐	  MEFs	  at	  the	  indicated	  time	  points	  after	  10	  Gy	  of	  ionising	  radiation.	  The	  graphs	  
show	  percentage	  of	  fociated	  (red	  arrows)	  or	  diffuse	  nuclear	  stained	  (white	  arrows)	  nuclei	  
of	  n=35	  cells.	  
WT	   and	   Lsh-­/-­	   MEFs	   were	   counted	   and	   classified	   as	   either	   containing	   foci	   or	  
having	  diffuse	  nuclear	   staining	  at	  1	  h	  and	  4	  h	  post	   irradiation	  and	   the	   results	  
plotted	   as	   a	   percentage	   of	   cells	   counted.	   As	   expected,	   prior	   to	   treatment	   the	  
majority	   of	   cells	   show	   diffuse	   nuclear	   staining.	   Upon	   induction	   of	   DSBs,	   the	  
proportion	  of	  fociated	  cells	  shifts	  to	  nearly	  100%	  of	  the	  population	  both	  1	  h	  and	  
4	  h	  post	   treatment	   in	  WT	  MEFs	   (Figure	  4.8).	  However,	   a	  more	  heterogeneous	  
response	   was	   observed	   in	   Lsh-­/-­	   MEFs,	   with	   approximately	   30-­‐50%	   of	   cells	  
showing	  diffuse	  staining	  (Figure	  4.8).	  This	  is	  in	  agreement	  with	  the	  γH2AX	  data	  
as	  it	  also	  suggests	  impaired	  mediator	  complex	  assembly	  in	  the	  Lsh-­/-­	  MEFs.	  We	  
may	  have	  expected	  to	  see	  53BP1	  IRIF	  in	  all	  Lsh-­/-­	  MEFs	  but	  at	  a	  lower	  frequency	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than	   in	   the	   WT	   cells,	   similar	   to	   what	   was	   observed	   in	   γH2AX	  
immunofluorescence.	  However,	  unlike	  the	  γH2AX	  antibody,	  which	  is	  specific	  to	  
the	  protein	  when	  phosphorylated	  in	  response	  to	  damage,	   the	  antibody	  against	  
53BP1	  detects	  all	  53BP1	  in	  a	  cell	  pre	  and	  post	  ionising	  radiation	  treatment.	  By	  
observing	  translocation	  of	  the	  protein	  rather	  than	  activation,	  reduced	  mediator	  
complex	   assembly	   will	   result	   in	   an	   increase	   in	   un-­‐localised	   53BP1.	   This	   will	  
result	  in	  a	  higher	  background	  signal	  throughout	  the	  nucleoplasm,	  obscuring	  the	  




Figure	  4.9:	  Representative	  immunofluorescence	  images	  showing	  MDC1	  localisation	  in	  WT	  
and	  Lsh-­‐/-­‐	  MEFs	  at	  the	  indicated	  time	  points	  after	  10	  Gy	  of	  ionising	  radiation.	  The	  graphs	  
show	  percentage	  of	  fociated	  (red	  arrows)	  or	  diffuse	  nuclear	  stained	  (white	  arrows)	  nuclei	  
of	  n=35	  cells.	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We	   also	   examined	   MDC1	   recruitment	   to	   IRIF,	   as	   this	   protein	   is	   upstream	   of	  
53BP1	   and	   recruited	   directly	   by	   γH2AX.	   Translocation	   from	   an	   un-­‐localised	  
nucleoplasmic	   protein	   to	   IRIF	  was	   observed	   in	   response	   to	   ionising	   radiation	  
(Figure	  4.9),	  similar	  to	  the	  localisation	  of	  53BP1,	  and	  cells	  were	  again	  classified	  
as	  either	  fociated	  or	  diffuse	  at	  1	  h	  and	  4	  h	  post	  irradiation.	  	  The	  results	  showed	  a	  
similar	   pattern	   to	   that	   observed	   for	   53BP1.	  WT	  MEFs	   displayed	   a	   shift	   from	  
85%	  diffuse	  MDC1	   staining	  prior	   to	   treatment	   to	   approximately	  90%	   fociated	  
both	  1	  h	  and	  4	  h	  after	  ionising	  radiation,	  where	  as	  in	  Lsh-­/-­	  MEFs	  only	  40-­‐50%	  of	  
the	  population	  showed	  IRIF	  (Figure	  4.9).	  
These	  data	  clearly	  show	  that	  the	  formation	  of	  the	  mediator	  complex	  is	  impaired	  
in	  the	  Lsh-­/-­	  MEFs,	  as	  predicted	  by	  the	  reduced	  H2AX	  phosphorylation	  observed	  
in	  these	  cells.	  Furthermore	  the	  reduction	  in	  MDC1	  recruitment	  to	  IRIF	  suggests	  
that	   reduced	   or	   lack	   of	   H2AX	   phosphorylation	   at	   some	   DSBs	   is	   the	   cause	   of	  
inefficient	  mediator	   complex	   assembly	   in	   the	   Lsh-­/-­	   MEFs	   as	  MDC1	   is	   directly	  
recruited	  to	  γH2AX.	  
	  
4.6	  Cell	  cycle	  checkpoint	  signalling	  is	  impaired	  in	  LSH	  depleted	  cells	  
It	  was	  still	  unclear	  how	  impaired	  mediator	  complex	  assembly	  caused	  decreased	  
viability	  and	  increased	  sensitivity	  to	  DSB	  inducing	  agents	  in	  LSH	  depleted	  cells.	  
Since	   components	   of	   the	   mediator	   complex,	   such	   as	   MDC1	   and	   53BP1,	   are	  
required	  for	  recruitment	  of	  checkpoint	  proteins	  to	  DSBs	  and	  efficient	  cell	  cycle	  
arrest,	   we	   hypothesised	   that	   activation	   of	   cell	   cycle	   checkpoints	   may	   be	   less	  
efficient	   in	   LSH	   depleted	   cells	   with	   impaired	   mediator	   complex	   assembly.	  
Impaired	  activation	  of	  checkpoint	  proteins	  and	  cell	  cycle	  arrest	  can	  lead	  to	  cells	  
continuing	   though	   mitosis	   before	   DSBs	   are	   repaired.	   Cell	   division	   with	  
unrepaired	   DSBs	   can	   result	   in	   chromosomal	   abnormalities,	   such	   as	  
chromosome	  fusions	  and	  loss	  of	  entire	  chromosome	  arms.	  This	  in	  turn	  triggers	  
the	  apoptotic	  pathway,	  which	  may	  explain	  the	  higher	  rate	  of	  apoptosis	  observed	  
in	  LSH	  depleted	  cells	  following	  induction	  of	  DSBs.	  We	  attempted	  to	  examine	  the	  
activation	   of	   the	   checkpoint	   proteins	   CHK2	   and	   p53	   in	   response	   to	   ionising	  
radiation	  in	  the	  Lsh-­/-­	  and	  WT	  MEFs.	  However	  the	  Lsh-­/-­	  and	  WT	  MEFs	  had	  been	  
maintained	   in	   culture	   through	   spontaneous	   immortalisation,	   which	   often	  
	   74	  
results	   in	  defects	   in	  p53	  and	  apoptotic	   signalling.	  Unfortunately	  we	   found	   the	  
WT	   MEFs	   did	   not	   express	   p53,	   which	   made	   them	   unsuitable	   for	   examining	  
checkpoint	   signalling.	   In	   order	   to	   test	   this	   hypothesis	   we	   examined	   the	  
activation	   CHK2	   and	   p53	   in	   response	   to	   ionising	   radiation	   in	   shLSH	   and	  	  	  	  	  	  	  	  	  
non-­‐silencing	  control	  MRC5hT	  cells.	  
	  
Figure	  4.10:	  Nuclear	  extracts	  examined	  by	  Western	  blotting	  using	  an	  anti-­‐CHK2	  primary	  
antibody	  to	  examine	  CHK2	  levels	  in	  shLSH	  and	  non-­‐silencing	  MRC5hT	  cells	  at	  various	  time	  
points	  after	  5	  Gy	  of	  ionising	  radiation.	  An	  anti-­‐MRE11	  antibody	  was	  also	  used	  to	  show	  the	  
level	  of	  MRE11	  protein	  to	  act	  as	  a	  loading	  control.	  
To	   investigate	  CHK2	   activation,	  we	   examined	   the	  phosphorylation	   of	   CHK2	   in	  
response	   to	   DNA	   damage	   by	   Western	   blotting.	   Unfortunately	   the	  
phosphorylated	  CHK2	  antibody	  did	  not	  work	  in	  our	  hands.	  However,	  we	  could	  
separate	   the	   phosphorylated	   and	   un-­‐phosphorylated	   CHK2	   by	   size	   and	  
identified	   the	   bands	   using	   a	   general	   anti-­‐CHK2	   antibody.	   In	   nuclear	   extracts	  
made	   without	   phosphatase	   inhibitors	   the	   top	   band	   could	   not	   be	   identified,	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In	  non-­‐silencing	  control	  MRC5hT	  cells	  a	  band	  of	  phosphorylated	  CHK2	  appeared	  
following	   ionising	   radiation,	   peaking	  2	  h	   after	   treatment	   and	   fell	   back	   toward	  
basal	   levels	   after	   8	   to	   12	   h	   (Figure	   4.8).	   An	   inverse	   correlation	   in	   the	   un-­‐
phosphorylated	   band	  was	   seen,	  which	   decreased	   following	   ionising	   radiation,	  
reaching	   its	   lowest	   levels	   1	   to	   2	   h	   post	   treatment.	   This	   indicates	   that	   the	  
majority	  of	  CHK2	  becomes	  phosphorylated	  in	  the	  non-­‐silencing	  control	  MRC5hT	  
cells	   2	   h	   post	   treatment.	   However,	   in	   shLSH	   MRC5hT	   cells	   a	   phosphorylated	  
CHK2	   band	   cannot	   be	   detected	   after	   ionising	   radiation.	   Un-­‐phosphorylated	  
CHK2	   does	   decrease	   after	   treatment,	   but	   to	   a	   lesser	   extent	   than	   in	   the	  	  	  	  	  	  	  	  	  	  	  	  	  	  
non-­‐silencing	  control	  cells	  (Figure	  4.8),	  suggesting	  that	  a	  smaller	  proportion	  of	  
CHK2	   becomes	   phosphorylated	   in	   shLSH	   MRC5hT	   cells,	   which	   is	   below	   the	  
threshold	  of	  detection	  of	  the	  antibody.	  
	  
Figure	  4.11:	  Nuclear	  extracts	  examined	  by	  Western	  blotting	  using	  an	  anti-­‐p53	  and	  anti-­‐
p53pS15	  primary	  antibodies	  to	  examine	  un-­‐phosphorylated	  and	  phosphorylated	  p53	  levels	  
in	   shLSH	   and	   non-­‐silencing	   MRC5hT	   cells	   at	   various	   time	   points	   after	   5	   Gy	   of	   ionising	  
radiation.	  An	  anti-­‐MRE11	  antibody	  was	  also	  used	  to	  show	  the	  level	  of	  MRE11	  protein	  to	  


















































	   76	  
We	  also	  examined	  p53	  activation	  by	  Western	  blotting.	  Normally	  p53	  has	  a	  rapid	  
turnover	   rate,	  which	  becomes	  stabilised	  upon	  phosphorylation	  by	  ATM	  /	  ATR	  
kinases,	   we	   therefore	   examined	   total	   p53	   levels	   in	   shLSH	   and	   non-­‐silencing	  
MRC5hT	  cells	  following	  ionising	  radiation	  treatment.	  In	  addition	  to	  total	  p53	  we	  
examined	  active	  p53,	  using	  an	  antibody	  specific	  to	  p53	  phosphorylated	  at	  serine	  
15,	  the	  site	  of	  activation	  by	  phosphorylated	  ATM.	  In	  non-­‐silencing	  control	  cells	  
the	  total	  p53	  levels	  increase	  following	  ionising	  radiation	  treatment,	  specifically	  
1	  and	  2	  h	  post	   treatment,	   this	   is	  accompanied	  by	  a	  similar	   increase	   in	  p53pS15	  
levels	  (Figure	  4.11).	  Although	  p53pS15	  levels	  also	  increase	  in	  shLSH	  MRC5hT	  cells	  
post	  treatment,	  it	  is	  only	  accompanied	  by	  a	  modest	  increase	  in	  total	  p53,	  which	  
does	  not	  reflect	  the	  p53pS15	  signal	  (Figure	  4.11).	  These	  results	  show	  that,	  unlike	  
CHK2,	   p53	   can	   be	   phosphorylated	   in	   both	   shLSH	   and	   non-­‐silencing	   MRC5hT	  
cells.	  The	  reduced	  levels	  of	  total	  p53	  in	  shLSH	  cells	  suggests	  that	  stabilisation	  of	  
p53	  in	  response	  to	  ionising	  radiation	  is	  impaired,	  probably	  due	  to	  deficient	  p53	  
phosphorylation	  at	  other	  sites.	  Serine	  20	  phosphorylation	  by	  CHK2	  blocks	   the	  
interaction	   between	   p53	   and	   MDM2,	   required	   for	   nuclear	   export	   and	  
subsequent	  proteolytic	  degradation	  of	  p53	  and	  we	  have	  shown	  that	  activation	  
of	  CHK2	  in	  response	  to	  ionising	  radiation	  treatment	  is	  reduced	  in	  LSH	  deficient	  
cells	  (Figure	  4.10).	  
Since	   loss	   of	   LSH	   results	   in	   significantly	   slower	   DSB	   repair	   we	   would	   have	  
expected	  cell	  cycle	  checkpoint	  signalling	  to	  be	  extended	  in	  LSH	  depleted	  cells,	  in	  
order	   to	   produce	   a	   longer	   arrest	   period	   for	   damage	   to	   be	   repaired.	  However,	  
consistent	  with	  our	  hypothesis	  phosphorylation	  of	  CHK2	  is	  less	  efficient	  in	  LSH	  
depleted	   cells.	   p53	   is	   also	   stabilised	   less	   efficiently	   in	   response	   to	   ionising	  
radiation,	  also	  suggesting	  impaired	  cell	  cycle	  checkpoint	  signalling.	  The	  amount	  
of	   p53	   phosphorylated	   specifically	   by	   ATM	   at	   serine	   15	   does	   not	   appear	  
reduced	  in	  shLSH	  MRC5hT	  cells,	  however	  it	  also	  does	  not	  appear	  to	  be	  extended	  
compared	   to	   non-­‐silencing	   controls.	   These	   data	   suggest	   that	   a	   proportion	   of	  
breaks	   in	   LSH	   depleted	   cells	   do	   not	   correctly	   activate	   cell	   cycle	   check	   points,	  
consistent	  with	  the	  observed	  impaired	  mediator	  complex	  assembly.	  This	  could	  
result	  in	  cells	  undergoing	  mitosis	  with	  unrepaired	  DSB	  still	  present,	  which	  can	  
be	   lethal	   to	   the	   cells	   and	   would	   explain	   the	   increased	   cell	   death	   96	   h	   after	  
treatment	  in	  shLSH	  MRC5hT	  cells	  in	  which	  DSB	  have	  been	  induced	  (Figure	  3.2).	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4.7	  Summary	  
Detailed	   investigation	   of	   DSBs	   recognition	   and	   repair	   in	   LSH	   deficient	   cells	  
showed	  that	  broken	  DNA	  ends	  are	  correctly	  recognised	  in	  Lsh-­/-­	  MEFs.	  Although	  
we	  were	  unable	  to	  show	  localisation	  of	  the	  MRN	  complex	  to	  broken	  DNA	  we	  did	  
show	  that	  MRE11,	  a	  component	  of	   the	  MRN	  complex	  has	  an	   increased	  affinity	  
for	   chromatin	   following	   ionising	   radiation	   treatment	   (Figure	   4.1).	   We	   also	  
demonstrated	   similar	   activation	   of	   ATM	   in	   Lsh-­/-­	   and	  WT	  MEFs	   after	   ionising	  
radiation	  and	  showed	  no	  difference	   in	   the	   localisation	  of	  phosphorylated	  ATM	  
to	   IRIF	   15minutes	   and	   1hour	   after	   treatment	   (Figure	   4.2	   and	   4.3).	   Fewer	  
phosphorylated	  ATM	  IRIF	  were	  seen	  in	  the	  Lsh-­/-­	  MEFs	  4hours	  after	  treatment,	  
however	  localisation	  of	  phosphorylated	  ATM	  to	  broken	  DNA	  ends	  later	  in	  repair	  
involves	  additional	  interaction	  with	  components	  of	  the	  DSB	  mediator	  complex.	  
Investigation	   of	   H2AX	   phosphorylation,	   the	   initial	   step	   in	   mediator	   complex	  
assembly	   showed	   that	   γH2AX	   is	   reduced	   in	   LSH	   deficient	   cells	   (Figure	   4.4).	  
Further	   investigation	   revealed	   fewer	   γH2AX	   IRIF	   in	   Lsh-­/-­	   MEFs,	   which	  
suggested	   only	   a	   proportion	   of	   DSBs	   were	   effected	   (Figure	   4.6).	   Expression	  
array	  data	  revealed	  no	  expression	  changes	  in	  Lsh-­/-­	  MEFs	  that	  could	  account	  for	  
this	   (Table	   4.1)	   and	   chromatin	   retention	   assays	   showed	   no	   difference	   in	   the	  
amount	  of	  H2AX	  associated	  with	  the	  chromatin	  in	  Lsh-­/-­	  MEF	  (Figure	  4.1).	  
We	   show	   that	   reduced	   γH2AX	   resulted	   in	   less	   robust	   recruitment	   of	  
downstream	   mediator	   components,	   MDC1	   and	   53BP1	   (Figures	   4.8	   and	   4.9).	  
Mediator	  complex	  facilitates	  the	  recruitment	  of	  proteins	  required	  for	  DSB	  repair	  
by	  HR.	  This	  may	  explain	  why	  some	  DSBs	  are	  repaired	  slower	  in	  Lsh-­/-­	  MEFs.	  The	  
mediator	   complex	   also	   facilitates	   correct	   cell	   cycle	   checkpoint	   signalling	   by	  
recruiting	   checkpoint	   proteins	   to	   broken	   DNA	   ends.	   Analysis	   of	   checkpoint	  
activation	  showed	  similar	  activation	  of	  p53	  in	  shLSH	  and	  non-­‐silencing	  control	  
MRC5hT	   cells	   but	   reduced	   phosphorylation	   of	   CHK2	   (Figures	   4.10	   and	   4.11).	  
This	   showed	   that	   cell	   cycle	   checkpoint	   signalling	   is	   not	   extended	   to	  
accommodate	   the	   slower	  DSB	   repair	  of	  LSH	  deficient	   cells.	  This	   indicates	   that	  
DSB,	  which	  require	  LSH	   for	  H2AX	  phosphorylation	  and	  repair,	  do	  not	  activate	  
cell	  cycle	  arrest	  in	  LSH	  deficient	  cells.	  This	  would	  allow	  mitosis	  to	  occur	  which	  
unrepaired	   DSBs,	   which	   could	   result	   in	   chromosomal	   defects	   and	   explains	  
reduced	  survival	  of	  LSH	  deficient	  cells	  following	  ionising	  radiation	  treatment.	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Results	  -­	  Chapter	  Five	  
5.0	  Rescue	  of	  DNA	  DSB	  repair	  defects	  in	  Lsh-­/-­	  MEFs	  
	  
5.1	  Introduction	  
We	  have	  identified	  a	  phenotype	  of	  increased	  sensitivity	  to	  DSB	  inducing	  agents	  
in	   LSH	  deficient	   cells	   and	  have	   shown	   that	   a	   proportion	  of	  DSBs	   are	   repaired	  
slower	   in	   these	   cells.	   We	   have	   also	   demonstrated	   that	   mediator	   complex	  
assembly	  and	  cell	  cycle	  checkpoint	  signalling	  are	  impaired	  in	  the	  absence	  of	  LSH	  
and	  that	  these	  are	  most	  likely	  the	  cause	  for	  the	  observed	  increase	  in	  cell	  death	  
and	  sensitivity	  to	  DSB	  inducing	  agents.	  Although	  microarray	  data	  did	  not	  reveal	  
any	   obvious	   expression	   changes	   that	   could	   be	   responsible	   for	   the	   observed	  
phenotype,	  a	  direct	  involvement	  of	  LSH	  in	  DSB	  repair	  is	  yet	  to	  be	  demonstrated.	  
We	  therefore	  followed	  two	  lines	  of	  enquiry	  to	  identify	  if	  LSH	  is	  actively	  involved	  
in	   repair	  of	  DSBs.	  Firstly,	  we	   characterised	  Lsh-­/-­	  MEFs	   that	  had	  been	   infected	  
with	  lentiviruses	  expressing	  either	  WT	  LSH	  or	  a	  catalytically	  inactive	  LSH	  which	  
contained	  a	  lysine	  to	  glutamine	  mutation	  in	  the	  conserved	  ATPase	  domain.	  This	  
mutation	  has	  previously	  been	  shown	  to	  abolish	   the	  ATP	  hydrolysing	  ability	  of	  
LSH.	  This	  allowed	  us	  to	  test	   if	   the	  defective	  DSB	  repair	  phenotype	  of	   the	  Lsh-­/-­	  
MEFs	   can	   be	   complemented.	   It	   also	   allowed	   us	   to	   investigate	   whether	   the	  
ATPase	   activity	   of	   LSH	   is	   required	   for	   its	   function	   in	  DSB	   repair,	  which	   could	  
suggest	  chromatin	  remodelling	  by	  LSH.	  Secondly,	  we	  examined	  LSH	  localisation	  
pre	   and	   post	   ionising	   radiation	   treatment	   to	   determine	   if	   LSH	   is	   recruited	   to	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5.2	   WT	   but	   not	   catalytic	   null	   LSH	   improves	   survival	   of	   Lsh-­/-­	   MEFs	  
following	  IR	  
	  
Figure	  5.1:	  Nuclear	  extracts	  examined	  by	  Western	  blotting	  using	  anti-­‐Lsh	  and	  anti-­‐FLAG	  
primary	  antibodies	   to	  examine	  LSH	   levels	   in	  Lsh-­‐/-­‐	   and	   rescue	  MEF	  cells.	  An	  anti-­‐MRE11	  
antibody	  was	  also	  used	  to	  show	  the	  level	  of	  MRE11	  protein	  to	  act	  as	  a	  loading	  control.	  
Expression	  levels	  of	  LSH	  in	  Lsh-­/-­	  MEFs,	  which	  had	  been	  infected	  with	  either	  an	  
empty	   vector	   control,	   LSH-­‐3xFLAG	   (WT	   rescue)	   or	   catalytically	   inactive	   LSH-­‐
3xFLAG	  (mutant	  rescue)	  were	  examined	  by	  Western	  blotting	  and	  compared	  to	  
WT	  MEFs	  using	  both	  an	  anti-­‐LSH	  antibody	  and	  anti-­‐FLAG	  antibody	  specific	  for	  
the	   rescue	   construct.	   The	   results	   of	   the	   anti-­‐FLAG	  Western	   blot	   showed	   that	  
both	  WT	  and	  mutant	   constructs	  were	  expressed	  at	   similar	   levels	   (Figure	  5.1).	  
This	  was	  confirmed	  by	  Western	  blot	  probed	  with	  an	  anti-­‐LSH	  antibody,	  which	  
also	   showed	   LSH	   expression	   in	  WT	   and	  mutant	   rescues	   to	   be	   slightly	   higher	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Figure	  5.2:	  Giemsa	  stained	  plates	  and	  colony	  counts	  of	  empty	  vector	  control	  and	  rescue	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To	   establish	   whether	   the	   increased	   sensitivity	   of	   Lsh-­/-­	   MEFs	   to	   ionising	  
radiation	   can	   be	   rescued,	   survival	   studies	   were	   performed	   as	   previously	  
described	   comparing	   Lsh-­/-­	   cells	   expressing	   WT	   and	   mutant	   LSH	   with	   empty	  
vector	  controls.	  The	  results	  showed	  no	  difference	  between	  the	  survival	  of	  both	  
empty	  vector	  controls	  and	  mutant	   rescued	  cells,	  with	  approximately	  40%	  and	  
10%	  survival	  after	  either	  a	  5	  Gy	  or	  10	  Gy	  dose	  of	  ionising	  radiation,	  respectively	  
(Figure	  5.2).	  Furthermore,	  the	  results	  are	  comparable	  to	  the	  sensitivity	  of	  Lsh-­/-­	  
MEFs	   that	  was	   observed	   previously	   (Figure	   3.3).	   	   However,	  WT	   rescued	   cells	  
were	   much	   less	   sensitive	   to	   ionising	   radiation	   and	   even	   displayed	   an	  
improvement	   on	   the	   survival	   of	   WT	   MEFs	   that	   was	   observed	   previously	  
(Figures	  5.2	   and	  3.3).	   The	   improved	   survival	   of	   the	  Lsh-­/-­	   cells	   expressing	  WT	  
LSH	   indicates	   that	   LSH	   is	   able	   to	   reverse	   the	   increased	   sensitivity	   to	   ionising	  
radiation	  seen	  in	  LSH	  deficient	  cells.	  Furthermore,	  the	  failure	  of	  the	  mutant	  LSH	  
to	  improve	  the	  survival	  of	  Lsh-­/-­	  MEFs	  suggests	  that	  a	  functional	  ATPase	  domain	  
is	  required	  for	  the	  function	  of	  LSH	  in	  DSB	  repair.	  The	  improvement	  in	  survival	  
of	   Lsh-­/-­	   cells	   expressing	  WT	   LSH	   above	   the	   levels	   detected	   in	   the	  WT	   MEFs	  
could	  be	  due	   to	   the	   over	   expression	  of	   LSH,	   raising	   the	   interesting	  possibility	  
that	  excess	  LSH	  may	  improve	  the	  efficiency	  of	  DSB	  repair.	  
	  
5.3	  LSH	  ATPase	  activity	  is	  required	  to	  restore	  efficient	  mediator	  complex	  
assembly	  in	  Lsh-­/-­	  MEFs	  
The	   improved	   survival	   of	   WT	   rescued	   cells	   to	   ionising	   radiation	   treatment	  
suggests	   that	   DSBs	   are	   repaired	   more	   efficiently.	   To	   examine	   DSB	   repair	   in	  
more	  detail	  we	  explored	  H2AX	  phosphorylation	  and	  53BP1	   localisation	   in	  WT	  
and	   mutant	   rescued	   cells	   to	   determine	   whether	   we	   see	   improved	   mediator	  
complex	   assembly,	  which	  would	  be	   consistent	  with	   the	   results	   of	   the	   survival	  
study.	   γH2AX	   levels	   were	   investigated	   by	   Western	   Blots	   of	   nuclear	   extracts	  
prepared	  from	  Lsh-­/-­	  cells	  carrying	  either	  empty	  vector	  control,	  WT	  rescued	  or	  
mutant	   rescued	   constructs	   and	   WT	   MEFs	   at	   a	   range	   of	   time	   points	   after	  
treatment	  with	  ionising	  radiation.	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Figure	  5.3:	  Nuclear	  extracts	  examined	  by	  Western	  blotting	  using	  an	  anti-­‐γH2AX	  primary	  
antibody	   to	   examine	   γH2AX	   levels	   in	   empty	   vector	   control	   and	   rescue	   Lsh-­‐/-­‐	  MEFs	   at	   a	  
range	  of	  time	  points	  following	  10	  Gy	  of	  ionising	  radiation.	  An	  anti-­‐H4	  antibody	  was	  also	  
used	  to	  show	  the	  level	  of	  H4	  to	  act	  as	  a	  loading	  control.	  
As	   expected,	   empty	   vector	   control	   Lsh-­/-­	   MEFs	   showed	   reduced	   γH2AX	  when	  
compared	   to	   the	  WT	  MEFs	   (Figure	  5.3).	  Mutant	   rescue	   cells	   also	  had	   reduced	  
γH2AX	   levels	   compared	   to	   the	   WT	   MEFs	   and	   displayed	   a	   similar	   amount	   of	  
H2AX	  phosphorylation	   as	   empty	  vector	   control	   cells.	   This	   confirmed	   that	  LSH	  
without	   a	   functional	   ATPase	   domain	   cannot	   promote	   efficient	   DSB	   repair.	  
However	  in	  WT	  rescued	  cells	  the	  phosphorylation	  of	  H2AX	  was	  restored	  to	  WT	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Figure	  5.4:	  (A.)	  Representative	  immunofluorescence	  images	  showing	  53BP1	  localisation	  in	  
WT	  and	  mutant	   rescued	  Lsh-­‐/-­‐	  MEFs	  at	   the	   indicated	   time	  points	  after	  10	  Gy	  of	   ionising	  
radiation.	  (B.)	  The	  graphs	  show	  percentage	  of	  fociated	  or	  diffuse	  nuclear	  stained	  nuclei	  of	  
n=35	  cells.	  
To	   confirm	   that	   restored	   H2AX	   phosphorylation	   in	   WT	   rescued	   cells	   is	  
functioning	  correctly	  we	  also	  examined	  53BP1	  recruitment	  to	  IRIF	  as	  a	  sign	  of	  
correct	   mediator	   complex	   assembly.	   Immunofluorescence	   for	   53BP1	   was	  
carried	   out	   as	   previously	   described	   and	   cells	   were	   again	   classified	   as	   either	  
containing	   foci	  or	  having	  diffuse	  nuclear	  staining	  at	  1	  h	  and	  4	  h	  post	  10	  Gy	  of	  
ionising	  radiation.	  The	  localisation	  of	  53BP1	  in	  mutant	  rescued	  cells	  was	  similar	  
to	  what	  was	  previously	  observed	  in	  the	  Lsh-­/-­	  MEFs	  (Figure	  4.8),	  with	  IRIF	  only	  
identifiable	  in	  40%	  and	  60%	  of	  cells	  1hour	  and	  4hours	  after	  treatment	  (Figure	  
5.4).	  WT	  rescued	  cells	  exhibited	  a	  pattern	  of	  53BP1	  localisation	  that	  resembled	  
WT	  MEFs,	  with	  85%	  and	  100%	  of	  cells	  having	  IRIF	  1	  h	  and	  4	  h	  after	  treatment.	  
In	   summary	   the	   expression	   of	  WT	   or	   catalytically	   inactive	   LSH	   in	  Lsh-­/-­	  MEFs	  
clearly	  demonstrates	  that	  the	  inefficient	  DSB	  repair	  phenotype	  can	  be	  reversed	  
and	   that	   the	  ATPase	   activity	   of	   LSH	   is	   required	   for	   its	   function	   in	  DSB	   repair.	  
These	   data	   add	   further	   credibility	   to	   the	   hypothesis	   that	   LSH	   is	   required	   for	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5.4	  LSH	  does	  not	  accumulate	  at	  the	  sites	  of	  DNA	  damage	  
Another	  piece	  of	  evidence	  that	  would	  confirm	  that	  LSH	  is	  involved	  in	  DSB	  break	  
repair	  would	  be	   to	  show	  that	  LSH	   is	  recruited	  to	   the	  site	  of	  DNA	  damage.	  The	  
time	   of	   recruitment	  may	   also	   help	   to	   understand	   the	   function	   of	   LSH	   in	   DSB	  
repair.	  Late	  recruitment	  would	  suggest	  a	  role	  in	  repair,	  possibly	  in	  relaxing	  the	  
chromatin	   in	   preparation	   for	   strand	   invasion	   and	  homologous	   recombination.	  
This	  may	   explain	   the	   inefficient	   DSB	   repair	   seen	   in	  Lsh-­/-­	  MEFs.	   Alternatively,	  
early	  recruitment	  may	  suggest	  a	  role	  in	  DSB	  detection,	  possibly	  by	  remodelling	  
the	   chromatin	   to	   allow	   space	   for	   mediator	   complex	   assembly.	   This	   could	  
provide	   an	   explanation	   for	   the	   reduced	   H2AX	   phosphorylation	   and	   mediator	  
complex	  assembly	  in	  LSH	  deficient	  cells.	  
To	  address	  these	  questions	  we	  performed	  immunofluorescence	  on	  WT	  MEFs	  to	  
see	   if	  endogenous	  LSH	  localises	  to	  IRIF.	  Unfortunately,	  we	  could	  not	  obtain	  an	  
anti-­‐LSH	   antibody	   that	   was	   suitable	   for	   immunofluorescence	   in	   our	   hands.	  
However,	   the	  WT	  and	  mutant	   rescued	  cell	   lines	  expressing	  LSH	   tagged	  with	  a	  
triple	   FLAG	   peptide	   detectable	   by	   immunofluorescence	   using	   an	   anti-­‐FLAG	  
antibody	   were	   suitable	   for	   localisation	   studies.	   Since	   our	   investigation	   has	  
shown	  that	  the	  WT	  rescued	  cells	  can	  restore	  DSB	  repair	  to	  normal,	  we	  surmised	  
that	  LSH	  is	  functioning	  correctly	  in	  DNA	  repair	  in	  these	  cells.	  Therefore,	  the	  WT	  
rescued	   cells	   are	   a	   suitable	   model	   in	   which	   to	   investigate	   LSH	   localisation	  
following	  ionising	  radiation	  treatment.	  Mutant	  rescue	  cells	  were	  also	  examined	  
to	   determine	   whether	   any	   localisation	   in	   response	   to	   ionising	   radiation	  
treatment	   that	   could	   be	   seen	   in	   the	   WT	   rescue	   cells	   is	   dependent	   on	   ATP	  
hydrolysis.	   We	   predicted	   that	   if	   LSH	   is	   recruited	   to	   DSBs	   through	   protein-­‐
protein	  interactions,	  these	  could	  still	  occur	  with	  a	  catalytically	  inactive	  ATPase	  
domain	  so	  IRIF	  could	  still	   form.	  However	  if	  LSH	  translocates	  along	  the	  DNA	  to	  
the	   site	   of	   a	   DSB,	   ATP	   hydrolysis	   would	   be	   required	   so	   IRIF	   would	   not	   be	  
present	  in	  the	  mutant	  rescued	  cells.	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Figure	   5.5:	   Representative	   immunofluorescence	   images	   using	   an	   anti-­‐FLAG	   antibody	   to	  
show	  LSH	  localisation	  in	  WT	  and	  mutant	  rescued	  Lsh-­‐/-­‐	  MEFs	  at	  the	  indicated	  time	  points	  
after	  10Gy	  of	  ionising	  radiation.	  
Although	   localisation	   of	   FLAG-­‐tagged	   LSH	   to	   IRIF	   was	   not	   observed	   in	   the	  
mutant	  rescued	  cells,	  we	  also	  did	  not	  detect	   recruitment	  of	  LSH	  to	   IRIF	   in	   the	  
WT	   rescued	   cells	  post	   ionising	   radiation	   treatment	   (Figure	  5.5).	  These	   results	  
suggest	  that	  LSH	  is	  either	  not	  recruited	  to	  DSB	  or	  recruited	  at	  too	  low	  a	  level	  to	  
be	  detected	  above	  background	   levels	   in	   the	  nucleoplasm.	  A	   third	  possibility	   is	  
that	   LSH	   is	   not	   freely	   moving	   in	   the	   nucleoplasm	   but	   is	   associated	   with	   the	  
chromatin	  and	  doesn’t	  translocate	  far	  or	  accumulate	  at	  sites	  of	  DNA	  damage,	  but	  
rather	  acts	  locally	  and	  only	  aids	  in	  repair	  of	  DSBs	  that	  occur	  close	  to	  where	  it	  is	  
associated.	  
If	   LSH	   is	   normally	   recruited	   to	   DNA	   damage	   at	   levels	   too	   low	   to	   be	   detected	  
above	  nucleoplasm	  background	  we	   can	   improve	  our	   chance	   of	   observing	   LSH	  
recruitment	  by	  inducing	  a	  high	  frequency	  of	  DSBs	  within	  an	  defined	  area	  of	  the	  
nucleus.	  A	  high	  number	  of	  DSB	  will	  result	  in	  a	  stronger	  signal,	  which	  should	  be	  
seen	  over	  the	  nucleoplasmic	  background.	  To	  achieve	  this	   laser	   induced	  micro-­‐
irradiation	   was	   performed,	   whereby	   cells	   expressing	   GFP-­‐tagged	   LSH	   were	  
cultured	  with	  BrdU,	  which	  incorporates	  into	  the	  DNA	  making	  it	  more	  heat	  labile.	  
This	  was	  followed	  by	  passing	  a	  laser	  across	  a	  cell	  to	  disrupt	  the	  heat	  labile	  DNA	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We	  also	  wished	  to	  examine	  LSH	  localisation	  immediately	  after	  laser	  irradiation	  
in	  case	  it	   is	  recruited	  very	  early	  to	  DSBs	  and	  dissociates	  rapidly,	   in	  which	  case	  
LSH	  localisation	  to	  breaks	  could	  be	  missed	  in	  the	  time	  it	  took	  to	  fix	  the	  cells	  for	  
immunofluorescence.	   To	   overcome	   this	   we	   performed	   live	   cell	   imaging	   and	  
followed	   GFP-­‐tagged	   LSH	   within	   a	   cell	   immediately	   after	   Laser	   micro	  
irradiation.	   Fortunately	   VA13	   cells	   (SV40	   immortalised	   lung	   fibroblasts)	  
expressing	   LSH-­‐GFP	   were	   previously	   generated	   in	   the	   lab	   (Kevin	   Myant,	  
unpublished)	  allowing	  visualisation	  of	  LSH	  in	  vivo.	  Laser	  micro-­‐irradiation	  was	  
therefore	  performed	  on	  VA13	  LSH-­‐GFP	   cells	   and	   images	   taken	   in	   real	   time	   to	  
follow	  the	  localisation	  of	  LSH-­‐GFP	  within	  the	  nucleus.	  After	  4h	  cells	  were	  fixed	  
and	  immunofluorescence	  carried	  out	  for	  γH2AX	  as	  a	  control	  for	  the	  induction	  of	  
DSBs.	  
	  
Figure	  5.6:	  Confocal	  microscopy	  images	  showing	  LSH-­‐GFP	  in	  VA13	  cells	  at	  indicated	  time	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The	   path	   of	   the	   laser	   could	   be	   seen	   by	   γH2AX	   immunofluorescence,	   which	  
highlights	  a	  line	  of	  DSBs	  across	  the	  nucleus	  (Figure	  5.6).	  However,	  LSH-­‐GFP	  did	  
not	   associate	  with	   the	   laser	   induced	  damage	  either	   later	  or	   immediately	   after	  
irradiation	   (Figure	   5.6).	   This	   maybe	   because	   native	   LSH	   is	   also	   produced	   in	  
VA13	  cells	  and	  is	  recruited	  to	  DSBs	  in	  preference	  to	  GFP	  tagged	  LSH	  or	  it	  may	  be	  
that	   LSH	   is	   chromatin	   bound	   and	   acts	   to	   repair	   breaks	   locally	   and	   is	   not	  
recruited	  to	  DSBs	   in	  general.	   It	   is	  also	  possible	   that	  LSH	   is	  not	   involved	   in	   the	  
DNA	  damage	  response	  at	  sites	  of	  damage,	  but	  may	  facilitate	  the	  homogeneous	  
distribution	   of	   H2AX	   throughout	   chromatin.	   In	   LSH	   deficient	   cells	   this	   could	  
lead	   to	   regions	   of	  H2AX	  poor	   chromatin	  where	   there	   is	   insufficient	  H2AX,	   for	  
phosphorylation	  in	  response	  to	  the	  formation	  of	  a	  DSB,	  to	  form	  γH2AX	  IRIF.	  
	  
5.5	  The	  LSH	  is	  mainly	  chromatin	  bound	  and	  not	  free	  in	  the	  nucleoplasm	  	  
To	   test	   the	   hypothesis	   that	   LSH	   is	   not	   recruited	   to	   breaks,	   but	   rather	   aids	   in	  
repair	  of	  breaks	  close	  to	  where	  it	  is	  situated	  on	  the	  chromatin	  we	  investigated	  
whether	  LSH	  accumulates	   on	   chromatin	   after	   IR.	  A	   chromatin	   retention	   assay	  
was	  performed	  as	  previously	  described.	  If	  the	  hypothesis	  is	  correct	  we	  expect	  to	  
find	   the	  majority	  of	   LSH	   in	   the	   chromatin	  bound	   fraction	   rather	   than	   the	   free	  
nucleoplasmic	   fraction.	   The	   assay	  was	   carried	   out	   on	  WT	  MEFs	   pre	   and	   post	  
treatment	   with	   a	   10	   Gy	   dose	   of	   ionising	   radiation	   to	   explore	   whether	   the	  
chromatin	  affinity	  of	  LSH	  changed	  in	  response	  to	  the	  induction	  of	  DSBs.	  
	  
Figure	  5.7:	  Chromatin	  retention	  assay	  shown	  by	  Western	  blot	  analysis	  of	  WT	  MEFs	  using	  
an	  anti-­‐LSH	  primary	  antibody	  to	  show	  soluble	  and	  chromatin	  bound	  fractions	  before	  and	  
1	  h	  post	  10	  Gy	  of	   ionising	   radiation.	  Quantification	  of	  LSH	   is	  plotted	  as	  a	  percentage	  of	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These	  experiments	  showed	  that	  a	   large	  proportion	  of	  LSH	  (75%)	  is	  chromatin	  
bound	   (Figure	   5.7).	   Furthermore	   there	   was	   no	   increase	   in	   the	   amount	   of	  
chromatin	  bound	  LSH	  post	  irradiation	  suggesting	  that	  additional	  nucleoplasmic	  
LSH	  is	  not	  recruited.	  These	  data,	  together	  with	  the	  lack	  of	  LSH	  accumulation	  at	  
DSB	  are	  consistent	  with	  chromatin	  bound	  LSH	  acting	  locally	  to	  aid	  in	  DSB	  repair	  
or	   LSH	   evenly	   distributing	   H2AX	   throughout	   chromatin.	   Either	   of	   these	  
hypotheses	   may	   explain	   why	   in	   LSH	   depleted	   cells,	   H2AX	   phosphorylation	  
occurs	  at	  some	  breaks	  but	  not	  others	  (Figures	  4.3	  and	  4.5).	  
	  
5.6	  Summary	  
These	   results	   demonstrate	   that	   the	   DSB	   phenotype	   of	   the	   Lsh-­/-­	   MEFs	   can	   be	  
fully	  reversed	  by	  the	  reintroduction	  of	  LSH	  into	  these	  cells,	  with	  both	  survival	  
(Figure	  5.2)	  and	  H2AX	  phosphorylation	  (Figure	  5.3)	  returning	  to	  the	  level	  of	  WT	  
MEFs.	  The	  results	  also	  showed	  that	  LSH	  ATPase	  activity	  is	  vital	  to	  its	  function	  in	  
DSB	  repair,	  with	  catalytically	   inactive	  LSH	  having	  no	  restorative	  effect	  on	  DSB	  
repair	   in	   the	   Lsh-­/-­	   MEFs.	  While	   this	   does	   not	   provide	   evidence	   of	   chromatin	  
remodelling	   by	   LSH,	   the	   requirement	   of	   a	   functionally	   ATPase	   domain	   for	  
effective	   DSB	   repair	   is	   consistent	   with	   the	   hypothesis	   that	   chromatin	  
remodelling	  by	  LSH	  is	  what	  facilitates	  its	  role	  in	  DSB	  repair.	  	  
Unlike	   most	   DSB	   signalling	   and	   repair	   proteins,	   LSH	   does	   not	   accumulate	   at	  
broken	  DNA	  ends.	  This	  was	  demonstrated	  by	  a	   lack	  of	  LSH	  IRIF	   in	  Lsh-­/-­	  MEFs	  
expressing	  FLAG-­‐tagged	  LSH	  (Figure	  5.5)	  and	  the	  failure	  of	  GFP-­‐tagged	  LSH	  to	  
localise	   to	   sites	   of	  DNA	  damage	   in	  VA13	   cells	   (Figure	   5.6).	  We	   showed	   that	   a	  
possible	  explanation	  for	  this	  is	  because	  the	  majority	  LSH	  is	  normally	  associated	  
with	   the	   chromatin	  and	   that	   this	  does	  not	   change	   following	   ionising	   radiation	  
treatment.	  This	  suggested	  two	  possible	  hypotheses,	  either	  LSH	  only	  aids	  in	  the	  
repair	  of	  DSBs	  that	  occur	  close	  to	  where	  LSH	  is	  bound	  or	  the	  role	  of	  LSH	  in	  the	  
DSB	  response	  is	  not	  at	  broken	  DNA	  ends.	  The	  first	  hypothesis	   implies	  that	  not	  
all	  DSBs	  require	  LSH	  for	  repair	  and	  the	  second	  that	  LSH	  is	  not	  directly	  involved	  
in	  DSB	  repair	  but	  has	  a	  related	  function	  such	  as	  ensuring	  the	  even	  distribution	  
of	  H2AX.	  To	  test	  either	  of	  these	  we	  needed	  to	  compare	  the	  repair	  of	  individual	  
DSBs,	  which	  require	  LSH	  for	  repair,	  in	  WT	  and	  LSH	  deficient	  cells.	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6.0	   Generation	   of	   an	   inducible	   DSB	   system	   for	   further	  
investigation	  of	  LSH	  dependent	  repair	  
	  
6.1	  Introduction	  
The	  most	   identifiable	   DSB	   repair	   defect	   in	   LSH	   deficient	   cells	   is	   the	   reduced	  
H2AX	   phosphorylation.	   To	   further	   investigate	   how	   LSH	   is	   involved	   in	   DSB	  
repair	   we	   need	   to	   more	   closely	   examine	   in	   what	   way	   the	   γH2AX	   levels	   are	  
reduced	   in	   LSH	   deficient	   cells.	   As	   previously	   stated	   inefficient	   H2AX	  
phosphorylation	   in	  Lsh-­/-­	  MEFs	  could	  be	   the	  result	  of	  either	  a	  reduction	   in	   the	  
amount	   of	   H2AX	   phosphorylation	   at	   all	   DSBs	   or	   the	   failure	   to	   phosphorylate	  
H2AX	  at	  a	  proportion	  of	  breaks.	  The	  observation	  that	  fewer	  γH2AX	  IRIF	  can	  be	  
seen	  in	  Lsh-­/-­	  compared	  to	  WT	  MEFs,	  despite	  the	  same	  number	  of	  breaks	  being	  
induced	   indicates	   a	   failure	   to	   phosphorylate	   H2AX	   at	   a	   proportion	   of	   breaks.	  
This	  is	  supported	  by	  the	  observations	  that	  LSH	  is	  mainly	  chromatin	  bound	  and	  
does	  accumulate	  at	  breaks,	  which	  suggests	  that	  LSH	  is	  chromatin	  associated	  and	  
only	  acts	  to	  aid	  in	  repair	  of	  breaks	  which	  occur	  close	  to	  where	  it	  is	  bound.	  
To	   further	  explore	   the	  role	  of	  LSH	   in	  DSB	  repair,	   individual	  breaks	  have	   to	  be	  
examined	  rather	  than	  the	  cellular	  responses	  to	  DNA	  damage	  in	  general	  because	  
only	  a	  proportion	  of	  DSBs	  seem	  to	  require	  LSH	  for	  efficient	  repair.	  We	  therefore	  
need	   to	   compare	   DSBs	   in	  WT	   and	   LSH	   deficient	   cells	   to	   identify	   breaks	   that	  
undergo	  LSH	  dependent	  repair.	  Since	  we	  do	  not	  yet	  know	  in	  which	  way	  LSH	  is	  
mechanistically	  necessary	   for	   repair,	  we	  need	   to	  be	  able	   to	  characterise	  many	  
breaks	  and	  perform	  statistical	  correlations.	  To	  achieve	  this	  a	  system	  is	  required	  
that	   would	   allow	   DSBs	   to	   be	   induced	   at	   the	   same	   defined	   locations	   in	   the	  
genomes	   of	   WT	   and	   LSH	   deficient	   cells	   for	   direct	   comparison	   of	   repair	   at	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In	   order	   to	   achieve	   this,	   we	   employed	   the	   ER-­‐AsiSI	   system	   developed	   by	  
Lacovoni	  et	  al	  2010,	  which	  uses	  the	  restriction	  enzyme	  AsiSI	  under	  the	  control	  
of	   the	   estrogen	   receptor.	   Upon	   addition	   of	   4-­‐Hydroxytamoxifen	   (4OHT)	  	  	  	  	  	  	  	  	  	  	  
ER-­‐AsiSI	   translocates	   from	   the	   cytoplasm	   to	   the	   nucleus	  where	   it	   cleaves	   the	  
DNA	   creating	   a	   DSB	   at	   a	   precise,	   known	   location	   within	   the	   genome.	   γH2AX	  
ChIP-­‐Chip	  could	  then	  be	  performed	  to	  compare	  H2AX	  phosphorylation	  at	  DSBs	  
in	   the	   same	   location	   in	  both	  WT	  and	  LSH	  deficient	   cells,	   to	   identify	  DSBs	   that	  
require	  LSH	  for	  efficient	  repair.	  AsiSI	  has	  approximately	  1000	  recognition	  sites	  
within	  the	  human	  genome	  and	  has	  been	  reported	  to	  cut	  at	  approximately	  25%	  
of	  these	  providing	  a	  statistically	  significant	  number	  of	  sites	  to	  compare.	  	  
	  
6.2	  Generation	  of	  cells	  expressing	  ER-­AsiSI	  
The	  AsiSI	  restriction	  enzyme	  employed	  in	  the	  ER-­‐AsiSI	  inducible	  DSB	  system	  is	  
methylation	  sensitive.	  Only	  25%	  of	  potential	  AsiSI	  site	  are	  cut	  in	  cells	  with	  WT	  
levels	   of	   DNA	   methylation,	   which	   induces	   a	   similar	   number	   of	   DSBs	   as	   a	  	  	  	  	  	  	  	  	  	  	  
10-­‐15	  Gy	  dose	  of	   ionising	  radiation	  (Lacovoni	  et	  al	  2010,	  Rogakou	  et	  al	  1999).	  
Lsh-­/-­	   MEFs	   have	   a	   reduction	   in	   DNA	   methylation	   by	   approximately	   70%	  
compared	  to	  WT	  MEFs.	  This	  makes	  WT	  and	  Lsh-­/-­	  MEFs	  an	  unsuitable	  platform	  
for	  the	  ER-­‐AsiSI	  system	  as	  reduced	  methylation	  in	  Lsh-­/-­	  MEFs	  will	  make	  more	  
restriction	  sites	  available	  to	  AsiSI,	  resulting	  in	  more	  DSBs	  being	  induced	  in	  the	  
Lsh-­/-­	  MEFs	  than	  in	  the	  WT.	  We	  therefore	  opted	  to	  use	  non-­‐silencing	  and	  shLSH	  
MRC5hT	   cells	   as	   the	   basis	   for	   the	   ER-­‐AsiSI	   inducible	   DSB	   system.	   Although	  
previous	   work	   has	   shown	   that	   knockdown	   of	   LSH	   results	   in	   loss	   of	   DNA	  
methylation,	  it	  took	  over	  15	  population	  doublings	  for	  a	  significant	  difference	  in	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Initially	  ER-­‐AsiSI	  was	  introduced	  into	  MRC5hT	  cells,	  prior	  to	  shLSH	  knockdown	  
in	   order	   to	   base	   non-­‐silencing	   and	   shLSH	   cells	   on	   the	   same	   ER-­‐AsiSI	  MRC5hT	  
background.	  This	  was	  done	  to	  ensure	  the	  same	  level	  of	  ER-­‐AsiSI	  expression	   in	  
both	   non-­‐silencing	   and	   shLSH	   cells	   so	   that	   variation	   in	   ER-­‐AsiSI	   expression	  
levels	  didn’t	  affect	  efficiency	  of	  DSB	  induction.	  ER-­‐AsiSI	  is	  also	  HA	  tagged,	  which	  
allowed	   us	   to	   use	   an	   anti-­‐HA	   antibody	   suitable	   for	   immunofluorescence	   to	  
observe	  localisation	  of	  ER-­‐AsiSI	  prior	  to	  and	  following	  Tamoxifen	  treatment.	  
	  
Figure	   6.1:	   Representative	   immunofluorescence	   images	   using	   an	   anti-­‐HA	   antibody	   to	  
show	  ER-­‐AsiSI-­‐HA	  localisation	  in	  MRC5hT	  cells	  before	  and	  after	  Tamoxifen	  treatment.	  
These	   experiments	   showed	   that	   ER-­‐AsiSI	   was	   expressed	   in	   MRC5hT	   cells	   and	  
was	  distributed	  throughout	  the	  cytoplasm	  prior	  to	  4OHT	  treatment	  (Figure	  6.1).	  
Upon	   induction	   with	   4OHT	   clear	   nuclear	   staining	   is	   observered	   (Figure	   6.1),	  
indicating	   that	   the	   majority	   of	   ER-­‐AsiSI	   translocates	   to	   the	   nucleus	   and	   the	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6.3	   H2AX	   phosphorylation	   of	   AsiSI	   induced	   DSBs	   in	   non-­silencing	   and	  
shLSH	  MRC5hT	  ER-­AsiSI-­HA	  cells	  
shRNA	  knockdown	  of	  LSH	   in	  MRC5hT	   ER-­‐AsiSI	   cells	  was	  performed	  as	  previously	  
described	  and	  knockdown	  efficiency	  examined	  by	  Western	  blot.	  To	  ensure	  that	  
AsiSI	  induced	  breaks	  behave	  similarly	  to	  previously	  observed	  ionising	  radiation	  
induced	   DSBs	   we	   examined	   γH2AX	   levels	   following	   4	   h	   4OHT	   treatment	   to	  
induce	  AsiSI	  DSBs.	  
	  
Figure	  6.2:	  Nuclear	  extracts	  examined	  by	  Western	  blotting	  using	  either	  anti-­‐LSH	  or	  anti-­‐
γH2AX	  primary	  antibody	  to	  examine	  shLSH	  knockdown	  efficiency	  and	  γH2AX	  response	  to	  
AsiSI	  DSBs	  induced	  by	  4h	  4OHT	  treatment	  in	  WT,	  non-­‐silencing	  and	  shLSH	  MRC5hT	  ER-­‐AsiSI-­‐HA	  
cells.	  Anti-­‐HDAC1	  and	  anti-­‐H3	  antibodies	  were	  used	  as	  a	  loading	  control	  respectively.	  
The	   results	   showed	   shRNA	   knockdown	   reduced	   LSH	   to	   nearly	   undetectable	  
levels	   in	   shLSH	  MRC5hT	   ER-­‐AsiSI	   cells	   (Figure	  6.2).	  γH2AX	  Western	  blots	   showed	  
that	   H2AX	   phosphorylation	   occurred	   in	   response	   to	   4OHT	   treatment	   in	  	  	  
MRC5hT	  ER-­‐AsiSI	  cells,	  indicating	  DSB	  induction	  and	  repair	  response.	  Furthermore	  
levels	  of	  γH2AX	  were	  reduced	  in	  the	  shLSH	  MRC5hT	  ER-­‐AsiSI	  cells	  have	  compared	  
to	   WT	   or	   non-­‐silencing	   controls	   (Figure	   6.2),	   consistent	   with	   the	   previously	  
observed	  defects	  in	  DSB	  repair	  in	  LSH	  deficient	  cells	  following	  ionising	  radiation	  
treatment.	  This	  suggested	  that	  AsiSI	   induced	  DSBs	   in	  non-­‐silencing	  and	  shLSH	  
MRC5hT	  ER-­‐AsiSI	  cells	  provide	  a	  suitable	  model	  system	  for	  comparing	  DSB	  repair	  at	  
the	   same	   defined	   genomic	   locations	   in	   a	  WT	   or	   LSH	   deficient	   background	   in	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6.4	  Future	  characterisation	  of	  MRC5hT	  ER-­AsiSI	  cells	  to	  investigate	  the	  role	  of	  
LSH	  in	  DSB	  repair	  
To	   further	   investigate	  DSB	   repair	   at	   a	   variety	   of	   defined	   genomic	   locations	   in	  
shLSH	  MRC5hT	   ER-­‐AsiSI	   and	  non-­‐silencing	   control	   cells,	  we	   suggest	   γH2AX	  ChIP-­‐
Chip	   be	   carried	   out	   on	   these	   cells.	   By	   using	   H2AX	   phosphorylation	   as	   an	  
indicator	  of	  efficient	  DSB	  repair,	  breaks	  that	  undergo	  LSH	  dependent	  repair	  can	  
identified	   as	   broken	   DNA	   ends	   with	   reduced	   H2AX	   phosphorylation	   in	   the	  
shLSH	  MRC5hT	   ER-­‐AsiSI	   cells	   compared	   to	   the	  non-­‐silencing	   control	   cells.	   γH2AX	  
ChIP-­‐Chip	  may	  also	  indicate	  the	  reason	  for	  the	  reduced	  H2AX	  phosphorylation	  
observed	   on	   a	   cellular	   level	   in	   LSH	   deficient	   cells.	   For	   example,	   γH2AX	   ChIP-­‐
Chip	  could	  indicate	  a	  reduction	  or	  lack	  of	  H2AX	  phosphorylation	  at	  a	  proportion	  
of	  DSBs	  or	  a	  reduction	  in	  γH2AX	  spreading	  from	  the	  broken	  DNA	  end	  of	  some	  
breaks	  or	  a	  combination	  of	  these,	  all	  of	  which	  would	  result	   in	  reduced	  cellular	  
levels	  of	  γH2AX	  in	  response	  to	  the	  induction	  of	  DSBs	  
γH2AX	   ChIP-­‐Chip	  may	   show	   that	   DSBs,	  which	   require	   LSH	   for	   efficient	   H2AX	  
phosphorylation,	   occur	   sporadically	   or	   in	   clusters,	   which	   would	   suggest	   LSH	  
either	   functions	   over	   large	   regions	   or	   at	   specific	   locations.	   Statistical	  
comparisons	  between	  locations	  that	  require	  LSH	  for	  efficient	  DSB	  repair	  could	  
indicate	   a	   correlation	  with	   other	   known	   features	  within	   the	   genome,	   such	   as	  
repetitive	  elements	  or	  untranscribed	  regions.	  This	  may	  provide	  an	  insight	  into	  
how	  LSH	   functions	   in	  DSB	   repair	   as	   it	   has	   previously	   been	   shown	   to	   act	   as	   a	  
transcriptional	   repressor	   and	   be	   required	   at	   repetitive	   elements	   for	  
maintenance	  of	  DNA	  methylation.	  Identifying	  DSBs,	  which	  repair	  less	  efficiently	  
when	   LSH	   is	   depleted,	   will	   also	   indicate	   suitable	   regions	   for	   investigation	   in	  
more	   detail.	   For	   example,	   a	   range	   of	   different	   ChIPs	   could	   be	   performed	   to	  
examine	   heterochromatic	   or	   euchromatic	   marks	   or	   LSH	   occupancy	   in	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Discussion	  -­	  Chapter	  Seven	  
DNA	  damage	  from	  both	  normal	  metabolic	  activities	  and	  environmental	   factors	  
such	  as	  UV	  and	  radiation	  can	  cause	  as	  many	  as	  1	  million	  individual	  lesions	  to	  the	  
DNA	  per	  cell	  per	  day.	  It	  is	  vital	  that	  these	  lesions	  are	  repaired	  or	  the	  cells	  enter	  
senescence	   or	   undergo	   apoptosis	   to	   prevent	   the	   propagation	   of	   potentially	  
harmful	  mutations.	   If	  DNA	   lesions	  are	  allowed	   to	  persist	   through	  mitosis	   they	  
can	   affect	   transcript	   integrity	   and	   genome	   fidelity,	   leading	   to	   carcinogenesis.	  
The	   repair	   of	   DNA	   lesions	   is	   a	   complex	   process	   involving	   many	   different	  
mechanisms	   to	   cope	  with	   the	   variety	   of	   different	  DNA	   lesions	   that	   can	   occur.	  
Despite	   their	  different	   functions,	  all	  DNA	  repair	  mechanisms	  require	  access	   to	  
the	  DNA	  in	  order	  to	   facilitate	   its	  repair.	  However,	  DNA	  is	   found	  in	  a	  variety	  of	  
different	   chromatin	   states	   throughout	   the	  nucleus	  depending	  on	   its	   sequence,	  
chromosomal	   location,	   and	   transcriptional	   regulation.	   The	   DNA	   damage	  
response	   has	   to	   cope	  with	   DNA	   in	   a	   variety	   of	   different	   states	   of	   compaction	  
depending	  on	   the	  nucleosome	  occupancy,	  histone	  modifications	  and	  accessory	  
factors	  associated	  with	  the	  chromatin.	  It	  is	  unsurprising	  that	  histone	  modifying	  
enzymes	  and	  chromatin	  remodelling	  ATPases	  are	  associated	  with	  many	  of	   the	  
DNA	  damage	   response	   pathways	   to	   relax	   the	   chromatin	   and	   facility	   access	   to	  
the	  DNA	  for	  the	  repair	  machinery.	  	  
LSH	   is	   an	   ATP	   hydrolysing	   protein	   with	   functional	   domain	   and	   sequence	  
similarities	   to	   SNF2	   ATP	   dependent	   chromatin	   remodelling	   enzymes.	   To	   date	  
the	  majority	   of	   published	  work	   regarding	   LSH	   focuses	   on	   its	   requirement	   for	  
DNA	  methylation.	  However,	  unexplained	  phenotypes	   shown	  upon	  mutation	  of	  
LSH	  or	   its	  homologues	   in	  A.	   thaliana	   and	  S.	   cerevisiae	   suggest	   that	  LSH	   is	  also	  
involved	   in	   the	  DNA	   damage	   response.	  DDM1-­/-­	  A.	   thaliana	   have	   an	   increased	  
sensitivity	   to	   ionising	   radiation	   and	   UV,	  which	   is	   independent	   of	   the	   reduced	  
DNA	   methylation	   seen	   in	   these	   plants.	   These	   phenotypes	   indicate	   possible	  
defects	   in	   the	   repair	  of	  DSBs	  and	  NER.	  A	  homolog	  of	  Lsh,	   irc5	   is	   also	   found	   in	  	  	  	  	  	  
S.	  cerevisiae.	  Since	  S.	  cerevisiae	  lack	  DNA	  methylation,	  this	  suggests	  an	  additional	  
role	   for	   IRC5	   in	   yeast,	  which	  may	  be	   conserved	   in	  mammalian	  LSH.	   Synthetic	  
growth	   defects	   indicate	   that	   IRC5	   interacts	   with	   other	   known	   DSB	   repair	  
proteins.	  IRC5	  mutant	  S.	  cerevisiae	  also	  have	  increased	  numbers	  of	  RAD52	  foci,	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which	  are	  markers	  of	  DSB	  repair	  by	  HR.	  This	   suggests	   that,	   in	  addition	   to	   the	  	  	  	  	  	  
A.	  thaliana	  homolog	  of	  LSH,	  the	  S.	  cerevisiae	  homolog	  of	  LSH	  is	  also	  involved	  in	  
the	  DNA	  damage	  response.	  	  
Lsh-­/-­	  mice,	  which	  survive,	  have	  an	  unexplained	  premature	  aging	  phenotype	   in	  
addition	  to	  loss	  of	  DNA	  methylation.	  This	  is	  caused	  by	  an	  increase	  in	  the	  number	  
of	  senescent	  cells,	  often	  caused	  by	  DNA	  repair	  defects	   leading	  to	  a	  more	  rapid	  
accumulation	   of	   DNA	   damage.	   Interestingly	   LSH	   has	   also	   been	   observed	  
accumulating	   on	   meiotic	   chromosomes	   during	   the	   pachytene	   stage,	   prior	   to	  
synapse	   formation.	   This	   observation	   is	   coupled	   with	   the	   occurrence	   of	  
recombination	   defects	   in	   Lsh-­/-­	   oocytes,	   which	   suggests	   a	   role	   for	   LSH	   in	  
homologous	  recombination	  between	  chromosomes	  during	  meiosis.	  
	  
7.1	  LSH	  is	  required	  for	  efficient	  DSB	  repair	  
Initially,	   viability	   screening	   was	   performed	   using	   a	   range	   of	   different	   DNA	  
damaging	  agents	  to	  compare	  the	  DNA	  damage	  response	  of	  LSH	  deficient	  and	  WT	  
cells	   to	   a	   variety	   of	   different	   DNA	   lesions.	   Viability	   screening	   indicates	   the	  
sensitivity	  of	  a	  population	  of	  cells	  to	  DNA	  damage	  by	  identifying	  the	  proportion	  
of	  cells	  still	  viable	  following	  treatment	  with	  a	  DNA	  damaging	  agent.	  The	  results	  
showed	   that	   mammalian	   cells	   depleted	   of	   LSH	   are	   sensitive	   to	   DSB	   inducing	  
agents	   but	   not	   other	   forms	   of	   DNA	   damage.	   Survival	   studies	   were	   also	  
performed	   on	   both	   shLSH	  MRC5hT	   and	  Lsh-­/-­	  MEFs	   compared	   to	  WT	   controls,	  
using	   ionising	   radiation	   treatment	   to	   induce	   DSBs.	   These	   showed	   reduced	  
survival	   in	   LSH	   deficient	   cells	   compared	   to	   WT	   controls,	   which	   is	   consistent	  
with	   the	   reduced	  viability	  of	  LSH	  deficient	   cells	   following	   treatment	  with	  DSB	  
inducing	   agents.	   These	   results	   are	   consistent	   with	   observations	   in	   DDM1-­/-­	  	  	  	  	  	  	  	  	  
A.	   thaliana,	   which	   also	   have	   an	   increased	   sensitivity	   to	   ionising	   radiation	  
treatment.	  However,	  DDM1-­/-­	  A.	   thaliana	   are	   also	  more	   sensitive	   to	  UV,	  which	  
according	   to	   the	   viability	   screening	   data,	   does	   not	   appear	   to	   be	   a	   conserved	  
function	  of	  LSH	  in	  mammalian	  species.	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From	   the	   viability	   and	   survival	   data	   it	   was	   unclear	   whether	   the	   increased	  
sensitivity	  of	  LSH	  deficient	  cells	  to	  ionising	  radiation	  was	  a	  result	  of	  a	  failure	  to	  
repair	  DSBs	  or	  an	  increase	  in	  the	  number	  of	  DSBs	  induced.	  Neutral	  comet	  assays	  
were	  preformed,	   immediately	   following	   ionising	  radiation	   treatment	  and	  after	  
an	   8	   h	   recovery	   period,	   to	   examine	   the	   levels	   of	   DNA	   fragmentation.	   These	  
showed	  that	   ionising	  radiation	  treatment	   induces	  a	  similar	  number	  of	  DSBs	   in	  
both	  the	  Lsh-­/-­	  and	  WT	  MEFs,	  suggesting	  LSH	  does	  not	  play	  a	  role	  in	  protecting	  
DNA	  from	  the	  formation	  of	  DSBs.	  After	  an	  8	  h	  recovery	  period	  60%	  of	  the	  DSBs	  
were	  repaired	  in	  the	  WT	  MEFs,	  however	  only	  half	  the	  amount	  were	  repaired	  in	  
the	  Lsh-­/-­	  MEFs,	  which	  suggests	  that	  LSH	  aids	  repair	  of	  DSBs.	  
LSH	   has	   previously	   been	   reported	   to	   be	   an	   HDAC	   dependent	   transcriptional	  
repressor	   and	   to	   aid	   in	   correct	   DNA	   methylation	   establishment	   and	  
maintenance.	  Both	  of	  these	  functions	  could	  lead	  to	  changes	  in	  gene	  expression	  
of	  previously	   identified	  DNA	  repair	  proteins,	  which	  could	  cause	   the	   inefficient	  
DSB	  repair	   seen	   in	  LSH	  deficient	   cells.	  However,	  previous	  work	  carried	  out	   in	  
the	  lab	  used	  expression	  arrays	  to	  compare	  the	  Lsh-­/-­	  MEFs	  with	  WT	  MEFs	  from	  
matched	   littermates	   (Myant	   et	   al	   2011).	   This	   data	   revealed	   no	   significant	  
changes	   in	   the	   expression	   of	   known	   DSB	   repair	   proteins	   in	   the	   Lsh-­/-­	   MEFs,	  
which	  suggested	  that	  LSH	  is	  involved	  in	  the	  DSB	  break	  response.	  
	  
7.2	  LSH	  deficient	  cells	  correctly	  recognise	  DSBs	  	  
When	  LSH	  is	  depleted	  DSBs	  repair	  less	  efficiently,	  which	  sensitises	  LSH	  deficient	  
cells	  to	  DSB	  inducing	  agents.	  However	  it	  was	  unclear	  how	  the	  DSB	  response	  was	  
affected	  or	  how	  LSH	  was	  involved.	   It	  was	  possible	  that	  LSH	  is	   involved	  in	  DSB	  
detection	   and	   that	   DSBs	   are	   not	   recognised	   in	   LSH	   deficient	   cells.	   The	   MRN	  
complex,	   comprised	   of	   MRE11,	   RAD50	   and	   NBS1,	   binds	   broken	   DNA	   ends.	  
Attempts	   to	   examine	   recognition	   of	   the	   broken	   DNA	   end	   were	   hampered	   by	  
limitations	   of	   the	   available	   antibodies	   against	   the	   components	   of	   the	   MRN	  
complex.	   However,	   we	   showed	   that	   MRE11	   has	   an	   increased	   affinity	   for	  
chromatin	   following	   ionising	   radiation	   treatment,	  which	   is	   similar	   in	  both	   the	  
Lsh-­/-­	   and	  WT	  MEFs.	  We	   also	   investigated	   activation	   and	   localisation	   of	   ATM	  
kinase,	  which	   is	   recruited	   to	   the	  broken	  DNA	  end	  by	   the	  MRN	  complex	  and	   is	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required	  for	  cell	  cycle	  checkpoint	  signalling	  and	  establishing	  mediator	  complex	  
assemble.	   Western	   blot	   analysis	   showed	   similar	   phosphorylation	   of	   ATM	   at	  
serine	  residue	  1981	  in	  the	  Lsh-­/-­	  and	  WT	  MEFs	  in	  response	  to	  the	   induction	  of	  
DSBs	   and	   immunofluorescence	   showed	   similar	   localisation	   of	   phosphorylated	  
ATM	   to	   broken	   DNA	   ends	   immediately	   after	   DSB	   induction.	   This	   not	   only	  
showed	  that	  ATM	  responds	  correctly	  to	  the	  induction	  of	  DSBs,	  but	  also	  suggests	  
that	  the	  MRN	  complex	  correctly	  binds	  broken	  DNA	  ends,	  as	  MRN	  is	  responsible	  
for	  initial	  recruitment	  of	  phosphorylated	  ATM.	  Further	  downstream	  in	  the	  DSB	  
response	  phosphorylated	  ATM	  is	  recruited	  to	  DNA	  breaks	  by	  components	  of	  the	  
DSB	   mediator	   complex	   such	   as	   MDC1.	   This	   is	   interesting	   as	  
immunofluorescence	   also	   showed	   a	   reduction	   in	   phosphorylated	   ATM	  
recruitment	  to	  broken	  DNA	  ends	  in	  the	  Lsh-­/-­	  MEFs	  4h	  after	  induction	  of	  DSBs.	  
This	  suggested	  that	  the	  Lsh-­/-­	  MEFs	  had	  defects	  in	  mediator	  complex	  assembly.	  
	  
7.3	  H2AX	  phosphorylation	  is	  reduced	  in	  LSH	  deficient	  cells	  
H2AX	   phosphorylation	   by	   ATM	   is	   a	   vital	   step	   in	   the	   establishment	   of	   the	  
mediator	  complex	  at	  the	  broken	  DNA	  end,	  which	  reinforces	  DSB	  recognition	  and	  
recruits	   proteins	   required	   for	   cell	   cycle	   checkpoint	   signalling	   and	   repair	   by	  
homologous	   recombination.	   Since	   H2AX	   phosphorylation	   is	   the	   initial	   step	   in	  
the	   formation	   of	   the	   mediator	   complex	   at	   broken	   DNA	   ends,	   we	   examined	  
γH2AX	   by	   immunofluorescence.	   We	   showed	   that	   the	   amount	   of	   H2AX	  
phosphorylation	   in	   the	   Lsh-­/-­	   MEFs	   was	   reduced	   compared	   to	   the	   WT	   MEFs	  
following	  ionising	  radiation	  treatment.	  Upon	  counting	  the	  γH2AX	  IRIF	  we	  could	  
see	   fewer	   foci	   in	   the	   Lsh-­/-­	   MEFs.	   Unfortunately	   we	   could	   not	   examine	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
co-­‐localisation	   of	   ATM	   and	   γH2AX	   as	   both	   were	   detected	   using	   monoclonal	  
antibodies	  and	  we	  could	  not	   find	  polyclonal	   antibodies	   suitable	   for	  examining	  
phosphorylated	  ATM	  or	  γH2AX	  IRIF	   in	  our	  hands.	  However,	   comet	  assays	  and	  
ATM	   immunofluorescence	   suggested	   that	   in	   the	   Lsh-­/-­	   and	  WT	  MEFs	   the	   same	  
number	   of	   DSBs	   were	   being	   induced	   and	   correctly	   recognised	   by	   binding	   of	  
phosphorylated	  ATM.	  Therefore	  the	  reduced	  number	  of	  γH2AX	  IRIF	  in	  the	  Lsh-­/-­	  
MEFs	   suggested	   that	   only	   a	   proportion	  of	   broken	  DNA	  ends	   required	  LSH	   for	  
correctly	  phosphorylation	  of	  H2AX.	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Expression	  arrays	  had	  revealed	  that	  a	  70%	  reduction	   in	  DNA	  methylation	  and	  
loss	   of	   LSH	   mediated	   HDAC	   dependent	   transcriptional	   silencing	   in	   the	   Lsh-­/-­	  
MEFs	   causes	   no	   significant	   changes	   in	   the	   expression	   of	   known	   DSB	   repair	  
proteins.	  However	   it	  was	   possible	   that	   reduced	  DNA	  methylation	   in	   the	  Lsh-­/-­	  
MEFs	  was	  having	  an	  unknown	  affecting	  on	  DNA	  repair,	  which	  causes	   reduced	  
H2AX	  phosphorylation	  at	  a	  proportion	  of	  broken	  DNA	  ends.	  However,	  Western	  
blot	   analysis	   of	   H2AX	   phosphorylation	   following	   ionising	   radiation	   treatment	  
showed	   no	   difference	   between	   the	  WT	   or	  p53-­/-­	  MEFs	  when	   compared	   to	   the	  
Dnmt1-­/-­,	  p53-­/-­	  MEFs,	  which	   have	   a	   90%	   reduction	   in	   DNA	  methylation.	   	   The	  
Lsh-­/-­	  MEFs	  have	  reduced	  levels	  of	  γH2AX	  compared	  to	  the	  WT	  MEFs,	  consistent	  
with	   the	   reduced	   number	   of	   γH2AX	   observed	   by	   immunofluorescence.	   This	  
indicated	   that	   the	   loss	   of	   DNA	   methylation	   in	   Lsh-­/-­	   MEFs	   is	   not	   causing	   a	  
reduction	  in	  H2AX	  phosphorylation	  in	  response	  to	  the	  induction	  of	  DSBs.	  	  
We	   also	   performed	  Western	   blot	   analysis	   of	   H2AX	   phosphorylation	   following	  
ionising	  radiation	  treatment	  in	  human	  MRC5hT	  cells,	  in	  which	  LSH	  was	  depleted	  
by	  shRNA	  knockdown	  and	  compared	  this	  non-­‐silencing	  control	  cells.	  A	  similar	  
reduction	  in	  the	  amount	  of	  γH2AX	  was	  observed	  in	  the	  MRC5hT	  cells	  as	  was	  seen	  
in	  the	  Lsh-­/-­	  MEFs,	  which	  demonstrates	  that	  the	  phenomenon	  is	  not	  an	  artefact	  
of	   Lsh-­/-­	   MEFs.	   We	   also	   considered	   the	   possibility	   that	   LSH	   is	   involved	   in	  
distributing	   H2AX	   throughout	   the	   chromatin	   and	   that	   the	   reduced	   H2AX	  
phosphorylation	   in	   LSH	  deficient	   cells	   is	   due	   to	   a	   lack	   of	  H2AX	  on	   chromatin.	  
However	   chromatin	   retention	   assays	   showed	   no	   difference	   in	   the	   amount	   of	  
H2AX	  associated	  with	  the	  chromatin	  in	  the	  Lsh-­/-­	  and	  WT	  MEFs.	  	  
	  
7.4	  LSH	  deficient	  cells	  have	  impaired	  cell	  cycle	  checkpoint	  signalling	  
To	  determine	  how	  reduced	  H2AX	  phosphorylation	   leads	   to	  LSH	  deficient	   cells	  
becoming	   sensitised	   to	   DSB	   inducing	   agents	   we	   examined	   mediator	   complex	  
assembly	  and	  cell	   cycle	   checkpoint	   signalling.	   Immunofluorescence	   imaging	  of	  
mediator	  complex	  proteins	  MDC1	  and	  53BP1	  showed	  that	  the	  formation	  of	  IRIF	  
is	  impaired	  in	  the	  Lsh-­/-­	  MEFs.	  This	  suggested	  that	  mediator	  complex	  formation	  
at	  broken	  DNA	  ends	  is	  less	  robust	  in	  Lsh-­/-­	  MEFs.	  Less	  robust	  mediator	  complex	  
formation	   can	   result	   in	   less	   efficient	   repair	   by	   homologous	   recombination	   as	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failure	  to	  bind	  53BP1	  will	  reduced	  the	  amount	  of	  BRCA1	  recruited	  to	  the	  broken	  
DNA	   end,	   which	   will	   impair	   nucleoprotein	   filament	   formation	   and	   strand	  
invasion	  of	  the	  homologous	  repair	  template.	  This	  hypothesis	  is	  supported	  by	  the	  
comet	  assay	  data,	  which	  showed	  reduced	  DSB	  repair	  efficiency	  in	  Lsh-­/-­	  MEFs.	  
Recruitment	  of	  checkpoint	  proteins	  to	  broken	  DNA	  ends	  by	  components	  of	  the	  
mediator	   complex	   is	   essential	   for	   activation	   of	   checkpoint	   proteins	   by	   ATM	   /	  
ATR	  kinases	  and	  cell	  cycle	  arrest.	  LSH	  deficient	  cells	  have	  impaired	  assembly	  of	  
mediator	  complex	  at	  broken	  DNA	  ends.	  These	  may	  recruit	  checkpoint	  proteins	  
less	   efficient	   and	   fail	   to	   activate	   cell	   cycle	   arrest,	   which	   could	   result	   in	   LSH	  
depleted	  cells	  continuing	  through	  mitosis	  with	  unrepaired	  DSBs.	  We	  wished	  to	  
test	   this	  hypothesis	   in	  Lsh-­/-­	  MEFs,	  however	   the	  Lsh-­/-­	   and	  WT	  MEFs	  had	  been	  
maintained	   in	   culture	   through	   spontaneous	   immortalisation,	   which	   often	  
results	   in	   defects	   in	   p53	   and	   apoptotic	   signalling.	   Unfortunately	   the	   MEFs	  
obtained	  from	  the	  WT	  littermates	  of	  the	  Lsh-­/-­	  mice	  did	  not	  express	  p53,	  which	  
made	   them	   unsuitable	   for	   examining	   checkpoint	   signalling.	   We	   therefore	  
examined	  CHK2	  and	  p53	  phosphorylation	   in	   response	   to	  DSB	   induction	  using	  
the	   MRC5hT	   cells,	   which	   also	   displayed	   reduced	   H2AX	   phosphorylation	   when	  
LSH	  is	  depleted	  by	  shRNA	  knockdown.	  
Western	   blot	   analysis	   showed	   that	   CHK2	   is	   phosphorylated	   less	   efficiently	   in	  
the	   shLSH	   MRC5hT	   cells	   compared	   to	   the	   non-­‐silencing	   controls	   following	  
ionising	   radiation	   treatment.	   This	   is	   consistent	   with	   CHK2	   activation	   being	  
dependent	  on	  binding	  to	  MDC1	  at	  broken	  DNA	  ends	  and	  the	  impaired	  mediator	  
complex	   assembly	  observed	   in	  LSH	  deficient	   cells.	  Western	  blots	   also	   showed	  
that	  p53	  can	  be	  phosphorylated	  at	  the	  serine	  15	  residue	  equally	  well	  in	  both	  the	  
shLSH	   and	   non-­‐silencing	   MRC5hT	   cells.	   This	   is	   interesting	   as	   53BP1,	   which	  
recruits	   p53	   to	   broken	   DNA	   ends,	   is	   reduced	   in	   LSH	   deficient	   cells	   and	  
suggested	   that	   activation	   of	   p53	   by	   ATM	   does	   not	   require	   53BP1	   dependent	  
localisation	   of	   p53	   to	   broken	   DNA	   ends.	   However	   the	   total	   levels	   of	   p53	   are	  
reduced	  shLSH	  MRC5hT	  cells,	  which	  showed	  that	  stabilisation	  of	  p53	  in	  response	  
to	  ionising	  radiation	  is	  decreased	  when	  mediator	  complex	  assembly	  is	  impaired.	  
This	  could	  be	  due	  to	  a	  decrease	  in	  p53	  phosphorylation	  at	  other	  sites	  that	  block	  
MDM2	   mediated	   nuclear	   export	   of	   p53	   and	   subsequent	   degradation	   by	   the	  
proteasome.	  This	  is	  consistent	  with	  reduced	  phosphorylation	  of	  CHK2	  kinase	  in	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response	   to	  DSBs	   in	   shLSH	  MRC5hT	   cells,	   as	   phosphorylation	   of	   p53	   at	   serine	  
residue	   20	   by	   CHK2	   blocks	   interactions	  with	  MDM2.	   The	   data	   suggested	   that	  
despite	   reduced	   CHK2	   phosphorylation	   and	   stabilisation	   of	   p53	   in	   shLSH	  
MRC5hT	  cells,	  there	  is	  sufficient	  nuclear	  p53	  for	  phosphorylation	  by	  ATM.	  	  
The	  comet	  assay	  data	  showed	  that	  LSH	  deficient	  cells	  repair	  DSBs	  less	  efficiently	  
and	   have	   more	   unrepaired	   DSBs	   8h	   after	   ionising	   radiation	   treatment.	   We	  
would	   therefore	   expect	   cell	   cycle	   checkpoint	   signalling	   to	   be	   extended	   in	   LSH	  
deficient	   cells	   to	   produce	   a	   longer	   arrest	   period	   for	   damage	   to	   be	   repaired.	  
However,	  p53	  serine	  15	  phosphorylation	  is	  not	  elevated	  above	  WT	  levels	  in	  LSH	  
deficient	   cells	   8	   h	   after	   ionising	   radiation	   treatment	   and	   phosphorylation	   of	  
CHK2	   is	   less	   efficient.	   This	   suggested	   that	   a	   proportion	   of	   breaks	   do	   not	  
correctly	  activate	  cell	  cycle	  checkpoints	  when	  LSH	  is	  depleted.	  This	  could	  result	  
in	   cells	   undergoing	   mitosis	   with	   unrepaired	   DSB	   still	   present,	   which	   can	   be	  
lethal	   to	   the	   cells	   and	   would	   explain	   the	   increased	   cell	   death	   96	   h	   after	  
treatment	  of	  shLSH	  MRC5hT	  cells	  with	  DSB	  inducing	  agents.	  
	  
7.5	  LSH	  ATPase	  activity	  is	  necessary	  for	  its	  function	  in	  DSB	  repair	  
To	   determine	   whether	   the	   DSB	   repair	   defects	   of	   Lsh	   deficient	   cells	   could	   be	  
reversed,	  we	  examined	  the	  repair	  of	  DSBs	  in	  Lsh-­/-­	  MEFs	  that	  had	  been	  infected	  
with	  lentiviruses	  expressing	  WT	  LSH.	  We	  also	  examined	  Lsh-­/-­	  MEFs	  expressing	  
a	  catalytically	  inactive	  LSH	  to	  determine	  whether	  the	  ATPase	  activity	  of	  LSH	  is	  
required	   for	   its	   function	   in	   DSB	   repair,	   which	   could	   suggest	   chromatin	  
remodelling	  by	  LSH.	   Survival	   studies	  demonstrated	   that	   the	  efficient	   repair	  of	  
DSB	  can	  be	  restored	  in	  the	  Lsh-­/-­	  MEFs	  by	  the	  reintroduction	  of	  LSH	  into	  these	  
cells.	   We	   also	   showed	   that	   H2AX	   phosphorylation	   and	   efficient	   mediator	  
complex	   assembly	   at	   broken	   DNA	   ends	   is	   restored	   in	   the	   Lsh-­/-­	   MEFs	   by	   the	  
reintroduction	  of	  LSH.	  However	  catalytically	  inactive	  LSH	  could	  not	  improve	  the	  
DSB	   response	   defects	   of	   the	   Lsh-­/-­	   MEFs.	   Although	   this	   does	   not	   demonstrate	  
chromatin	   remodelling	   by	   LSH	   at	   sites	   of	   DNA	   damage,	   it	   showed	   that	   the	  
ATPase	   activity	   of	   LSH	   is	   important	   for	   its	   function	   in	   DSB	   repair	   and	   adds	  
credibility	   to	   the	   hypothesis	   that	   LSH	   is	   required	   for	   efficient	  DSB	   repair	   and	  
suggests	  its	  function	  is	  connected	  to	  chromatin	  remodelling.	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7.6	  DSB	  repair	  doesn’t	  involve	  recruitment	  of	  LSH	  to	  broken	  DNA	  ends	  
Although	   we	   have	   been	   able	   to	   demonstrate	   that	   LSH	   ATPase	   activity	   is	  
required	   for	   H2AX	   phosphorylation	   at	   a	   proportion	   of	   broken	   DNA	   ends	   and	  
efficient	   repair	   of	   DSBs,	   we	   have	   been	   unable	   to	   demonstrate	   a	   direct	  
interaction	  between	  LSH	  and	  broken	  DNA	  ends	  during	  repair.	  The	  majority	  of	  
DSB	   repair	   proteins	   accumulate	   at	   broken	  DNA	   ends	   following	  DSB	   induction	  
and	  can	  be	  observed	  forming	  foci	  by	  immunofluorescence.	  However,	  anti-­‐FLAG	  
immunofluorescence	   imaging	   of	   WT	   rescue	   LSH	   in	   Lsh-­/-­	   MEFs	   after	   ionising	  
radiation	  treatment	  showed	  that	  LSH	  does	  not	   form	  IRIF,	  which	   indicates	   that	  
LSH	  is	  not	  recruited	  to	  broken	  DNA	  ends.	  Likewise,	  live	  cell	  imaging	  of	  LSH-­‐GFP	  
in	  VA13	  cells	  in	  which	  DSBs	  were	  induced	  at	  a	  high	  frequency	  at	  defined	  nuclear	  
locations	  by	  Laser	  micro	   irradiation	  also	  showed	  that	  LSH	  does	  not	   localise	   to	  
site	  of	  DNA	  damage.	  	  
Interestingly,	  when	  we	  examined	  the	  general	  association	  between	  the	  LSH	  and	  
chromatin	  we	  saw	  that	  the	  majority	  of	  LSH	  is	  chromatin	  bound,	  prior	  to	  ionising	  
radiation	  treatment	  and	  that	  this	  doesn’t	  alter	  after	  the	  induction	  of	  DSBs.	  This	  
indicated	  that	  LSH	  might	  not	  have	  a	  high	  degree	  of	  mobility	  within	  the	  nucleus,	  
which	   explains	  why	   LSH	   is	   not	   recruited	   to	   IRIF.	   The	   observation	   that	   LSH	   is	  
chromatin	  bound	  prior	   to	   the	   induction	  of	  DSBs	   also	   suggested	  possible	   roles	  
for	   LSH	   in	   DSB	   repair.	   One	   possibility	   is	   that	   LSH	   could	   be	   bound	   to	   the	  
chromatin	  to	  evenly	  distribute	  variant	  histone	  H2AX	  throughout	  the	  chromatin	  
via	  ATP	  dependent	  chromatin	  remodelling.	  Although	  we	  see	  no	  difference	  in	  the	  
amount	  of	  H2AX	  bound	  to	  the	  DNA	  in	  LSH	  deficient	  cells,	   it	  could	  be	  unevenly	  
distributed	  leaving	  H2AX	  low-­‐density	  regions	  where	  there	  is	  insufficient	  H2AX	  
for	   its	   phosphorylation	   to	   stimulate	   mediator	   complex	   assembly.	   This	   is	   one	  
possible	  explanation	  for	  a	  lack	  of	  γH2AX	  at	  some	  DSBs.	  Alternatively	  LSH	  could	  
be	  bound	  to	  the	  chromatin	  at	  specific	  DNA	  elements,	  such	  as	  repetitive	  elements	  
at	   which	   LSH	   is	   known	   to	   be	   required	   for	   heterochromatin	   formation	   and	  
silencing.	   LSH	   may	   only	   aid	   in	   the	   repair	   of	   DSBs	   that	   occur	   close	   to	   these	  
regions	   by	   relaxing	   the	   heterochromatin	   through	   ATP	   dependent	   chromatin	  
remodelling	   activity,	   allowing	   the	  DSB	   repair	  machinery	   access	   to	   the	   broken	  
DNA	  end.	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7.7	  Concluding	  remarks	  
We	   have	   shown	   that	   LSH	   deficient	   cells	   have	   an	   increased	   sensitivity	   to	   DSB	  
inducing	  agents	  and	  that	  LSH	  is	  required	  for	  efficient	  repair	  of	  a	  proportion	  of	  
DSBs.	  This	  is	  consistent	  with	  observations	  that	  suggest	  LSH	  homologs	  in	  plants	  
and	   yeast	   also	   have	   a	   role	   in	   the	   DNA	   damage	   response.	   We	   can	   therefore	  
conclude	  that	  LSH	  has	  a	  role	  in	  the	  DNA	  damage	  response	  that	  is	  conserved	  in	  
mammals.	  	  
We	   have	   further	   clarified	   the	   role	   of	   LSH	   in	   mammalian	   DSB	   repair	   by	  
demonstrating	   that	   mediator	   complex	   assembly	   and	   cell	   cycle	   checkpoint	  
signalling	  are	  impaired	  in	  the	  absence	  of	  LSH.	  Although	  microarray	  data	  did	  not	  
reveal	   any	   obvious	   expression	   changes	   that	   could	   be	   responsible	   for	   this	  
phenotype,	   we	   could	   not	   see	   an	   accumulation	   of	   LSH	   at	   broken	   DNA	   ends.	  
Instead	  we	   showed	   that	   the	  majority	   of	   LSH	   is	   associated	  with	   the	   chromatin	  
and	  suggest	  several	  possible	  mechanisms	  that	  could	  explain	  the	  requirement	  of	  
LSH	  for	  DSB	  repair	  that	  does	  not	  involve	  LSH	  accumulating	  at	  broken	  DNA	  ends.	  
We	   have	   created	   a	  model	   system	   for	   comparing	   DSB	   repair	   at	   many	   defined	  
genomic	  location	  in	  WT	  and	  LSH	  deficient	  cells	  and	  suggest	  future	  experiments,	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Summary
LSH, a protein related to the SNF2 family of chromatin-remodelling ATPases, is essential for the correct establishment of DNA
methylation levels and patterns in plants and mammalian cells. However, some of the phenotypes resulting from LSH deficiency cannot
be explained easily by defects in DNA methylation. Here we show that LSH-deficient mouse and human fibroblasts show reduced
viability after exposure to ionizing radiation and repair DNA double-strand breaks less efficiently than wild-type cells. A more detailed
characterisation of this phenotype revealed that, in the absence of LSH, the histone variant H2AX is not efficiently phosphorylated in
response to DNA damage. This results in impaired recruitment of MDC1 and 53BP1 proteins to DNA double-strand breaks and
compromises phosphorylation of checkpoint kinase CHK2. Furthermore, we demonstrate that the ability of LSH to hydrolyse ATP is
necessary for efficient phosphorylation of H2AX at DNA double-strand breaks and successful repair of DNA damage. Taken together,
our data reveal a previously unsuspected role of LSH ATPase in the maintenance of genome stability in mammalian somatic cells, which
is independent of its function in de novo DNA methylation during development.
Key words: DNA damage, DNA methylation, LSH, Chromatin, Chromatin remodelling
Introduction
Genetic information within the eukaryotic nucleus is organised
into a highly conserved structural polymer, chromatin, which
supports and controls crucial functions of the genome. The
organisation of DNA into chromatin is inhibitory to most
biological processes that utilise DNA as a template, such as
transcription, replication, recombination and repair. There are
several mechanisms by which chromatin structure and
composition can be altered. One of the most fundamental of
these is ATP-dependent chromatin-remodelling carried out by
specialised proteins (Becker and Hörz, 2002; Lusser and
Kadonaga, 2003). A number of chromatin remodelling proteins,
often organised into large multi-subunit complexes, have been
identified in mammalian cells (Lusser and Kadonaga, 2003;
Narlikar et al., 2002). The catalytic subunit in these complexes,
the ATPase, uses the energy from ATP hydrolysis in order to
reposition, reorganize, modify or evict nucleosomes from DNA.
Several chromatin-remodelling complexes including INO80,
SWI/SNF, CHD4 and ISWI have been implicated in DNA
damage repair in yeast, plants and mammalian cells (Polo and
Jackson, 2011).
The Lymphoid-Specific Helicase LSH, also known as HELLS
or PASG, is a ubiquitously-expressed 100 kDa protein related to
the SNF2 family of chromatin-remodelling ATPases. Knockout
of Lsh (Hells) gene in mice leads to postnatal lethality and 50–
70% reduction in the global levels of DNA methylation,
including repetitive sequences and large chromosomal domains
throughout the genome (Dennis et al., 2001; Myant et al., 2011;
Tao et al., 2011). In addition, Lsh2/2 embryos exhibit defects in
male and female meiosis, which are manifested by incomplete
chromosome synapses and failure to load crossover-associated
foci (De La Fuente et al., 2006; Zeng et al., 2011). It has been
hypothesised that LSH remodels chromatin to render DNA
accessible to DNA methyltransferase enzymes and therefore it
supports de novo DNA methylation and stable gene silencing
(Zhu et al., 2006). In agreement with this, it has been reported
that LSH is required for developmentally programmed DNA
methylation during embryogenesis (Myant et al., 2011).
Nevertheless, ATP-dependent chromatin remodelling activity of
LSH has never been demonstrated in vitro. In vivo, deletion of
exons 10–12 was shown to truncate the catalytic SNF2 domain
generating a hypomorph Lsh allele. Mice homozygous for the
truncated Lsh allele also display DNA methylation defects, but
they survive longer after birth, exhibit signs of premature ageing
and upregulated expression of senescence-associated markers
(Sun et al., 2004). It is yet unclear whether the loss of DNA
methylation and cellular senescence are distinct or related to each
other phenotypes resulting from impaired function of LSH in
chromatin remodelling.
Here, we investigate the response of LSH-deficient mouse and
human cells to DNA damage induced by ionizing radiation (IR).
We find that LSH-deficient cells display reduced survival and
inefficient repair of DNA double-strand breaks (DSBs) compared
to cells with wild-type levels of LSH. Our characterisation of this
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phenotype reveals that the LSH-deficient cells show normal
activation of DNA damage-responsive kinase ATM, but weaker
and more transient phosphorylation of ATM substrate, the variant
histone H2AX (cH2AX). This results in inefficient recruitment
and retention of DNA damage response mediator proteins MDC1
and 53BP1 at DSBs and leads to compromised ATM-dependent
phosphorylation of checkpoint kinase CHK2. We also show that
the DSB repair defects in LSH-deficient cells are independent of
changes in DNA methylation and can be reversed by re-
expression of wild-type, but not a catalytically inactive, LSH
protein in Lsh2/2 mouse embryonic fibroblasts (MEFs). Taken
together our data imply that, in addition to promoting DNA
methylation during development, LSH has a conserved, DNA
methylation-independent function in DNA DSB repair.
Results
Inefficient repair of ionizing radiation-induced DNA
damage in LSH-deficient cells
In order to investigate whether LSH is required for repair of
DSBs in mammalian cells, we plated wild-type and Lsh2/2 MEFs
at clonal density and subjected them to increasing doses of
ionizing radiation (IR). We monitored the survival of non-
irradiated and irradiated cells by colony formation assay.
Interestingly, the viability of Lsh2/2 MEFs after IR was
significantly impaired compared to wild-type MEFs, indicating
that LSH-deficient cells are more sensitive to DNA damage
induced by IR (Fig. 1A,B).
As LSH is involved in the formation of heterochromatin
(Myant and Stancheva, 2008; Myant et al., 2011; Yan et al.,
2003), it is possible that the same dose of IR generates a greater
number of breaks in Lsh2/2 fibroblasts than in wild-type MEFs
due to general chromatin relaxation. To examine this, we
employed single cell electrophoresis (comet assay) to measure
the relative extent of DNA damage induced by IR in wild-type
and LSH-deficient MEFs. We also examined whether the IR-
induced DSBs are repaired equally well in both cell types. As is
apparent from the comparable comet tail length after exposure to
10 Gy of IR, the wild-type and the Lsh2/2 cells acquired a
similar number of DNA breaks (Fig. 1C,D). However, the
Lsh2/2 MEFs failed to repair ,50% of these lesions compared
to wild-type cells when investigated 8 hours after irradiation
(Fig. 1C–E). Taken together, these data suggest that reduced
viability of Lsh2/2 MEFs after IR exposure reflects inefficient
repair of DSBs rather than acquisition of greater DNA damage.
LSH-deficient MEFs display normal activation of DNA
damage signalling
In mammalian cells, IR-induced DSBs lead to activation of a
DNA damage response (DDR) signalling which promotes the
recruitment of mediator and repair proteins to the sites of DNA
damage and simultaneously orchestrates cell cycle arrest while
the breaks are repaired (Polo and Jackson, 2011). DDR signalling
cascade in G1 and G2 of the cell cycle is initiated by the ATM
(Ataxia telangiectasia mutated) kinase, which undergoes auto-
phosphorylation at Serine 329 in response to DNA damage
(Bakkenist and Kastan, 2003). ATM subsequently binds to the
MRN (MRE11, RAD50, NBS) complex that assembles at DNA
breaks (Lee and Paull, 2004; Lee and Paull, 2005). The MRN-
bound ATM phosphorylates multiple effectors proteins, including
Serine 139 of the histone variant H2AX which is present in
approximately every fifth nucleosome throughout chromatin
(Burma et al., 2001). Phosphorylated H2AX (cH2AX) appears
Fig. 1. Inefficient repair of DNA damage induced by IR in Lsh2/2 MEFs. (A) Wild-type (WT) and Lsh2/2 MEFs were plated at clonal density and subjected to
increasing doses of IR. The number of colonies appearing after ten days on the irradiated plates indicate the reduced viability of Lsh2/2 MEFs after exposure to IR.
(B) Quantification of experiments (as shown in A) performed in triplicate. ‘% survival’ represents the number of colonies appearing on irradiated plates relative to the
number of colonies on non-irradiated plates seeded in parallel. (C) Comet assays show DNA fragmentation in wild-type and Lsh2/2 MEFs without IR, immediately
after treatment with 10 Gy of IR and 8 hours of recovery post-IR. (D) Quantification of the relative tail length from the experiments shown in C. A total of 50 cells
were examined at each time point for each of the two genotypes. (E) The % repaired DNA damage was calculated from the values shown in D for 10 Gy and
10 Gy+8 hours time points. All error bars represent standard deviation (S.D.).
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within minutes of DNA damage, spreads over large megabase-
long domains flanking the DSB and serves as a platform for the
recruitment of DNA damage repair machinery (Iacovoni et al.,
2010; Rogakou et al., 1999; Rogakou et al., 1998). Accumulation
of cH2AX and repair proteins at the sites of the DNA damage
leads to the formation of discrete cytologically detectable foci
which disperse as DNA damage is repaired (Polo and Jackson,
2011).
To investigate whether DDR initiates correctly in the Lsh2/2
MEFs, we monitored the association of MRE11 with chromatin
and the phosphorylation and localisation of ATM before and after
IR. Chromatin retention assays showed that, unlike LSH, which
stably associates with chromatin independently of DNA damage
(Fig. 2A), MRE11 was enriched on DNA after exposure to IR
and this occurred at similar levels in wild-type and Lsh2/2 cells
(Fig. 2B). Moreover, we detected no difference between wild-
type and Lsh2/2 MEFs in the kinetics of ATM phosphorylation
after IR (Fig. 2C), the localisation of ATM to DSBs (Fig. 2D)
and the number of ATM foci at the onset of DNA repair
(supplementary material Fig. S1A). Collectively, our data suggest
that the activation of ATM, detection of DSBs and initiation of
DNA damage response are not impaired in the Lsh2/2 MEFs.
Reduced phosphorylation of H2AX in LSH-deficient cells
To examine the events that take place downstream of ATM
activation, we followed the kinetics of cH2AX accumulation after
IR in wild-type and Lsh2/2MEFs by indirect immunofluorescence
and western blots (Fig. 3A–C). In wild-type cells, cH2AX was
Fig. 2. Normal activation of DNA damage response in wild-type (WT) and Lsh2/2 MEFs. (A) Western blot detecting LSH before and after IR in the soluble
(Sol) and chromatin-bound (Chrom) fractions of nuclear proteins. Quantification of western blots from several independent experiments indicates that before and
after IR,,60% of LSH is constitutively bound to DNA/chromatin and,40% is in the soluble nucleoplasm fraction. RAN and H2AX serve as loading controls for
the soluble and chromatin fractions, respectively. (B) MRE11 accumulates equally well on chromatin after IR in wild-type and Lsh2/2 MEFs and is partly
depleted from the soluble nucleoplasm fraction. The bar graph shows quantification of MRE11 in the soluble and chromatin fractions from three independent
experiments. The error bars in A and B represent S.D. (C) The activating phosphorylation of ATM at Serine 329 (pS329) displays similar kinetics after irradiation
of the wild-type and Lsh2/2 MEFs. DNMT1 is a loading control. The numbers on the left indicate molecular weight in kDa. The graph shows quantification of
phosphorylated ATM relative to DNMT1 during the time course. (D) Phosphorylated ATM is recruited to DNA damage foci after irradiation of the wild-type and
Lsh2/2 MEFs. The scale bars represent 10 mm.
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detectable 15 minutes after the exposure of cells to IR, peaked
1 hour post-IR, persisted at lower, but significant levels at 2- and 4-
hour time points, and gradually declined to basal levels by the
24-hour time point (Fig. 3A,C, top panels). In contrast, the
accumulation and the persistence of cH2AX in the Lsh2/2 MEFs
were significantly reduced (Fig. 3A,C, bottom panels; see also the
graph in Fig. 3B). In the irradiated LSH-deficient cells, cH2AX
never reached the same levels as in the wild-type cells at the 1-hour
time point and decreased dramatically 4 hours post-IR (Fig. 3A,C,
bottom panels). Quantification of cH2AX in immunofluorescence
experiments and western blots showed that the phosphorylation of
the variant histone is reduced by ,50% in the Lsh2/2 MEFs
compared to their wild-type counterparts (Fig. 3B; supplementary
material Fig. S2). The inefficient phosphorylation of H2AX was
neither due to a reduced total amount of the variant histone in
chromatin of LSH-deficient cells (Fig. 2B, Fig. 3C; supplementary
material Fig. S2), nor caused by the overexpression of a known
phosphatase that may dephosphorylate cH2AX prematurely
(supplementary material Table S1). Thus, despite the normal
activation and localisation of ATM kinase to IR-induced DSBs,
the phosphorylation of H2AX is significantly impaired in the
absence of LSH.
Potentially, the lack of LSH could affect cH2AX either
globally, at all DSBs, or locally – only at a subset of DNA
lesions. To investigate this, we counted the cH2AX foci in wild-
type and Lsh2/2 MEFs exposed to IR and found that the number
of detectable cH2AX foci in Lsh2/2 MEFs is reduced compared
to their wild-type counterparts (supplementary material Fig.
S1B). This indicates that LSH may not be required for high levels
of cH2AX at all DSBs.
Reduction of cH2AX is independent of DNA methylation
levels and is conserved between mouse and human
LSH-deficient fibroblasts
In the Lsh2/2 MEFs, the global levels of DNA methylation are
reduced by ,50%, affecting many gene promoters and large
chromosomal domains (Myant et al., 2011; Tao et al., 2011).
Potentially, DNA hypomethylation may compromise the
efficiency of DSBs repair either directly, by altering chromatin
structure, or indirectly, by changing the expression of DNA repair
genes. In order to investigate whether lack of DNA methylation
affects the efficiency of H2AX phosphorylation, we irradiated
MEFs genetically null for maintenance DNA methyltransferase
DNMT1 and p53 (Dnmt12/2; p532/2) as well as p53-null MEFs
(p532/2) (Lande-Diner et al., 2007) as controls and followed the
cH2AX levels during DNA damage repair. Despite the almost
complete lack of DNA methylation (,10%), Dnmt12/2; p532/2
MEFs displayed normal kinetics of cH2AX compared to wild-type
and p532/2 control MEFs (Fig. 4A). This indicates that DNA
methylation is not essential for efficient phosphorylation of H2AX
near the sites of DNA damage.
In order to determine whether reduced cH2AX in response to
IR is specific to LSH-deficient mouse fibroblasts or can be
observed in other mammalian cell types, we stably knocked down
Fig. 3. Reduced phosphorylation of H2AX in Lsh2/2 MEFs subjected to IR. (A) Immunostaining of wild-type (WT) and Lsh2/2 MEFs with antibodies against
cH2AX (red) before and after 10 Gy of IR. The nuclei were counterstained with DAPI (blue). The analysed time points are shown above the panels. The scale bars
represent 10 mm. Note that Lsh2/2 MEFs display significantly weaker staining for cH2AX. (B) Quantification of relative intensity of cH2AX staining in the
immunofluorescence experiments shown in A. A total of 100 cells of each genotype were analysed at every time point. The error bars represent S.D. (C) Western
blots showing the kinetics of cH2AX relative to H2AX and histone H4 in wild-type and Lsh2/2 MEFs. All samples were run on the same gel and detected
simultaneously. The numbers on the left indicate molecular weight in kDa.
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DSBs to induce cell cycle arrest by inhibitory phosphorylation of
CDC25 phosphatase (Lukas et al., 2003; Matsuoka et al., 1998).
On the other hand, 53BP1 is required for recruitment to DSBs of
other ATM substrates such as BRCA1 and transcription factor p53
(Abraham, 2002). In response to IR, p53 undergoes stabilisation
and ATM-dependent phosphorylation at Serine 15 (S15) (Canman
et al., 1998). S15-phosphorylated p53 can either induce cell cycle
arrest or promote apoptosis in cells that fail to repair DNA damage
(Dumaz and Meek, 1999; Lambert et al., 1998).
In order to investigate whether reduced cH2AX and premature
dissociation from DSBs of mediator proteins MDC1 and 53BP1
compromise DNA damage checkpoints, we examined the kinetics
of CHK2 and p53 phosphorylation after IR in wild-type and LSH-
deficient cells. As MEFs often spontaneously immortalize and lose
p53 expression, we performed these analyses in human MRC5
fibroblasts infected with either the control non-silencing shRNA
vector or MRC5 cells with stable KD of LSH (Fig. 4B). Consistent
with cH2AX kinetics and MDC1 recruitment to IRIF, the CHK2
phosphorylation increased gradually after IR and peaked at the 2-
hour time point in the control cells (Fig. 6A, Control KD). In
contrast, the phosphorylated CHK2 was barely detectable in LSH-
deficient cells at all time points after irradiation (Fig. 6A, LSH
KD). However, LSH-deficient human fibroblasts displayed
relatively normal ATM-dependent phosphorylation of p53 at
Serine 15 (pS15) in response to IR. Although in the LSH KD cells
the p53 protein levels did not peak as dramatically at 1- and 2-hour
time points as in the control cells, we observed earlier and more
persistent phosphorylation of p53 at S15 after DNA damage
(Fig. 6B). These observations suggest that despite the reduced
phosphorylation of CHK2 the LSH-deficient cells either undergo
p53-dependent cell cycle arrest or apoptosis.
To investigate whether the control and LSH KD cells can
arrest in response to DNA damage we followed their proliferation
rate and viability after exposure to IR. Both cell lines showed
robust exponential growth and no apparent cell death when
grown under normal conditions (Fig. 6C,D, 2IR). In response to
radiation, both cell lines underwent cell cycle arrest, but resumed
proliferation after 48 hours (Fig. 6C, +IR). However, the
viability of LSH-deficient cells rapidly decreased after
resuming proliferation. 42% of LSH KD cells compared to
24% of controls stained positive with trypan blue 96 hours post-
irradiation (Fig. 6D, +IR). This indicates that despite the reduced
phosphorylation of CHK2, LSH-deficient cells can undergo
transient cell cycle arrest in response to DNA damage, but as they
repair DSBs less efficiently, they exit the cell cycle arrest with
unrepaired DNA damage which results in accelerated cell death.
The ATPase activity of LSH is required for efficient
phosphorylation of H2AX
Despite having a conserved SNF2 domain, the ability of
mammalian LSH to hydrolyse ATP and remodel chromatin
remains largely unknown. In our hands, recombinant full-length
mouse LSH did not reposition nucleosomes in vitro, but had a
detectable, albeit weak, DNA-dependent ATPase activity
(supplementary material Fig. S5). ATP hydrolysis by
recombinant LSH in vitro was completely abolished by
substitution of a highly conserved Lysine to Glutamine (K237Q)
in the ATP-binding site (supplementary material Fig. S5C).
Considering this, we asked whether the wild-type and mutant
LSH can rescue the kinetics of cH2AX after exposure of Lsh2/2
MEFs to DNA damage. To do so, we infected the Lsh2/2 MEFs
with lentiviral vectors expressing FLAG-tagged either wild-type
or K237Q mutant form of LSH at levels close to endogenous
(Fig. 7A). Lsh2/2 MEFs infected with empty vector (MSCV)
served as a control. After exposure of these cell lines to radiation,
we found that Lsh2/2 MEFs expressing wild-type LSH survived
Fig. 5. Impaired recruitment of MDC1 and
53BP1 to the sites of DNA damage in Lsh2/2
MEFs. (A) Immunostaining of non-irradiated and
irradiated wild-type (WT) and Lsh2/2 MEFs with
antibodies detecting cH2AX binding protein MDC1.
Note that diffuse staining for MDC1 can be seen in
Lsh2/2 MEFs 1 and 4 hours after exposure to IR.
(B) Immunostaining of non-irradiated and irradiated
wild-type and Lsh2/2 MEFs with antibodies against
53BP1. Similar to MDC1, there is more diffuse
staining for 53BP1 in Lsh2/2 MEFs at 1- and 4-hour
time points. The co-localisation of 53BP1 with
cH2AX shown in the bottom two panels clearly
shows diffuse 53BP1 staining in Lsh2/2 MEFs that
does not overlap with cH2AX. Note the reduced
number of cH2AX foci in Lsh2/2 MEFs at this time
point in comparison to the wild-type MEFs. The
scale bars represent 10 mm. (C) Quantification of
53BP1 staining in the nucleoplasm in wild-type and
Lsh2/2 MEFs 4 hours post-IR. The error bars
represent S.D.
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IR as well as the wild-type MEFs, while cells expressing
ATPase-deficient LSH K237Q had reduced survival, similar to
Lsh2/2 MEFs infected with empty vector (Fig. 7B). In addition,
the expression of wild-type LSH in Lsh2/2 MEFs restored to
normal levels the phosphorylation of H2AX after IR (Fig. 7C)
and the recruitment of 53BP1 to IRIF (Fig. 7D). In contrast, the
Lsh2/2 MEFs expressing the mutant LSH K237Q retained
reduced phosphorylation of H2AX post-IR, diffuse localisation of
53BP1 to IRIF and were undistinguishable from Lsh2/2 MEFs
carrying the empty vector (Fig. 7C,D). From these experiments
we conclude that the ability of LSH to hydrolyse ATP is required
for efficient H2AX phosphorylation and repair of DNA damage.
Discussion
Several chromatin-remodelling proteins are implicated in the
efficient repair of DNA damage in mammalian cells, including
BRG1, CHD1L/ALC1, CHD4, INO80 and ISWI proteins ACF1
and SNF2H (Ahel et al., 2009; Kashiwaba et al., 2010; Lan et al.,
2010; Larsen et al., 2010; Lee et al., 2010; Nakamura et al., 2011;
Park et al., 2009; Park et al., 2006; Polo et al., 2010; Sánchez-
Molina et al., 2011; Smeenk et al., 2010). Most of the chromatin-
remodelling proteins are recruited to DNA breaks in a cH2AX-
dependent manner and function to modulate chromatin structure
and modifications in order to facilitate the access to either DNA
or chromatin of factors involved in DNA damage signalling and
repair. The function of chromatin remodellers in supporting DNA
repair is often conserved from yeast to mammalian cells,
indicating that chromatin reorganization during DNA repair is
vital for maintenance of genome stability.
LSH has been extensively studied as a protein that promotes
DNA methylation and silencing of retrotransposons and genes in
plants and mammalian cells (Dennis et al., 2001; Lippman et al.,
2004; Myant et al., 2011; Tao et al., 2011; Teixeira et al., 2009).
However, genetics screens in budding yeast (Alvaro et al., 2007;
Costanzo et al., 2010), which carry an LSH homologue
YFR038W/IRC5 (Flaus et al., 2006), but entirely lack DNA
methylation, and experiments in Arabidopsis thaliana (Costanzo
et al., 2010; Shaked et al., 2006) have suggested that LSH may
have additional functions that are independent of its role in DNA
methylation and regulation of gene expression. Here, we provide
experimental evidence that LSH is essential for efficient repair of
DNADSBs in human and mouse fibroblasts. This function of LSH
is neither related to alterations in DNA methylation nor caused by
mis-expression of known genes involved in DNA repair
(supplementary material Table S1). Thus Lsh2/2 MEFs, but not
Dnmt12/2MEFs lacking DNAmethylation, exhibit reduced levels
of cH2AX in response to IR. This effect is conserved in human
cells as stable KD of LSH in hTERT-immortalized lung fibroblasts
compromised the phosphorylation of H2AX in response to DNA
damage without detectable change in DNA methylation levels.
Our data are consistent with earlier observations in plants (Shaked
et al., 2006), and strongly suggest that SNF2 family ATPase LSH
has at least two distinct functions in vivo, namely, to promote de
novo DNAmethylation during development and to facilitate repair
Fig. 6. Reduced phosphorylation of CHK2 in LSH-
deficient cells. (A) Western blots detecting CHK2,
phosphorylated CHK2 and MRE11 in nuclear extracts of
non-irradiated and irradiated control KD and LSH KD
MRC5 cells. Note that the slower migrating, phosphorylated
form of CHK2 is barely detectable throughout the time
course of recovery after IR in the LSH KD cells. Extracts
prepared without phosphatase inhibitors (bottom panels) do
not show the slower migrating phosphorylated form of
CHK2. (B) The control KD and LSH-deficient cells display
stabilisation of p53 and ATM-dependent phosphorylation of
p53 at Serine 15 (pS15) after IR. MRE11 serves as a loading
control. The numbers on the left indicate molecular weight
markers in kDa. (C) Proliferation of non-irradiated (2IR)
and 2.5 Gy irradiated (+IR) control and LSH KD MRC5
cells at indicated time points. ‘[PD]’ indicates population
doublings. (D) Viability of non-irradiated and irradiated
control and LSH KD cells as detected by trypan blue staining
at indicated time points. The error bars represent standard
error of the mean.
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of DSBs in somatic cells. Our KD experiments in human
fibroblasts demonstrate that these two functions can be
successfully uncoupled from each other.
Whether deficient DNA repair can explain the meiotic defects
observed in Lsh2/2 germ cells (De La Fuente et al., 2006) and
premature ageing phenotype in mice expressing hypomorph
alleles of LSH (Sun et al., 2004) is yet to be investigated in detail.
The formation of synaptonemal complexes during meiosis
requires DNA recombination initiated at SPO11-generated
DSBs. If such breaks are formed, but not correctly marked
by cH2AX, this may compromise recombination between
homologous chromosomes and thus impair meiosis (Celeste
et al., 2002; Xu et al., 1996). However, cH2AX and RAD51
staining seem to persist longer in pachytene stage Lsh2/2 oocytes
than in their wild-type counterparts (De La Fuente et al., 2006).
This may indicate that the lack of LSH confers additional
defects in processing of meiotic DSBs during oogenesis
and spermatogenesis. On the other hand, accumulation of
endogenous unrepaired DNA damage in mice expressing
hypomorphic Lsh alleles may lead to cellular senescence and
premature ageing. Thus, some of the phenotypes resulting from
LSH deficiency can be, at least in part, a direct consequence of
the defective repair of DNA DSBs.
Although the detection of DNA damage, as evident by ATM
activation and binding of MRE11 and ATM to DSBs, are not
affected by LSH deficiency, reduced phosphorylation of H2AX
at DNA repair sites in LSH-deficient cells indicates that LSH is
involved in the early steps of DSB repair. The inefficient
recruitment to DSBs of DNA damage signalling mediators
MDC1 and 53BP1, compromised phosphorylation of CHK2 and
reduced viability are expected outcomes of altered cH2AX levels
and patterns in irradiated LSH-deficient cells. However, p53
stabilisation and phosphorylation by ATM remain unaffected by
the lack of LSH and may contribute to cell cycle arrest and
apoptosis of LSH-deficient cells with unrepaired DNA damage.
How LSH promotes cH2AX accumulation in response to DNA
damage is currently unclear. As is evident from our rescue
experiments in the Lsh2/2 MEFs, the ability of LSH to hydrolyse
ATP is essential for normal levels of cH2AX and successful
DNA repair. Unlike BRG1, which also supports efficient
accumulation of cH2AX (Lee et al., 2010; Park et al., 2006),
and other chromatin-remodelling proteins implicated in DNA
Fig. 7. Wild-type LSH, but not the ATP-binding-
deficient LSH K237Q, can rescue the kinetics of cH2AX
in irradiated Lsh2/2 MEFs. (A) Western blots with
antibodies against LSH and FLAG show the levels of LSH
protein in wild-type (WT) MEFs, Lsh2/2 MEFs infected
with empty MSCV lentivirus and cells infected with
lentivirus expressing either wild-type or mutant 36FLAG-
tagged LSH protein. MRE11 serves as a loading control.
(B) % survival after IR of Lsh2/2 MEFs carrying empty
MSCV vector, wild-type LSH and mutant LSH K237Q.
The error bars indicate S.D. (C) Lsh2/2 MEFs expressing
wild-type LSH, but not cells expressing the K237Q mutant
form of LSH, display normal kinetics of cH2AX after IR
when compared to control cells. H2AX serves as a loading
control. All samples were run on the same gel and detected
simultaneously. The numbers on the left indicate molecular
weight markers in kDa. (D) Immunostaining with anti-
FLAG and anti-53BP1 antibodies detect normal
localisation of 53BP1 to DNA damage foci in Lsh2/2
MEFs expressing wild-type LSH. Irradiated Lsh2/2 MEFs
infected either with empty MSCV virus or expressing LSH
K237Q show diffuse staining for 53BP1. The scale bars
represent 10 mm.
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damage repair (Ahel et al., 2009; Larsen et al., 2010; Polo et al.,
2010; Smeenk et al., 2010; van Attikum et al., 2004), LSH neither
accumulates at repair foci (Fig. 7D), nor binds more tightly to
chromatin specifically after the induction of DNA damage
(Fig. 2A). In fact, chromatin retention assays indicate that a
significant proportion of LSH is constitutively bound to DNA or
chromatin in mammalian cells. Therefore, it is possible that LSH
renders the C-terminus of H2AXmore receptive to ATM-mediated
phosphorylation by acting locally, at DSBs that occur in the
vicinity of DNA/chromatin-bound LSH. Alternatively, LSH may
not function specifically during DSB repair, but instead facilitate
the even distribution of variant histone H2AX in chromatin
throughout the genome. It is currently accepted that in mammalian
cells on average every fifth nucleosome contains H2AX (Rogakou
et al., 1999). However, it is yet unclear when during the cell
cycle and how H2AX is incorporated into chromatin. Uneven
distribution of H2AX throughout the genome of LSH-deficient
cells would result in areas that lack H2AX and repair DSBs less
efficiently. Either one of these two hypotheses could explain the
reduced levels of cH2AX and number of detectable cH2AX foci in
the Lsh2/2 MEFs (supplementary material Fig. S1B). Future
experiments will aim to investigate the accumulation and
spreading of cH2AX at defined DNA lesions (Iacovoni et al.,
2010) as well as the distribution of H2AX in the genome of LSH-
deficient cells. It will also be essential to determine whether or not
LSH and BRG1 have redundant function in promoting cH2AX
accumulation in response to IR-induced DNA damage.
Collectively, the data we provide in this report identify LSH as
an important and functionally conserved, from plants to mammals,
component of DSB repair process. Frequent deletions within the
SNF2 domain of LSH have been detected in human lymphoid
malignancies and may contribute to stress-induced genomic
instability in cancers carrying LSH mutations (Lee et al., 2000).
Compared to quiescent cells, LSH is highly expressed in all rapidly
proliferating cell types, including most immortalized and cancer-
derived cell lines (Lee et al., 2000). Therefore, it is conceivable
that development of small molecules that inhibit the ATPase
activity of LSH would be beneficial for applications aiming to
sensitise cancer cells to DNA damage in order to aid successful
radiotherapy.
Materials and Methods
Cell lines and viral infections
Wild-type and Lsh2/2MEFs were cultured in DMEM supplemented with 10% FCS,
penicillin, streptomycin and L-glutamine. Vectors expressing 36FLAG C-
terminally-tagged LSH and K237Q mutant LSH were generated by cloning
synthetic cDNAs (Life Technologies) into pMSCV-puro vector (Clontech). The
vectors were packaged into lentiviral particles in amphotropic Phoenix cell line and
used for infection of Lsh2/2 MEFs at multiplicity of infection (MOI)51. The cells
were selected with 2.5 mg/ml of puromycin for two weeks and individual stable
colonies were expanded and tested for LSH expression. Human foetal lung fibroblast
MRC5 (ATCC number: CRL-171) were cultured in MEM supplemented with 10%
FCS, non-essential amino acids, sodium pyruvate, penicillin, streptomycin and L-
glutamine. MRC5 cells were immortalized by transduction with pBabe-hTERT-Neo
plasmid packaged into retroviral particles in Phoenix cells. The infected cells were
selected with 400 mg/ml G418 for 10 days. LSH was stably knocked down in
MRC5hTERT cells by introducing at MOI54 two independent pGIPZ-shRNAmir
plasmids V2LHS_155499 and V2LHS_155497 packaged into lentiviral particles
(Open Biosystems). Control cells were infected under the same conditions with non-
silencing pGIPZ-shRNAmir particles RHS4348 (Open Biosystems). The infected
cells were selected with 2.5 mg/ml of puromycin for 7 days and the LSH knockdown
assessed by western blots and quantitative RT-PCR.
Irradiation experiments
Wild-type and LSH-deficient either mouse or human fibroblasts were plated on
10 cm dishes in triplicate at a density of 200 cells/plate and irradiated with
indicated doses of IR in a Torrex X-ray cabinet (Faxitron Ltd). In survival assays,
the irradiated cells were left to recover and form colonies for 10–14 days, fixed,
stained with Giemsa and counted. For time course experiments, the cells were
plated on 20 cm dishes at ,60% confluency, subjected to indicated dose of IR
(usually 10 Gy) and collected 15 minutes, 1, 2, 4, 8, 12 and 24 hours after
irradiation. Nuclear extracts were prepared as described previously (Myant et al.,
2011) in buffers supplemented with phosphatase (Pierce) and protease (Sigma
Aldrich) inhibitors. For short-term analyses of cell proliferation and viability,
human fibroblasts were plated on 6-well plates (26105 cells/well) irradiated with
2.5 Gy and counted in trypan blue solution by Countess Cell Counter (Life
Technologies).
Comet assays
Cells were plated on 10 cm dishes at ,60% confluency, subjected to 10 Gy of IR
and either collected immediately or left to recover for 8 hours. Cells were diluted
to 66105 cells/ml with PBS, mixed 1:10 with 0.6% low melting point agarose and
placed onto glass slides pre-coated with 1% agarose. Slides were placed in lysis
buffer (2.5 M NaCl, 10 mM Tris, 1% Triton-X, pH 10) overnight at 4 C̊. Lysis
buffer was removed, the slides washed twice with dH2O and electrophoresis was
carried out in a cold alkaline buffer (300 mM NaCl, 1 mM EDTA, pH 13) at
100 A, 12 V for 20 minutes. Slides were neutralised with 365 minute washes with
cold 0.4 M Tris, pH 7.5 followed by 10 minute wash with cold dH2O. Staining
was carried out with a 20 mg/ml propidium iodide solution followed by
265 minute washes in cold dH2O. Images were collected by an Olympus BX61
microscope equipped with 206 objectives and AnalySIS software (Soft Imaging
Systems). Comet tail lengths were quantified using customized macro in ImagePro
9.0 software (Media Cybernetics).
Chromatin retention assays
Cells were plated on 20 cm dishes at ,60% confluency, subjected to the indicated
dose of IR and collected at the indicated time point after irradiation. Nuclei were
prepared by disrupting the cells in hypotonic buffer (NE1) as previously described
(Myant et al., 2011). Soluble nuclear proteins and those loosely associated with
chromatin were extracted using NE1 supplemented with 100 mM NaCl. After
centrifugation the pellets containing chromatin bound proteins were resuspended
in NE1 buffer supplemented with 25 U of Benzonase nuclease (Merck). Following
1 hour incubation on ice, NaCl was added to a final concentration of 500 mM and
incubated at 4 C̊ for 1 hour. After centrifugation the supernatant containing the
chromatin associated proteins was collected. All buffers were supplemented with
phosphatase (Pierce) and protease inhibitors (Sigma Aldrich).
Western blots
50 mg of each nuclear extract was resolved on either 8.5% or 15% SDS-PAGE,
transferred to nitrocellulose membrane (BioRad) and detected by anti-LSH (Santa
Cruz; sc-46665), anti-cH2AX (Millipore; 05-636), anti-H2AX (Active Motif),
anti-H4 (Millipore; 07-108), anti-phospho-ATM (Millipore; 05-740), anti-MRE11
(Calbiochem; PC388), anti-CHK2 (Cell Signaling; 2662), anti-p53 (Santa Cruz,
sc126 for human cells and Cell Signaling 2524 for mouse cells) and anti-p53 pS15
(Cell Signaling; 9284) antibodies followed by secondary either anti-mouse IR800
or anti-rabbit IR680 (LiCOR Biosciences). The western blots were imaged on
Odyssey Imager (LiCOR Biosciences) and quantified where indicated with the aid
of Odyssey V3.0 software.
Immunofluorescence
Cells were fixed either with 4% paraformaldehyde or with cold 100% methanol for
5 minutes, permeabilized by incubation in PBS with 0.1% Tween for 10 minutes,
blocked with 4% BSA in PBS, incubated with diluted primary antibodies for
2 hours and after washes with secondary anti-rabbit Alexa 488 or anti-mouse
Alexa 565 labelled antibodies. The slides were washed with PBS, counterstained
with DAPI and mounted in Vectashield (Vector Laboratories). Images were
collected by Olympus BX61 microscope equipped with 206 and 406 PlanApo
objectives (Olympus), ColourViewII camera and AnalySIS software (Soft Imaging
Systems). Where indicated, fluorescent images were quantified using a customized
macro in ImagePro 9.0 software (Media Cybernetics). Antibodies used for
immunofluorescence were: anti-pATM (Millipore; 05-740) 1:2000 dilution; anti-
cH2AX (Millipore; 05-636) 1:4000 dilution; anti-MDC1 (Abcam; ab11171)
1:1000 dilution; anti-53BP1 (Cell Signaling; 4397) 1:1000; and anti-FLAG M2
(Sigma Aldrich) 1:2000.
DNA methylation assays
The global levels of 5-methyl cytosine in the genome of MRC5hTERT, LSH KD and
control KD cells were investigated by ELISA assays using an ImprintTM kit
(Sigma Aldrich) according to manufacturer’s instructions.
Quantitative RT-PCR
RNA was extracted from cells with Trizol reagent (Life Technologies). 4 mg of
each RNA were treated with RNase-free DNase (Fermentas) and reverse
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transcribed using poly-dT primer and SuperscriptIII reverse transcriptase (Life
Technologies). Q-PCRs were carried out in triplicate with SYBR Green Master
Mix (Roche) and primers detecting LSH and GAPDH mRNA on a Lightcycler 480
instrument (Roche). Relative levels of LSH mRNA were quantified relative to
GAPDH using the standard methods (Pfaffl, 2001).
Chromatin remodelling and ATPase assays
Full-length cDNA of wild-type and K237Q mutant mouse LSH were cloned into a
shuttle pFastBac vector (Invitrogen) in frame with a N-terminal 66Histidine tag
and introduced into DH10Bac E. coli (Life Technologies) to obtain recombinant
Bacmids. Expression in SF2 cells and purification by nickel affinity and ion
exchange chromatography were carried out using standard protocols. Chromatin
remodelling assays were performed as described (Stockdale et al., 2006) with
nucleosomes assembled by salt dialysis (Narlikar et al., 2002) on Cy5 labelled 601
nucleosome positioning sequence (Lowary and Widom, 1998) carrying either
54 bp of linker DNA on either site (54A54) or 601 with 54 bp linker DNA on one
side and 0 on the other side (54A0) in the presence of either recombinant wild-type
LSH or S. cerevisiae RSC protein as control. Remodelling reactions were resolved
on 5% acrylamide gel in 0.56TBE buffer and scanned on ProXPRESS proteomics
imaging system (Perkin Elmer Life Sciences, UK). ATPase activity assays were
carried out with either wild-type or mutant LSH in the presence of 32P-cATP and
indicated substrates for 30 minutes at 37 C̊. The reactions were stopped on ice and
spotted on PEI Cellulose TLC plates (Merck). Separation was achieved in 0.5 M
LiCl/1 M formic acid buffer. The plates were dried, exposed and scanned on Storm
860 Phosphorimager (Molecular Dynamics). ATP hydrolysis was calculated from
the signal intensity of the released free phosphate (32Pi) using ImageQuant
software. Detailed protocols of these methods are available upon request.
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Supplemental Figure 1  Quantification of ATM       and H2AX foci in wild-type and Lsh-/- MEFs     
A. Counts of ATM         foci in non-irradiated and irradiated wild-type and Lsh-/- MEFs at indicated time points. 
Each dot on the graph represents a single cell. The mean value and the standard error of the mean are indicated for
each group of cells.  Note that there is no significant difference between the wild-type and Lsh-/- cells in the 
number of ATM         foci observed 15 minutes and 1 hour post-IR indicating that the initial recognition of DSBs is 
not impaired in LSH-deficient cells. Comparable number of foci also correlates well with equal amount of DNA 
damage induced by IR in both cell lines as quantified by the comet assays in Figure 1D. However, the number of 
ATM         foci are significantly reduced in Lsh-/- MEFs 4 hours after IR. This is consistent with reduced H2AX levels 
in Lsh-/- MEFs at this time point and the existence of a feed back loop at later time points after DNA damage where 
spreading of H2AX from the break recruits more ATM in MDC1/MRN-dependent manner allowing continuous ATM 
signalling at slow repairing breaks (Lou et al, 2006; van Atticum and Gasser, 2009). 
B. Counts of H2AX foci in wld-type and Lsh-/- MEFs. The mean value and the standard error are indicated.
Note that Lsh-/- MEFs show reduced number of foci at 1h and 4h time points after IR, which is consistent with the 
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Supplemental Figure 2  Inefficient phosphorylation of H2AX in irradiated Lsh-/- MEFs    
A.  A representative quantitative Western blot detecting H2AX, H2AX and histone H4 in nuclear extracts of wild 
type and Lsh-/- MEFs before and after exposure to 10Gy of ionizing radiation. Irradiated MEFs were collected at 
indicated time points.
B.  Average levels of H2AX relative to H2AX in wild-type and Lsh-/- MEFs during recovery from IR quantified from 
Western blots representing three independent experiments (biological replicates). Note that Lsh-/- MEFs do not
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Supplemental Figure 3   Sensitivity of control and LSH-deficient MRC5 cells to DNA damaging agents
Control MRC5 cells expressing non-silencing shRNA and LSH KD MRC5 cells were tested for viability after
treatment with UV, MMS, hudroxyurea (HU) and hydrogen peroxide (H O ). Note that LSH KD cells are more 
sensitive to most DNA damaging agents, but not UV or camptothecin (not shown). The % viable cells was
determined as described in Figure 7D. 
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B WT MEFs Lsh-/- MEFs
Supplemental Figure     Localization of 53BP1 in wild type and Lsh-/-  MEFs
A. Representative images of wild type and Lsh-/- MEFs before and after IR (1- and 4-hour time points) stained with 
antibodies against 53BP1. In the panels showing irradiated Lsh-/- MEFs cells the white arrows indicate cells with diffuse 
53BP1 staining and the red arrows point to cells that form discrete 53BP1 foci. The scale bar represents 10 m
B.  Quantification of cells with diffuse and punctated 53BP1 staining. “n” indicates the number of cells counted at each
time point.  
n = 76 n = 106 n = 96 n = 123 n = 147 n = 116
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Supplemental Figure 5    Nucleosome repositioning and ATPase activity of recombinant LSH
A. Recombinant wild type and mutant 6xHis-tagged LSH proteins were expressed in insect cells and purified by
Ni-affinity chromatography followed by ion exchange chromatography to remove any LSH-bound DNA. M represents
molecular weight marker.
  
B.  Recombinant wild type LSH does not reposition either a centrally (54A54) or end positioned nucleosome (54A0) in 
the presence of ATP. Recombinant yeast RSC protein (100 nM) was used as a control protein that repositions a centrally
positioned nucleosome. The triangles indicate increasing concentrations of LSH protein in the reaction (25, 50, 100, 200, 
300 nM).
C. LSH shows a weak DNA-stimulated ATPase activity, which is disrupted by the K237Q mutation in ATP binding site. 
The rate of ATP hydrolysis represents molecules ATP hydrolysed per minute per mol LSH.   
LSH
LSH K237Q
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Table S1. Expression of DNA repair genes in wild-type and Lsh-/- MEFs
The table contains an extract of expression microarray data from Myant et al (2011) Genome Res 21, 83-94 comparing the wild-type (WT)
and Lsh-/- (KO) MEFs.
M.KO = log2(KO-WT)
FDR.KO = false discovery rate, after p-value adjustment for multiple testing (Benjamini-Hochberg method)
KO = log2(KO)
WT = log2 (WT)
Chr Gene Name Gene_ID Description M.KO FDR.KO KO WT Fold change
chr9 H2afx 15270 \H2A histone family, member X\"" -0.2 0.071 13.1 13.0 0.9
chr9 Mre11a 17535 meiotic recombination 11 homolog A (S. cerevisiae) -0.5 0.052 11.9 12.4 0.7
chr11 Rad50 19360 RAD50 homolog (S. cerevisiae) -0.1 0.658 12.9 13.0 0.9
chr4 Nbn 27354 nibrin -0.1 0.573 12.5 12.7 0.9
chr15 Xrcc6 (Ku70) 14375 X-ray repair complementing defective repair in Chinese hamster cells 6-0.7 0.013 12.3 12.9 0.6
chr1 Xrcc5 (Ku80) 22596 X-ray repair complementing defective repair in Chinese hamster cells 5-0.2 0.551 12.7 12.9 0.9
chr9 Atm 11920 ataxia telangiectasia mutated homolog (human) -0.3 0.135 11.3 11.5 0.8
chr9 Atr 235533 ataxia telangiectasia and Rad3 related -0.1 0.743 8.4 8.6 0.9
chr16 Prkdc 19090 \protein kinase, DNA activated, catalytic polypeptide\"" 0.6 0.008 11.8 11.1 1.5
chr18 Rbbp8 (CtIP) 225182 retinoblastoma binding protein 8 -0.6 0.039 8.9 9.4 0.7
chr1 Exo1 26909 exonuclease 1 -0.5 0.114 8.8 9.3 0.7
chr7 Blm 12144 Bloom syndrome homolog (human) -1.2 0.000 11.3 12.4 0.4
chr5 Xrcc2  Rad51 57434 X-ray repair complementing defective repair in Chinese hamster cells 2-1.1 0.002 8.4 9.5 0.5
chr11 Rad51c 114714 Rad51 homolog c (S. cerevisiae) -0.4 0.083 7.6 8.0 0.8
chr12 Rad51l1 19363 RAD51-like 1 (S. cerevisiae) -0.2 0.769 7.5 7.7 0.9
chr11 Rad51l3 19364 RAD51-like 3 (S. cerevisiae) -0.2 0.626 7.5 7.8 0.9
chr11 Rpa1 68275 replication protein A1 -0.5 0.041 12.2 12.5 0.7
chr6 Rad52 19365 RAD52 homolog (S. cerevisiae) -0.3 0.153 11.6 11.9 0.8
chr9 Rad54l2 81000 Rad54 like 2 (S. cerevisiae) 0.4 0.102 10.4 10.1 1.3
chr4 Rad54l 19366 RAD54 like (S. cerevisiae) -0.7 0.011 12.3 13.0 0.6
chr17 Mdc1 240087 mediator of DNA damage checkpoint 1 0.2 0.004 9.8 9.6 1.1
chr19 Rad9 (53BP1) 19367 RAD9 homolog (S. pombe) -0.3 0.020 12.8 13.0 0.8
chr2 Dclre1c (Atrtemis) 227525 \DNA cross-link repair 1C, PSO2 homolog (S. cerevisiae)\""0.0 0.983 7.9 8.0 1.0
chr13 Xrcc4 (Ligase IV) 108138 X-ray repair complementing defective repair in Chinese hamster cells 40.0 0.889 9.9 10.0 1.0
chr7 Xrcc1  DNA lig3 22594 X-ray repair complementing defective repair in Chinese hamster cells 1-0.5 0.033 12.6 13.1 0.7
chr12 Xrcc3 HJ resolvase 74335 X-ray repair complementing defective repair in Chinese hamster cells 30.3 0.219 10.2 9.9 1.3
chr15 Rad1 19355 RAD1 homolog (S. pombe) 0.0 0.941 11.3 11.3 1.0
chr15 Rad21 19357 RAD21 homolog (S. pombe) 0.0 0.983 14.0 13.9 1.0
chr13 Rad17 19356 RAD17 homolog (S. pombe) -0.2 0.420 12.4 12.6 0.9
chr9 Rad54l2 81000 Rad54 like 2 (S. cerevisiae) 0.4 0.102 10.4 10.1 1.3
chr8 Rad23a 19358 RAD23a homolog (S. cerevisiae) 0.6 0.007 13.5 13.0 1.5
chr6 Rad18 58186 RAD18 homolog (S. cerevisiae) -0.8 0.002 11.1 11.9 0.6
chr5 Rad9b 231724 RAD9 homolog B (S. cerevisiae) 0.7 0.059 7.3 6.7 1.6
chr4 Rad54l 19366 RAD54 like (S. cerevisiae) -0.7 0.011 12.3 13.0 0.6
chr4 Rad23b 19359 RAD23b homolog (S. cerevisiae) -0.3 0.245 14.3 14.5 0.8
chr6 Rad52 19365 RAD52 homolog (S. cerevisiae) -0.3 0.153 11.6 11.9 0.8
chr11 Brca1 12189 breast cancer 1 -0.2 0.001 11.8 11.7 0.9
chr5 Brca2 12190 breast cancer 2 -0.3 0.002 11.0 11.3 0.8
1.0
chr9 Chek1 (Rad27) 12649 checkpoint kinase 1 homolog (S. pombe) -0.2 0.000 9.7 9.9 0.9
chr5 Chek2 (Rad53) 50883 CHK2 checkpoint homolog (S. pombe) -0.9 0.003 8.7 9.6 0.6
chr11 Trp53 22059 transformation related protein 53 0.9 0.002 13.8 12.9 1.9
chr19 Htatip (Tip60) 81601 \HIV-1 tat interactive protein, homolog (human)\"" -0.1 0.821 12.6 12.6 1.0
chr7 Htatip2 53415 \HIV-1 tat interactive protein 2, homolog (human)\"" 0.4 0.002 7.8 7.4 1.4
chr19 Ddb1 13194 damage specific DNA binding protein 1 -0.2 0.397 14.8 15.0 0.9
chr2 Ddb2 107986 damage specific DNA binding protein 2 0.5 0.103 10.1 9.7 1.4
chr8 Cul4a 99375 cullin 4A -0.5 0.031 13.4 13.9 0.7
chrX Cul4b 72584 cullin 4B -0.3 0.148 13.1 13.5 0.8
chr17 Rnf8 58230 ring finger protein 8 -0.8 0.003 11.5 12.2 0.6
chr16 Rnf168 70238 ring fnger protein 168 0.0 0.967 10.6 10.6 1.0
chr1 Smarcal1 54380 \Swi/SNF related matrix associated, actin dependent regulator of chromatin, subfamily a-like 1\""0.5 0.092 10.7 10.3 1.4
chr2 Inoc1 (Ino80) 68142 INO80 complex homolog 1 (S. cerevisiae) 0.1 0.871 11.1 11.0 1.0
chr3 Smarca3 Hltf 20585 \SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3\""-1.2 0.000 9.9 11.1 0.4
chr3 Smarca3 20585 \SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3\""-0.9 0.002 7.6 8.6 0.5
chr3 Chd1l (ALC1) 68058 chromodomain helicase DNA binding protein 1-like -1.5 0.000 10.9 12.3 0.3
chr6 Smarcad1 13990 \SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1`\""-0.5 0.051 10.5 10.9 0.7
chr8 Smarca5 Snf2h , WCRF135 93762 \SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5\""-0.5 0.059 13.4 13.9 0.7
chr9 Smarca4 (Brg) 20586 \SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4\""-0.2 0.504 13.4 13.5 0.9
chr19 Smarca2 (Brm) 67155 \SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2\""-0.1 0.827 13.6 13.6 1.0
chrX Smarca1  Snf2L 93761 \SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1\""-2.1 0.001 6.9 8.9 0.2
chr6 Chd4 107932 chromodomain helicase DNA binding protein 4 0.2 0.636 14.4 14.2 1.1
chr19 Ppp1ca 19045 \protein phosphatase 1, catalytic subunit, alpha isoform\"" -0.4 0.056 14.4 14.8 0.8
chr11 Ppp2ca 19052 \protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform\""0.0 0.924 12.7 12.7 1.0
chr7 Ppp4c 56420 \protein phosphatase 4, catalytic subunit\"" 0.2 0.477 14.2 14.0 1.1
chr2 Ppp6c 67857 \protein phosphatase 6, catalytic subunit\"" 0.5 0.057 13.4 12.9 1.4
chr11 Ppm1d (Wip1) 53892 \protein phosphatase 1D magnesium-dependent, delta isoform\""0.0 0.924 10.0 10.0 1.0
